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1.1. Introduction
Classical swine fever (CSF) is feared for the major impact that CSF epidemics can
have on the economy of the pig production sector, on the economy and welfare of
pig farmers, and on the welfare of pigs. After the large CSF epidemic in the
Netherlands in 1997 and 1998, which led to the killing and destruction of
approximately 12 million pigs, discussions were raised on the effectiveness of the
used control strategy and on the ethics of destroying for the most part healthy pigs.
The damage caused by CSF epidemics has to be reduced by preventing entry of
CSF virus (CSFV) into the domestic pig population, and by efficient control of
CSFV during CSF epidemics. Generally, prevention has to take account of the risk
of importing CSFV infected pigs, which made the virus enter the Netherlands in
1997 (Elbers et al., 1999; Fritzemeier et al., 2000; Sharpe et al., 2001; Taylor, 1995),
and of the two routes by which CSFV can enter a pig herd from outside the domestic
pig population. The first is swill feeding, which caused CSFV entry in many recent
CSF epidemics (Elbers et al., 1999; Fritzemeier et al., 2000; Sharpe et al., 2001;
Taylor, 1995), although it is not allowed by EU legislation (Anonymous, 2001). The
second is contact with infected wild boar, which has caused many CSF cases in
Germany and Italy (Sardinia) (Fritzemeier et al., 2000; Laddomada, 2000). It is tried
to control CSF in wild boar by hunting and by oral vaccination programs by means
of baits (Chenut et al., 1999; Kaden and Lange, 2001; Kaden et al., 2000;
Laddomada, 2000). Although prevention of virus entry is an important aspect of
CSF control, this thesis merely focuses on control of CSF epidemics after virus
entry.
In 1998, an STW(Technology Foundation)-funded project was started to carry
out research to improve the control of CSF epidemics in the Netherlands. The
project has focused on management and organisation of CSF epidemic control
(Crauwels et al., 2001; Crauwels et al., 2000), on the economics of CSF epidemics
(Mangen, 2002), and on the epidemiology of CSF. In this thesis, the epidemiological
research of the project is described. The goal of the epidemiological part was to
describe the transmission of CSFV within and between pig herds by means of
mathematical models, and to use these models to answer relevant questions
regarding CSF control.
Chapter 1 serves to describe the historical context of CSF control, which is the
basis of the current EU legislation on the control of CSF epidemics. In addition, it
points out the shortcomings of the current CSF control strategy and comes up with
two pillars of optimal control of CSF epidemics. First, preparation before epidemics
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to ensure quick and effective action upon CSFV detection, and second, information
during epidemics to enable steering of the control strategy for each epidemic
specifically. Both pillars need attention to minimise the damage of CSF epidemics.
Finally, the role of epidemiological research to contribute to improvement of control
of CSF epidemics is explained, and an overview of the remaining chapters in this
thesis is given.
1.2. Early history of CSF eradication
Many authors have described aspects of the history of classical swine fever
eradication (Beynon, 1969; Campbell, 1969; Dahle and Liess, 1992; Dunne, 1966;
Robijns, 1971; Saulmon, 1973; Taylor, 1995). Classical swine fever, also known as
hog cholera, was first reported in the 1830’s in Ohio, in the United States (Saulmon,
1973). The first European reports date from the 1860’s (Beynon, 1969; Saulmon,
1973) and the first case in the Netherlands was described in 1899 (Robijns, 1971). In
the beginning of the 20th century, the causative agent was shown to be a virus
(Campbell, 1969; Saulmon, 1973), which was quickly followed by the development
of the first vaccines, consisting of virus and serum (Saulmon, 1973). In 1936, the
crystal-violet (CV) vaccine was developed, which consisted of blood from infected
pigs in which the virus was inactivated by crystal-violet (Campbell, 1969; Saulmon,
1973). In the 1950’s, the first attenuated strains of CSF virus came into use as
modified-live vaccines (Dunne, 1966; Saulmon, 1973).
CSF caused great losses in affected farms, and therefore eradication of the virus
was desired. Great Britain started eradication already in 1879, by making CSF a
notifiable disease (Beynon, 1969; Dahle and Liess, 1992). Various control strategies
were used in the years after, like slaughter of infected pigs and their contacts, the use
of virus/serum vaccines, and isolation of infected herds (Beynon, 1969). In 1953, the
British implemented an officially-registered vaccination scheme with the CV
vaccine (Beynon, 1969; Campbell, 1969), but in 1963, it was realised that the best
eradication strategy would be by slaughter and disinfection of infected farms, and by
imposing an import ban for pigs and pig products from CSFV infected countries
(Beynon, 1969). Additional measures were tracing and killing of virus-exposed pigs,
and movement restrictions in infected areas. In 1964, vaccination was prohibited,
because it was believed that vaccinated herds could still become infectious and
because it made diagnosis of CSFV infections very complicated: vaccines interfered
with diagnostic tests and reduced clinical symptoms (Beynon, 1969; Campbell,
1969). In 1966, the last outbreak was detected before Great Britain was CSF free for
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the first time, although occasional small epidemics have occurred since (Beynon,
1969; Sharpe et al., 2001; Taylor, 1995).
The United States also had a negative experience with the use of vaccines, but
for other reasons than Great Britain. The US eradication program started in 1961,
but the use of modified-live vaccines hampered control seriously, because the
vaccines themselves caused about 30% of the outbreaks (Saulmon, 1973).
Therefore, as of 1968 more and more states prohibited the use of vaccines until
production of such vaccines in the US was completely stopped in 1971 (Saulmon,
1973). Another major problem of CSF eradication in the US appeared to be the
movement of infected swine, which repeatedly caused new infected areas (Saulmon,
1973). This led to federal quarantines on infected states and intensified control,
which in the end resulted in eradication of CSF in 1973 (Dahle and Liess, 1992).
In the Netherlands, CSF eradication was started in 1936 by making it a notifiable
disease. Isolation of infected farms was the only action upon CSF diagnosis until
1961, when slaughter of infected animals was added as a control measure (Robijns,
1971). The uninfected animals in infected farms were vaccinated with an attenuated
live vaccine in combination with a highly immune serum. In the subsequent years,
the control program was more and more intensified until in 1968, infected farms
were stamped out and disinfected, and vaccination was discouraged (Robijns, 1971).
Incidence decreased in those years, although CSF remained endemic in the
Ede/Barneveld region and virus introductions from abroad led to occasional
epidemics (Robijns, 1971). Vaccination was reintroduced as a control measure in
1973 (Terpstra, 1978; Terpstra and Robijns, 1977; Terpstra and Wensvoort, 1987),
because of the development of the C-strain attenuated vaccine and the notion that
eradication was impossible without European co-operation (Robijns, 1971). It
appeared possible to clear CSFV from an infected area by a massive vaccination
campaign, but new virus entries prevented keeping the areas CSFV free (Pensaert,
1978; Terpstra, 1978; Terpstra, 1988; Terpstra and Robijns, 1977).
1.3. CSF eradication in the EU
Because of the harmonisation of the free market within the European Community,
the joining of the CSF free countries Great Britain, Ireland and Denmark to the EC
in 1973 had to lead to a community CSF policy (Dahle and Liess, 1992; Edwards et
al., 2000; Vandeputte and Chappuis, 1999). In 1980, EC legislation was
implemented to reach the CSF-free status for all EC countries (Anonymous, 1980).
The European non-vaccination policy is based on the distinction of health
statuses (Van Oirschot, 1994). It is directly derived from the International Animal
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Health Code (IAHC) of the OIE, which serves to regulate international trade (OIE,
2002; OIE is the International Office of Epizootics). The IAHC gives the highest
health status to regions with an uninfected and unvaccinated pig population. Those
regions are economically the most profitable, because they are allowed to refuse
animal imports from regions with a lower health status. In accordance with the
IAHC, the EC legislation states that regions are declared CSF free for the first time
if no vaccinated animals are present, and no disease has been detected and no
vaccination has been applied in the past 12 months (Vandeputte and Chappuis,
1999). If CSF outbreaks are diagnosed in these CSF free areas, they have to be
followed by thorough surveillance before an area can be declared CSF free again,
and the 12-month delay is not needed.
Immediately after implementation of the EC legislation, all countries with CSF
started eradication programs, in which increased surveillance and mass vaccination
of heavily infected regions with the C-strain vaccine were the most important
measures (Pittler, 1986; Vandeputte and Chappuis, 1999). Vaccination was stopped
if no disease was detected anymore. By this eradication program, the Netherlands
became CSF free in 1986 (Terpstra, 1988; Terpstra et al., 2000; Vandeputte and
Chappuis, 1999).
Although vaccination in the CSF eradication campaigns in Great Britain and the
USA seemed to hamper eradication, it appeared a successful strategy in the EC in
the 1980’s. This can be attributed to the fact that vaccination campaigns should
reduce virus transmission to achieve eradication, whereas vaccines were often
judged by their capability to reduce clinical disease. In the British and American
campaigns, the vaccination programs probably did not reduce virus transmission
sufficiently, as the inactivated crystal-violet vaccine (used in Britain) could not
prevent outbreaks and the modified-live vaccines (used in the USA) even caused
outbreaks themselves (Campbell, 1969; Dunne, 1966). Then, obviously, vaccination
even frustrates eradication because it hampers detection (Beynon, 1969; Campbell,
1969; Dunne, 1966). In the European campaigns in the 1980’s, the used C-strain
vaccine was able to inhibit virus multiplication in tonsils (Biront et al., 1987; Taylor,
1995) and to stop virus spread, thereby causing CSFV eradication with full
vaccination coverage in affected areas (Terpstra, 1988; Terpstra and Wensvoort,
1987; Vandeputte and Chappuis, 1999). To put it in epidemiological terminology,
the European vaccination campaigns succeeded in reducing the reproduction ratio
between herds Rh (the average number of herds infected by one typical infectious
herds) to below the threshold value 1, which ascertains extinction of the disease.
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1.4. Current CSF control in the EU (2002)
Maintenance of an uninfected pig population in the European Union has not been
easy up to now (Vagsholm, 1996). Epidemics have, for instance, occurred in the UK
in 1971, 1986 and 2001 (Sharpe et al., 2001; Taylor, 1995; Williams and Matthews,
1988), in Belgium in 1993/1994 (Koenen et al., 1996), in Germany in 1994
(Staubach et al., 1997), and in the Netherlands in 1997/1998 (Moennig, 2000;
Stegeman et al., 2000; Vandeputte and Chappuis, 1999). The Dutch epidemic had
originated in Germany and led to some cases in Belgium, Italy, and Spain (Edwards
et al., 2000; Elbers et al., 1999; Mintiens et al., 2001; Moennig, 2000; Terpstra et al.,
2000; Vandeputte and Chappuis, 1999). Furthermore, in Germany and Italy
(Sardinia) many cases occurred in the 1990’s due to contact of domestic pigs with
infected wild boar (Fritzemeier et al., 2000; Laddomada, 2000).
CSF epidemics in the EU are controlled by use of EU-prescribed control
measures (Anonymous, 2001; Edwards et al., 2000; Stegeman et al., 2000;
Vandeputte and Chappuis, 1999). According to these control measures, infected
herds are stamped out and protection and surveillance zones are installed in areas of
3 and 10 km around the infected herds, respectively. In these zones a transport ban is
imposed, and in the protection zone each herd has to be inspected clinically within 7
days. Furthermore, the infectious contacts of the detected herds are traced, so as to
determine the possible sources of infection and to find out which herds might have
been infected by the detected herds. Before declaring the surveillance zone CSF
free, each herd has to be inspected and serologically tested to exclude CSFV
infection.
In addition to the EU-prescribed control measures, preventive slaughter was
applied during some CSF epidemics, namely, the Belgian 1993/1994 epidemic, the
German 1994 epidemic, and – though not immediately – during the Dutch
1997/1998 epidemic (Koenen et al., 1996; Staubach et al., 1997; Stegeman et al.,
2000; Vandeputte and Chappuis, 1999). Subject to preventive slaughter were not
only herds with traced contacts with infected herds, but also herds located within 1
km of detected herds, because it appeared that neighbouring herds had an increased
probability of being infected (Koenen et al., 1996; Staubach et al., 1997; Stegeman
et al., 2000; Terpstra et al., 2000; Vandeputte and Chappuis, 1999).
The experience of the CSF epidemics in the 1990’s, especially the Dutch
epidemic in 1997/1998, has revealed that CSF control is still a problem (Edwards et
al., 2000). The direct costs of the control program can become very high if the
epidemic takes long, and the indirect costs due to trade restrictions can even be
much higher (Mangen et al., 2002; Meuwissen et al., 1999; Saatkamp et al., 2000).
Also, during an epidemic, many animals are killed and destroyed, animals from
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infected herds, animals from preventively slaughtered herds (if preventive slaughter
is applied), but also animals from uninfected herds because of welfare slaughter
(Stegeman et al., 2000; Terpstra et al., 2000). Aside from the economic loss
(destruction of capital), destruction of animals from probably uninfected farms
raises ethical concerns and is questioned by the public opinion (Saatkamp et al.,
2000; Terpstra et al., 2000; Van Oirschot, 1994). Finally, farmers suffer the
uncertainty and stress caused by an epidemic (Terpstra et al., 2000).
1.5. CSF control in the future
Because CSF is still endemic in wild boar in regions in the EU, and because the last
decade has shown that swill feeding still causes CSF outbreaks every now and then,
it is important to be as well-prepared as possible to new CSF epidemics. The
harmful consequences of CSF epidemics are minimal when the number of
slaughtered farms is kept as small as possible and when the duration of the epidemic
is reduced. Optimal control of CSF epidemics rests on two pillars:
1. Preparation. As soon as CSF is diagnosed, it is essential to act quickly and
adequately. Therefore, the control organisation has to be clear on all
management levels, from government to surveillance teams. It must also be
clear which control measures are compulsory, and which are optional.
Knowledge on the likely effect of specific control strategies, epidemiological as
well as economic, is of great importance for quick and adequate action. In this
light, a high level of agreement on the possible control strategies by all parties
involved, e.g. the farmers, the veterinarians, and the general public, will be the
ultimate goal of the preparation.
2. Information. Each CSF epidemic is unique in factors like virus strain, location
of infected herds, and random effects. In spite of all preparation, during each
ongoing epidemic information is needed for steering the control. For instance,
contact tracing must reveal information about possibly infected farms, to enable
a quicker detection. On the strategic level, where the decisions are made on the
control strategy, the overall effectiveness of the current control strategy needs to
be evaluated to decide upon the change of the strategy. Essential for good
execution of the control program is clear communication to all parties involved,
in order to explain why certain control measures are taken.
Both pillars have been addressed in the STW-funded project, started to improve
the control of CSF epidemics after CSFV enters the domestic pig population. Also in
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the present thesis, which describes the epidemiological part of the project,
contributions are made to both preparation to epidemics and information during
epidemics:
1. Preparation.
During the Dutch CSF epidemic in 1997/1998, the basic set of EU-prescribed
control measures appeared insufficient, which made the use of preventive slaughter
as an additional measure necessary (Stegeman et al., 2000; Stegeman et al., 1999b).
Vaccination was not an option: because the European legislation considered
vaccinated pigs as CSFV-infected, it would have taken much longer before the
affected areas were officially virus-free, unless the vaccinated animals were
slaughtered at the end (Vagsholm, 1996). In the last decade, two E2 subunit marker
vaccines have been developed, vaccines with an accompanying diagnostic test to
establish CSFV infection through serology (Hulst et al., 1993; Moormann et al.,
2000; Moormann et al., 1997; Van Oirschot, 1994; Van Oirschot, 1999). In the most
recent EU CSF legislation (Anonymous, 2001), the use of marker vaccines is taken
into account, thereby making the option to use emergency vaccination and market
the meat of vaccinated pigs under strict conditions more realistic.
Four chapters of this thesis deal with research carried out to quantify the
effectiveness of the E2 subunit marker vaccines during CSF epidemics (Hulst et al.,
1993; Moormann et al., 2000; Moormann et al., 1997). Chapters two, three, and four
discuss transmission experiments, in which CSFV transmission was studied. In
transmission experiments, some virus-infected animals are housed together with
uninfected contact animals (Bouma et al., 1996; Bouma et al., 2000; De Jong and
Kimman, 1994; Kroese and De Jong, 2001). Subsequently, CSFV transmission is
followed in time by several diagnostic tests, like virus isolation on blood samples, or
serological tests to examine the virus-induced antibody response.
A mathematical model of pathogen transmission, the so-called SIR (susceptible-
infectious-removed) model (cf. Anderson and May, 1991; Diekmann and
Heesterbeek, 2000; Kermack and McKendrick, 1991), is used for statistical
inference, for example, to test the effectiveness of vaccination or to estimate the
reproduction ratio between individual animals Ri. Ri is an important epidemiological
parameter and is defined – comparable to Rh on herd level – as the average number
of animals that is infected by one typical infectious animal in an infinite, susceptible
population (cf. Anderson and May, 1991; Diekmann and Heesterbeek, 2000). Ri has
an important threshold property: only if it is larger than 1, epidemics can occur,
otherwise the disease will certainly die out. By statistical inference on Ri, the
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effectiveness of vaccination in experiments can be extrapolated to the effectiveness
in larger populations, like groups of pigs in pig farms.
- The second chapter describes a method to estimate Ri from transmission
experiments with CSFV. The method is illustrated by using previously
published CSFV transmission experiments. The method is also used in chapters
3 (though slightly altered) and 4, which describe the analysis of CSFV
transmission experiments to test the E2 vaccine.
- In the third chapter, a series of experiments with two different E2 vaccines is
analysed. The experiments were carried out to determine how long the vaccines
take to achieve an Ri smaller than 1 and to establish whether the vaccines are
equally effective.
- The fourth chapter describes a transmission experiment, in which the effect of
maternal antibodies on the effectiveness of vaccination is investigated, when
piglets are vaccinated at the age of two weeks. This is an important issue, since
maternal antibodies are known to inhibit the active immune response upon
vaccination with the C-strain vaccine (Biront et al., 1987; Precausta et al., 1978;
Precausta et al., 1983; Terpstra and Tielen, 1976; Terpstra and Wensvoort,
1987).
Whereas chapters 2 through 4 deal with virus transmission within groups of pigs,
chapter five extrapolates the results to CSFV transmission between pig herds:
- In chapter 5, various vaccination strategies are compared in a mathematical
model of CSFV transmission between pig herds. The model describes the virus
transmission in the context of the basic EU control measures during the
1997/1998 Dutch epidemic. Control strategies are compared with respect to the
average duration of epidemics and the average number of infected herds. Tested
control measures include vaccination of finishing herds and of piglets in
multiplier herds. Furthermore, the epidemiological consequences of a limited
transport permission to continue production and do away with welfare problems
are considered.
2. Information.
Aside from the general research into transmission dynamics of CSFV and the
effectiveness of control measures and control scenarios, mathematical
epidemiological models can also be used to interpret epidemiological data in
ongoing epidemics:
- In chapter 6, a previously published method to analyse simple epidemiological
data (Meester et al., 2002) is tested with simulated epidemics. The method is
based on a branching process model to describe CSFV transmission between
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pig herds, and the only data that is needed is the number of detected herds per
week. It is tested whether the model parameters can be accurately estimated,
and whether the method is able to give an unbiased estimate for the number of
undetected infected herds during an epidemic.
3. Concluding chapter
- The thesis concludes with a chapter (chapter 7) on the use of the E2 subunit
vaccines in an emergency vaccination campaign. The relevant publications are
discussed and two potential problems are recognised, relating to vertical
transmission of CSFV (from sow to the unborn foetus) and to the serological
endscreening after the epidemic. The chapter gives possible solutions to both
problems and concludes that emergency vaccination with the E2 vaccines can
be a successful control measure.

Chapter 2
Within- and between-pen transmission of
classical swine fever virus: a new method to
estimate the basic reproduction ratio from
transmission experiments
D. Klinkenberg, J. de Bree, H. Laevens, M.C.M. de Jong
Reprinted from Epidemiology & Infection, Vol 128, Pages 293-299, Copyright
(2002), with permission from Cambridge University Press
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Abstract
We present a method to estimate basic reproduction ratio 0R  from transmission
experiments. By using previously published data of experiments with Classical
Swine Fever Virus more extensively, we obtained smaller confidence intervals than
the martingale method used in the original papers. Moreover, our method allows
simultaneous estimation of a reproduction ratio within pens wR0  and a modified
reproduction ratio between pens bR0′ . Resulting estimates of wR0  and bR0′  for
weaner pigs were 100 (95% CI 54.4-186) and 7.77 (4.68-12.9), respectively. For
slaughter pigs they were 15.5 (6.20-38.7) and 3.39 (1.54-7.45), respectively. We
believe, because of the smaller confidence intervals we were able to obtain, that the
method presented here is better suited for use in future experiments.
2.1. Introduction
Classical Swine Fever (CSF) or hog cholera is a highly contagious pig disease
(Dahle and Liess, 1992; Taylor, 1995; Terpstra, 1987), an epidemic of which can
cause huge problems like reduction in animal welfare, and high economic losses as a
result of export limitations and mass destruction (Meuwissen et al., 1999). The
disease is caused by the Classical Swine Fever Virus (CSFV) (Dahle and Liess,
1992; Taylor, 1995; Terpstra, 1987). Transmission of the virus between pigs can be
quantified by estimating parameters from transmission experiments, in which a
number of pigs within a pen are inoculated with the virus and the transmission
process is followed (De Jong and Kimman, 1994). An important parameter of virus
transmission is the basic reproduction ratio 0R , defined as the number of secondary
infected individuals caused by one typical infectious individual in an infinite
susceptible population. If 0R  is smaller than 1, then on average every infectious
animal infects less than one other animal causing the outbreak to wane. If on the
other hand 0R  is greater than 1, major outbreaks can occur (Anderson and May,
1979).
In 1998 and 1999 Laevens et al. did two transmission experiments with CSFV;
one with weaner pigs and the other with slaughter pigs (Laevens et al., 1998;
Laevens et al., 1999). In both experiments there were 3 adjacent pens with either 15
weaner pigs or 6 slaughter pigs in each pen. In the middle pen one pig was
inoculated with CSFV and every 2 days blood samples of all the pigs were taken to
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measure viraemia. From these measurements the infectious period of every pig was
reconstructed by assuming that a pig is infectious when it is viraemic. Subsequently
0R  was estimated using the martingale estimation method, based on the stochastic
SIR model (Becker, 1989; De Jong and Kimman, 1994). This model describes
transmission of a virus in a group of animals by describing the change in the
numbers of susceptible (S) and infectious (I) animals in terms of these numbers and
the total number of animals (N). In the model, infection of susceptible animals and
recovery of infectious animals are assumed to be generated by a Poisson process
with rates NSIβ  and Iα , where β  and α  are the transmission and recovery
parameter, respectively. The 0R  is estimated from the number of animals ultimately
infected during the experiment, when no susceptible or no infectious animals
remain. The sum of the fractions of infectious periods remaining when the last
susceptible animal is infected is used if relevant. Laevens et al. (1998; 1999) used
only the data of the middle pen to estimate 0R  because in the other pens
transmission was not solely caused by infectious animals in the same pen. The
estimates obtained were 81.3 (s.e. 109, i.e., 95% CI: –132-295) and 13.7 (s.e. 13.7,
i.e., 95% CI: –13.2-40.6) for weaner and slaughter pigs, respectively. This meant
that despite the fact that the infection process took place very quickly and all
animals were infected, the estimated 0R s were not significantly greater than 1.
Since some aspects of the data were not used for the estimation (infection times and
infectious periods of all animals known for all three pens), searching for an
alternative estimation method would be worthwhile, using as much information
from the data as possible. Hopefully this will lead to a smaller confidence interval.
In an attempt to obtain an 0R  estimate with a smaller confidence interval, we did
separate estimations of β , the infectivity parameter, and α, the recovery parameter,
which are used to calculate 0R  ( αβ=0R ). For β  estimation, the infection
process was partitioned into intervals with known numbers of infection cases (C)
and susceptible (S) and infectious (I) animals. These sets of (S, I, C) were used to
construct a likelihood function, which we maximised to get a maximum likelihood
estimator for β . For α  estimation, the lengths of the infectious periods were used
to fit a generalised linear model.
2.2. Materials and methods
We used the data obtained in the transmission experiments of Laevens et al (for
more detail see Laevens et al. (1998; 1999)). In both experiments there were three
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adjacent pens with equal numbers of pigs: 15 weaner pigs in one experiment and 6
slaughter pigs in the other. One of the pigs in the middle pen was inoculated with
CSFV and every two days blood samples were taken from all animals, which were
tested for viraemia. From this data the infectious period of each pig was
reconstructed, assuming that the animal is infectious when it is viraemic.
By assuming a latent period of 6 days (infected but not yet infectious) (Taylor,
1995), we were able to reconstruct the entire virus transmission process in the three
pens. These reconstructions enabled us to estimate the parameters, by using the
following stochastic SIR model (Anderson and May, 1979), incorporating both
within- and between-pen transmission:
( ) ( )SNINISSrate bbbwww ββ +=−→ 1 (2.1)
( ) IIIrate α=−→ 1 . (2.2)
In this model, wβ  is the within-pen transmission parameter defined as the expected
number of new infections in the same pen per day per typical infectious animal in a
fully susceptible population. Likewise, bβ  is the between-pen transmission
parameter defined as the expected number of new infections in other pens per day
per typical infectious animal in a fully susceptible population. The parameter α
represents the recovery rate per infectious animal. Because there are two
transmission parameters wβ  and bβ , we also make a distinction between a within-
pen reproduction ratio wR0  and a between-pen reproduction ratio bR0 . wR0  is
defined as the expected number of secondary infected animals caused by one typical
infectious animal in the same pen. bR0  is defined as the expected number of
secondary infected pens caused by one typical infectious pen, considering a pen as
infected when at least one pig is infected. Estimates for wR0  and bR0  can be
calculated as follows:
α
βw
wR =0 (2.3)
( ) ( )totbtotbb IEIERR ⋅=⋅′= α
β
00 . (2.4)
In this equation, ( )totIE  is the expected number of animals ultimately infected
within one pen. ( )totIE  can under our model assumptions easily be determined if
wR0  is known (Diekmann and Heesterbeek, 2000), but will not be further discussed
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in this paper. bR0′  is the expected number of secondary infected pens caused by one
typical infectious animal. bR0′ , being independent of ( )totIE , is the parameter that
will be estimated in this paper. For notational convenience, we have introduced the
vectors βr ( )bw ββ ,= , βrlog ( )bw ββ log,log= , 0Rr ( )bw RR 00 , ′= , and
0log R
r ( )bw RR 00 log,log ′= . Because infection and recovery are independent
processes, 0R
r
 was calculated from separate estimations of βr  and α .
In order to estimate transmission parameters βr , the infection process has been
divided into time intervals of two days, the intervals between two subsequent
samplings. For each interval, the number of susceptible pigs at the start of the
interval (S), the number of infectious pigs (I) and the number of new cases (C) was
determined (Table 2.1). In each time interval k, the probability of a susceptible
animal escaping infection from the constant rate ( )bkbkbwkwkw NINI ββ +  is,
according to the Poisson distribution, ( )bkbkbwkwkw NINIe ββ +− . Therefore, the probability
of getting Ck cases, with Sk susceptibles and ik as the fraction of infectious pigs
(Ik/Nk) in the same pen and jk as the fraction of infectious pigs in the other pens is,
according to the binomial distribution:
( ) ( ) ( ) kkkbkwkkbkw CSjiCji
k
k
kkkk eeC
S
SjiCprob
−−−−−−


= ββββ1,, . (2.5)
The probabilities for all time intervals have been used to make up the log-likelihood
function, which may be written as:
( ) ( ) ( )[ ]∑ +−−= +
k
kbkwk
ji
kbw jiSeCL kbkw ββββ ββ 1log,log , (2.6)
where 



k
k
C
S
log  has been omitted because it plays no role. Maximising this function
results in maximum likelihood estimators for wβ  and bβ .
Three methods were used to derive confidence intervals for wβ . After
comparing several features (e.g. mathematical background, practical value), a
decision was made as to which method should be used for interval estimation of bβ ,
wR0  and bR0′ . The first method, which we shall refer to as the construction method,
is based on the likelihood ratio and on the equivalence of testing and construction of
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a confidence interval. The test used here is derived from the observation that the
likelihood ratio for testing one value of wβ  (H0: 0ββ =w ) against another value of
wβ  (HA: 0βββ <′=w ) is a monotonic and decreasing function of each C. It
allowed us to construct a critical region for the C by using the probability function
of C itself, without invoking any approximate probability distribution of the
likelihood ratio. For details, see the appendix. With this method confidence intervals
can be constructed for one of the two β s ( wβ  or bβ ) treating the other as a
constant at its estimate. Unfortunately, the computation is almost prohibitively time-
Table 2.1. Course of transmission experiments
Time (days): 4-6 6-8 8-10 10-12 12-14 14-16 16-18 18-20 20-22 22-24
Weaner pigs
pen 1 S 15 15 15 15 13 7 4 2
I 0 0 0 0 0 0 1 5
C 0 0 0 2 6 3 2 2
N 15 15 15 15 15 15 15 15
pen 2 S 14 5 0 0 0 0 0 0
I 1 1 1 5.5 12 11.5 10 10
C 9 5 0 0 0 0 0 0
N 15 15 15 15 14.5 11.5 10 10
pen 3 S 13 13 13 13 6 3 1 0
I 0 0 0 0 0 0 3.5 8.5
C 0 0 0 7 3 2 1 0
N 14 14 14 14 13 13 13 13
Slaughter pigs
pen 1 S 5 5 5 5 5 4 4 3 1 1
I 0 0 0 0 0 0 0 0.5 1 1.5
C 0 0 0 0 1 0 1 2 0 1
N 6 6 6 6 6 6 6 6 5 5
pen 2 S 5 4 3 1 0 0 0 0 0 0
I 0.5 1 1 1 1.5 3 4.5 5 4.5 4
C 1 1 2 1 0 0 0 0 0 0
N 6 6 6 6 6 6 6 6 6 6
pen 3 S 6 6 6 6 6 6 6 2 0 0
I 0 0 0 0 0 0 0 0 0 2
C 0 0 0 0 0 0 4 2 0 0
N 6 6 6 6 6 6 6 6 6 6
Division of the virus transmission process in two-day time periods, stratified by pen.
Time starts at day of inoculation. S is the number of susceptible animals at the start of the
interval; I is the number of infectious animals; C is the number of new cases and N is the
total number of animals, where 0.5 is an animal present for only one of two days in a
certain category.
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consuming, and just how to construct a confidence area for the parameter vector βr
or how to determine confidence intervals for 0R  is not clear. The second method is
the likelihood ratio ( λ ) test as described by Neyman & Pearson (reference in
Birkes, 1998), which relies on the asymptotic chi-square distribution of λlog2−
with, in our case, 1 degree of freedom. This method calculates 95% confidence
limits by solving the equation 84.3log2 =− λ  for one of the two β s ( wβ  or bβ )
treating the other as a constant at its estimate. This is a much faster method than the
first one; nonetheless it suffers from the same construction difficulties with regard to
simultaneous confidence intervals. The third method is based on the asymptotic
(multivariate) normal distribution of a maximum likelihood estimator (Beaumont,
1980). The assumption is made that the estimator of βrlog  (instead of βr ), being
also a ML-estimator, is asymptotically normally distributed because then non-
realistic (negative) values of wβ  and bβ  cannot occur. This results in the following
covariance matrix M:
( ) ( )( )
( )( ) ( )
1
222
222
logloglogloglog
logloglogloglogM
−




∂∂∂∂
∂∂∂∂−=
bbw
bww
LL
LL
βββ
βββ  . (2.7)
This method is computationally fast and, since it provides an estimate of the
covariance matrix, it obviously enables construction of confidence areas for βrlog
and 0log R
r
 1.
The recovery/death rate parameter α  has been estimated using a generalised
linear model for survival analysis with censoring, as described by Aitken et al.
(1989). In this model for each animal two explanatory variables kT  and ky  can be
observed. The first one, kT , is the observed length of the infectious period. The
second one, ky , is a censoring variable: ky  is 1 if kT  is the true survival time,
                                                          
1 Note that, if only one transmission parameter is estimated, this likelihood variance
method is in fact the same as a generalised linear model with response variate C,
binomially distributed with index S, and a complementary log-log LINK function,
and ( )NIlog  as offset. Because in this case we want to estimate two transmission
parameters simultaneously, it is not possible to use this GLM.
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whereas ky  is 0 if the true survival time is greater than kT . The likelihood function
reads as follows:
( ) ( ) ( ) ( ) ∏∏∏∏
==
−
=
−
=
−−− === n
k
y
k
n
k
Ty
k
n
k
Ty
n
k
yTyT kkkkkkkkk TeTeeeL
1111
1 αααα αααα . (2.8)
The kernel of this likelihood is the same as it would be with a set of n observations
ky  each having an independent Poisson distribution with mean kTα  (see Aitkin et
al., 1989). The analysis was performed in Genstat (1998), using the RSURVIVAL
procedure, where ky  denotes the response variate, kTlog  the offset, and the model
is fitted with a log LINK function and a Poisson distribution. The output is an
estimate of αlog  and its estimated variance.
The estimator of 0log R
r
 is given by:
αβ logloglog 0 −=R rr . (2.9)
Derivation of a confidence area for 0log R
r
 is done by adding the covariance matrices
for βrlog  and αlog :
( ) ( ) ( ) 


+=
11
11
logvarlogvarlogvar 0 αβrrR . (2.10)
The estimated 0log R
r
s and ( )0logvar Rr s for weaner and slaughter pigs were used to
construct a confidence area for the difference of the two 0log R
r
s, and to assess
whether wR0  or bR0′  differ significantly between weaner and slaughter pigs.
2.3. Results
The maximum likelihood estimation method used to estimate transmission
parameters wβ  and bβ  produced point estimates of 8.52 and 0.656 for weaner pigs
and 1.85 and 0.402 for slaughter pigs, respectively. Three methods were used to
determine 95% confidence intervals for wβ . With the construction method based on
the likelihood ratio λ , the intervals for wβ  obtained were (4.77-14.1) and
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(0.704-3.63) for weaner pigs and slaughter pigs, respectively. With the λlog
method the intervals were (4.78-14.1) and (0.709-3.79), respectively, and the
likelihood variance method produced intervals of (4.98-14.6) and (0.817-4.18).
Because the construction method does not assume specific distributions based on
asymptotic features, we believe that the estimated confidence intervals from this
method would be the most precise. The λlog  method, which is much faster than the
numerical method, performed quite well, while the likelihood variance method
resulted in slightly upwards shifted intervals. However, we decided to use this last-
mentioned method for further calculations, because the obtained covariance matrices
for βr  together with the variances for α  can be used to estimate covariance matrices
for 0R
r
.
The covariance matrices M of βrlog  thus calculated were:




−
−=
0438.000128.0
00128.00752.0
weanerM (2.11)




−
−=
118.00132.0
0132.0175.0
slaughterM (2.12)
To compare the estimated βrlog s of weaner and slaughter pigs, the difference of the
two was calculated ( βrlog∆ ), together with the accompanying covariance matrix,
Figure 2.1. Shaded area is the 95% confidence area for βrlog∆
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Mweaner + Mslaughter. The 95% confidence area of this difference in figure 2.1 shows
that this area does not cross the line 0log =∆ wβ  and therefore the wβlog s of
weaner and slaughter pigs differ significantly. This is not the case for the bβlog s.
Estimation of recovery parameter α  resulted in a αlog  for weaner pigs of –2.47
with variance 0.0231 and for slaughter pigs of –2.13 with variance 0.0433.
Estimation of 0log R
r
 resulted in these vectors and covariance matrices:



=
05.2
61.4
log 0weanerR
r
 and covariance matrix 



0669.00218.0
0218.00983.0
(2.13)



=
22.1
74.2
log 0slaughterR
r
 and covariance matrix 



162.00300.0
0300.0218.0
(2.14)
This means that the estimated wR0  and bR0′  for weaner pigs were 100 (CI 54.4-186)
and 7.77 (CI 4.68-12.9), and for slaughter pigs 15.5 (CI 6.20-38.7) and 3.39 (CI
1.54-7.45), respectively. Testing whether weanerR0log
r
 differs from slaughterR0log
r
 has
been done by calculating the difference and accompanying covariance matrix, and
subsequently plotting the 95% confidence area (Figure 2.2). It illustrates that the
confidence area does not cross the line 0log 0 =∆ wR , but does cross the line
0log 0 =′∆ bR . Therefore, the conclusion is that wR0  differs between weaner and
slaughter pigs, but bR0′  does not.
Figure 2.2: Shaded area is the 95% confidence area for 0log R
r∆
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2.4. Discussion
The maximum likelihood method presented in this paper resulted in a much smaller
confidence interval of wR0  than the martingale method (Laevens et al., 1998;
Laevens et al., 1999). This was probably due to the more extensive use of the data,
by dividing the virus transmission process into intervals with known numbers of
new cases and susceptible and infectious pigs. Also, the maximum likelihood
method uses data from all the pens, in contrast with the martingale method, which
only uses the data of the middle (the primarily infected) pen. We are convinced that
the method presented here is more suitable to be used in data analysis of future
experiments.
Three different methods were used to calculate confidence intervals for wβ : a
construction method based on the likelihood ratio λ , the λlog  method, and the
likelihood variance method. The construction method is not based on asymptotic
features (i.e. many data points), and is in this sense a reliable method. However, its
disadvantages were that the calculation time was long, it was impossible to construct
a confidence area for two parameters ( wβ  and bβ ) simultaneously, and it was not
possible to use the results to construct intervals for 0R . The other two methods are
based on asymptotic features of the λlog2−  and of the likelihood function itself.
Both of these methods are fast. The advantage of the λlog  method is that it uses the
likelihood ratio, just like the construction method, and that the results are very
similar. The advantage of the likelihood variance method, however, is that it allows
derivation of confidence areas for wβ  and bβ  simultaneously and that the estimated
variances can be used to obtain variances of the 0log R
r
 estimates. That is why this
likelihood variance method is used to estimate variances for bβ  and 0log Rr  as well.
With the maximum likelihood method presented in this paper, the wR0  and bR0′
appeared to be significantly greater than 1 for both weaner and slaughter pigs. This
conclusion could not be made from the martingale estimation, but was expected
because of the large outbreak in both experiments (all animals infected) and the
ability of the virus to cause CSF epidemics.
A more surprising result was the significant difference between the two age
groups: the wR0  of weaner pigs is larger than the wR0  of slaughter pigs. This can be
due to several causes, which should be judged by the fact that the bR0′ s do not differ.
First, the resistance to infection in younger pigs could be lower (higher
susceptibility). Second, the smaller volume of younger pigs could be responsible for
a higher virus concentration in the animals and consequently a higher virus excretion
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(higher infectiousness). Third, weaner pigs might have more intensive contacts with
each other, which is the most probable cause, because the first two mentioned would
also result in higher bR0′ s. However, it is also possible that the bR0′ s do differ, but
that this was not observed in these experiments.
From an epidemiological point of view, the difference between the groups can be
important because virus transmission in units with younger pigs (weaner pigs in a
sow herd) will be quicker than in units with older pigs (in a finishing herd).
Therefore it is important to know whether this difference exists with other CSF
strains as well. If the difference is mainly due to more intensive animal contacts, this
is to be expected.
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Appendix 2.
Here a numerical method is derived to construct confidence intervals (CI) for the
transmission parameters βr . To keep the derivation more orderly, it is shown here
for only one transmission parameter β , as if there were only within-pen
transmission. When the other parameter is kept constant, as in the examples in the
text, the derivation is similar. The log-likelihood equation with one parameter β  is,
analogous to (2.6):
( ) ( ) ( )[ ]∑ −−=
k
kk
i
k iSeCL k ββ β 1loglog (2.15)
Now, with the equivalence of testing and CI construction in mind, a test is suggested
of H0: 0ββ = , against HA: 0βββ <′= . Then, letting β ′  tend to 0β , a test will be
obtained to test 0β  against any 0ββ <′ . This test can be used to construct an upper
limit of a confidence interval. A similar procedure is followed for the lower limit.
The test, Φ , is based on the likelihood ratio ( λ ) (Lehmann, 1959):


<
≥=Φ
d
d
λ
λ
log if 0
log if 1
, (2.16)
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where d is determined by ( ) 05.0
0
=ΦβE  (for a 95% CI). H0 is rejected when Φ = 1
and H0 is not rejected when Φ = 0. In (2.16), λlog  is:
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Observe that λlog  is monotonically decreasing in every Cjk:
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jljk eig
βββ −
=
−+= ∑ 1log)(  is a monotonic and increasing
function of β .
Hence, λlog  can be used to construct a test for 0ββ <′ .
The test is constructed for any 0ββ <′  (upper limit) by letting β ′  tend to 0β
( 0ββ ↑′ ), which results in:
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which determines the form of the test for the upper limit (since all other factors are
independent of 0β ):
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For the case 0ββ >′  (lower limit), the derivation is the same, except for the
inequality signs in formula (2.19), which are switched.
The test is used for an iterative search of that 0β  for which holds:
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Abstract
This paper presents a more comprehensive analysis of a previously published
Classical Swine Fever Virus (CSFV) transmission experiment. In the experiment,
two E2 subunit marker vaccines, one from Bayer, Germany (A) and one from
Intervet, the Netherlands (B), had been tested to establish the time interval between
vaccination and protection against horizontal virus transmission. The original
analysis led to the conclusion that the vaccines mutually differed and that they
reduced transmission as from 14 days after vaccination with either vaccine. In the
analysis, however, virus transmission was not quantified. Therefore, it did not allow
for extrapolation of the results to larger populations. Because the expected vaccine
effectiveness on population level will be important for the decision to use
emergency vaccination during a CSFV epidemic or not, a more comprehensive
analysis was deemed necessary. The new analysis tested the vaccines in their ability
to decrease the basic reproduction ratio R0, which is defined as the average number
of susceptible animals that will be infected by one infectious animal in a susceptible
population. An important property of R0 is its threshold value 1: if R0 < 1, no
epidemics can occur. Two methods for analysis were used. The first method, the
final size method, determined for each tested vaccination-challenge interval whether
R0 was significantly reduced. It appeared that R0 was significantly reduced after 14
days with vaccine A and after 21 days with vaccine B. The second method, the
entire course method, was used to determine the time the vaccines needed to bring
R0 below 1, and to determine R0 in an unvaccinated and in a vaccinated population.
With both vaccines R0 was significantly smaller than 1 after three weeks. In an
unvaccinated population, R0 was estimated at 9.9. Vaccine A let R0 decrease to
0.047, whereas vaccine B reduced R0 to 0.41. Although R0 with vaccine A
significantly differed from R0 with vaccine B, stochastic simulations showed that
either vaccine will limit most CSFV outbreaks in a pig unit of 100 pigs to only one
infected pig (95% CI with vaccine A: 1-2; with vaccine B: 1-6).
3.1. Introduction
Classical swine fever (CSF, syn. hog cholera) is an infectious disease of swine,
caused by the CSF virus (CSFV) (for more general information, cf. Taylor, 1995;
Van Oirschot, 1992). Introduction of CSFV into a susceptible pig population can
cause large epidemics which can affect many pig farms and become very costly, as
seen in the Dutch CSFV epidemic of 1997/1998 (Elbers et al., 1999; Meuwissen et
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al., 1999). Vaccination might reduce size and costs of CSFV epidemics, but the
legislation of the European Union (EU) does not allow prophylactic vaccination
against CSF since 1980 (Anonymous, 1980; Anonymous, 2001). Although use of
the C-strain vaccine has been shown to accomplish CSFV eradication in the 1980s
(Terpstra and Wensvoort, 1987) and the EU does allow emergency vaccinations
during epidemics (Anonymous, 2001), they have never been applied because of the
resulting export restrictions (Moennig, 2000).
The reason for export restrictions is that vaccinated animals cannot be
distinguished from infected animals, and therefore trade with vaccinated animals is a
risk. Because of this, marker vaccines have been developed, based on the E2-
glycoprotein of the virus (Hulst et al., 1993; König et al., 1995). Vaccination with an
E2 marker vaccine induces antibodies against only the E2 protein of the virus. An
ELISA was designed to detect antibodies against the Erns protein of the virus and can
be used as a discriminating test (Moormann et al., 2000; van Rijn et al., 1999).
Applying emergency vaccination with an E2 vaccine will only be useful if the
vaccine is sufficiently capable of reducing the size and costs of an epidemic.
Therefore, the EU financed three marker vaccine experiments to test the efficacy of
two E2 marker vaccines, BAYOVAC CSF marker (Bayer, Germany) and
PORCILIS PESTI (Intervet, The Netherlands) (Depner et al., 2001; Floegel-
Niesmann, 2001; Uttenthal et al., 2001). One of the experiments was to establish the
effect on horizontal virus transmission (Uttenthal et al., 2001). The main conclusions
of this experiment were that there is a difference in virus transmission between the
vaccines, and that vaccination reduces virus shedding and spreading as from 14 days
after vaccination.
A problem with the analysis of Uttenthal et al. (2001) is that it does not answer
the question whether the vaccines sufficiently reduce CSFV transmission to prevent
major outbreaks on pig farms. Since the conclusions were based on the Fisher’s
exact test and on qualitative data analysis, it is impossible to predict the effect of
vaccination on transmission, if the virus would enter a vaccinated pig herd. Better
predictions can be made if transmission of an infectious agent is quantified by the
basic reproduction ratio, R0: the average number of individuals that is infected by
one infectious individual in an entirely susceptible population (cf. Anderson and
May, 1991; Diekmann and Heesterbeek, 2000). A nice property of R0 is its threshold
value: if R0 is smaller than 1, only minor outbreaks can occur and only if R0 is larger
than 1, the virus can spread and major outbreaks can occur. Because of this
threshold property, it is very useful to analyse transmission experiments by use of
R0, either by testing the null-hypothesis that R0 is equal in two groups, or by
estimating R0 in the different groups and testing whether it is smaller (or larger) than
1.
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This paper presents an analysis of the EU horizontal-transmission trials with
respect to R0. The objective of the analysis was to determine whether the vaccines
are able to reduce R0 to a value smaller than 1, and to determine the time from
vaccination until R0 becomes smaller than 1. Since the trials were conducted in five
different laboratories, a meta-analysis of all trials was conducted. A meta-analysis
was considered appropriate, since many important aspects of the trials were the
same in all laboratories: the animals’ age and health status (no other infections), the
vaccine batches, the CSFV challenge strain, and the diagnostic tests used to assess
CSFV infection.
In our analysis, we used two methods, both based on a mathematical model that
describes the transmission of infectious agents, the SIR model (Bailey, 1975). With
the first method, the final size method (Kroese and De Jong, 2001), it was tested
whether the R0 of the vaccine groups was significantly reduced compared to the
control group. With the second method, the entire course method (Chapter 2), two
epidemiological parameters were estimated with time after vaccination, viz. the
transmission parameter β and the recovery parameter α. The estimates for β and α
were used to determine the time lag between vaccination and the situation where
R0 < 1, and to estimate R0 with and without vaccination.
3.2. Materials and Methods
3.2.1. Experimental procedures
The experimental procedures of the transmission trials are described in detail by
Uttenthal et al. (2001). Here we give a summary, where we focus on the aspects that
are important for interpretation of the results with respect to reduction of virus
transmission.
3.2.1.1. Experimental design
A total of 190 conventional weaner pigs of 5-6 weeks of age had been used in 19
transmission trials with ten pigs per trial. The 19 trials had been divided into nine
treatment groups. Four treatment groups consisting of two trials had been vaccinated
with vaccine A (BAYOVAC® CSF marker E2/98/B001, Bayer, Germany). Another
four treatment groups of two trials had been vaccinated with vaccine B (PORCILIS®
PESTI January 1999, Intervet, The Netherlands). The ninth treatment group of three
trials was used as the unvaccinated control group.
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All trials had started by challenging five out of ten animals with a CSFV field
strain isolated in Germany (Paderborn). Four different time intervals between
vaccination and challenge were studied in the four treatment groups per vaccine. The
intervals were 7 days (groups A7 and B7), 10 days (groups A10 and B10), 14 days
(groups A14 and B14), and 21 days (groups A21 and B21). The transmission trials
of the unvaccinated control group (group C) had started at day 0. After challenge,
every two to eight days the animals had been sampled for determination of viraemia
and antibodies against the Erns-epitope of the CSFV. Body temperature had been
measured daily. At the end of the trials, tissue samples had been taken for virus
detection.
3.2.1.2. Organisation of the experiment
Four national swine fever laboratories in Italy, Spain, France, and Denmark and the
EU reference laboratory for CSF in Germany had been involved in carrying out the
transmission trials. Besides the unavoidable differences between the laboratories
with regard to management and handling of the animals, more specific differences
are listed in Table 3.1. Because of the differences, Uttenthal et al. (2001) had
decided only to compare groups within laboratories. Because of the major
similarities between the trials in the different laboratories, we considered a meta-
analysis of all trials appropriate. The meta-analysis made a more comprehensive
analysis possible.
3.2.2. Statistical analysis
3.2.2.1. Transmission trials and R0
Transmission trials start with only five infectious pigs and five susceptible1 contact
pigs, whereas the basic reproduction ratio R0 is defined in an infinite population (cf.
Anderson and May, 1991; Diekmann and Heesterbeek, 2000). The stochastic SIR
model (Bailey, 1975) can be used to translate the data of transmission trials to R0.
‘SIR’ refers to the assumption that each animal is a member of one of the classes S
(susceptible), I (infectious), or R (removed, i.e. dead or immune). The animals can
proceed from the S class to the I class by infection, due to the presence of infectious
animals. Each infectious animal infects susceptible animals with rate β s/N, where s
                                                          
1 In this paper, ‘susceptible’ means ‘not yet infected’, so vaccinated animals can also
be susceptible.
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is the actual number of susceptible pigs, N the total number of present pigs, and β is
the transmission parameter. Animals in the I class can move to the R class by
recovery or death, which happens at rate α, the recovery parameter. The average
length of the infectious period is 1/α.
From the SIR model, R0 can be determined by regarding an infinite susceptible
population, in which s ≈ N. This results in an infection rate of β and a basic
reproduction ratio, which is the average number of new infections per day times the
average length of the infectious period, of R0 = β/α (Diekmann and Heesterbeek,
2000).
3.2.2.2. The final size method
The final size method (De Jong and Kimman, 1994; Kroese and De Jong, 2001) was
used to test whether the R0 in the eight different vaccine groups was significantly
lower than the R0 in the control group C. The null-hypothesis to test a vaccine group
V (e.g. group A7) against the control group C was H0: R0,V = R0,C. The method was
used, because it was perfectly fit for the design of the trials and because it was used
in previous transmission experiments (Bouma et al., 2000; Chapter 4). Interpretation
of the results is however not straightforward, because the method assumes a constant
R0 in each trial, which was probably unrealistic for the vaccination-challenge
intervals of 7 and 10 days, and maybe for 14 and 21 days as well. In the discussion
section, the interpretation will be addressed.
Table 3.1. Comparison of the experimental procedures in the participating
laboratories
Country Challenge IrregularitiesGroups
route dose
(TCID50)
France A14, A21,
B14, B21, C
Intranasal 102.54 some pigs were BVD+ a
Denmark A14, A21,
B14, B21, C
Oral 104.4 All trials in one isolation
unit
Spain A7, A10,
B7, B10
Intranasal 105
Italy A7, A10,
B7, B10
Intranasal 105
Germany C Oronasal 103
a At time of challenge, 20% of the French pigs was still BVD+. Before vaccination, BVD+
pigs had been equally distributed among the five trials.
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The data needed for the final size method were the initial state and the final size
of each transmission trial. The initial state consists of the number of challenged
(infectious) animals i0 and the number of contact (susceptible) animals s0 at the start
of the transmission trial. The final size is the number of contact animals that was still
susceptible by the end of the trial, st. Therefore, for each contact animal it had to be
determined whether it had been infected during the trial. As in Uttenthal et al.
(2001), a contact animal was defined infected if it had been positive at least once in
the Erns ELISA, virus isolation from blood samples, or virus detection from tissue
samples.
The test statistic for the final size method was the difference in the number of
contact infections between the vaccine and control group. The number of contact
infections was st – s0 for each trial. The calculated P-value is the probability that the
difference (or larger) is observed given H0. A P-value < 0.05 was regarded
statistically significant.
3.2.2.3. The entire course method
The entire course method was used to estimate the parameters β and α of the SIR
model in the second, third, and fourth week after vaccination, and from the fifth
week onwards. Although it is a complicated method, which needs more data and
assumptions than the final size method, it can cope with the fact that the parameters
change with time. Moreover, the estimates of β and α can be used to estimate R0.
Because a changing R0 due to a changing β or α is hard to interpret, R0 was only
determined for situations with constant β and α, which was in the unvaccinated
group C and three weeks after vaccination in groups A and B.
The data needed for the entire course method are exact reconstructions of all
transmission trials, that is, for each animal the time of infection, the period of
infectiousness, and the time of death were needed. Exact reconstructions could not
be made directly from the data, because they were not precise enough. Therefore,
100 possible exact reconstructions were drawn using distributions of the infection
times, and of the start and end of the infectious periods for each animal. The
distributions were obtained from the viraemia and serology data.
In short, the entire course method consisted of three successive steps. The first
was the interpretation of the viraemia and serology data to obtain distributions for
the time of infection and the start and end of the infectious period of each animal.
The second was the drawing of 100 exact reconstructions with these distributions.
The third was the estimation of β and α from these exact reconstructions.
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3.2.2.4. Entire course method step 1: data interpretation
To determine the start and end of the infectious period, the assumption was made
that infectiousness had coincided with viraemia, as had been assumed in previous
analyses (Chapter 2; Chapter 4; Laevens et al., 1998; Laevens et al., 1999). In all
trials, blood samples had been taken in time intervals of two to eight days for virus
isolation. It was assumed that the start of the infectious period of each animal was
uniformly distributed within the time interval before the first positive sample. The
end of the infectious period was either uniformly distributed within the time interval
after the last positive sample or it was determined by death of the animal when it had
still been virus-positive by then.
The time of infection could be reconstructed in one of four possibilities. First, if
the animal had been challenged, the time of infection was equal to the time of
challenge. Second, if the animal had not shown viraemia and had not been
seropositive in the Erns ELISA (the discriminatory ELISA), it had not been infected
at all, so there was no infection time. Third, if the animal had shown viraemia, it was
assumed that the infection time had been one latent period before the start of the
infectious period. The latent period is the interval between becoming infected and
infectious. It was determined from the challenged animals in the same laboratory as
the mode of their latent periods. Fourth, if the animal had not shown viraemia, but
had been seropositive, the interval of seroconversion was determined and the
moment of seroconversion was assumed to be uniformly distributed within the
interval. Subsequently, a distribution for the time between infection and first
seropositivity was needed. It was assumed that this was a lognormal distribution of
which the parameters — µA and σA2 for the test with vaccine A, or µB and σB2 for
the test with vaccine B — were determined from the data of the challenged animals
(see Appendix 3A).
For some situations, the interpretation of the viraemia and serology data as
described could not be followed. Then, exceptions were necessary and the data had
to be interpreted case by case. The exceptions are given in the Tables with the
Results section (Tables 3.2 – 3.5).
3.2.2.5. Entire course method step 2: exact reconstructions
Each transmission trial was reconstructed 100 times in five steps:
1. If the animal had been infectious, the start of the infectious period was drawn
from the interval of first viraemia.
2. If the animal had been infectious, the end of the infectious period was drawn
from the interval of last viraemia or it was set at the day of death.
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3. If the animal had been infected, the time of infection was determined. For
challenged pigs, it was the challenge day. For contact pigs, it was the length of
the latent period subtracted from the start of the infectious period, or it was
drawn from the appropriate distribution by using the interval of first
seropositivity.
4. The day of death of the animal. This was used to define the population size in
the trial at each time.
5. Finally, it was checked whether each drawn infection time coincided with at
least one animal that was infectious. If that was not the case, the process was
restarted at step 1 until a realistic reconstruction was obtained.
3.2.2.6. Entire course method step 3: parameter estimation
The reconstructions were divided into three sets, all vaccine A trials, all vaccine B
trials and all group C trials. The group C trials were used to estimate β, α, and R0 in
an unvaccinated population. Each set of vaccine trials was used to estimate β and α
in the second, third, and fourth week after vaccination, and from the fifth week
onwards. Then it was tested whether β and α were significantly different from week
to week. If β (or α) did not differ significantly in successive weeks, the weeks were
pooled and β (or α) was re-estimated for the longer period of two or more weeks.
The β and α from the periods the longest after vaccination, which include the fifth
week onwards, were used to estimate R0 in a vaccinated population.
Before estimation was possible, assumptions were necessary on how β and α
depend on time after vaccination. In the most complex situation, the recovery and
infection rates of an infectious animal at time tnow depend on (1) the time that the
animal was infected tinf and (2) tnow. Since the recovery rate reflects the ability of the
animal’s immune system to clear the virus, it highly depends on the state of the
immune system at the time of infection. Hence, α was assumed to depend only on
tinf. The infection rate of an animal reflects the animal’s immune response too, but it
also depends on the susceptibility of the yet uninfected animals. Therefore, β would
depend on both tinf as tnow, which would create a model with too many different β’s
in relation to the available data. Because the immune response is already covered by
α, it was assumed that β only depends on tnow. In short, the α of a certain week is the
rate by which animals that are infected in that week will recover and the β of a
certain week is, multiplied by s/N, the rate by which infectious animals cause new
infections within that very week.
Both β and α were estimated with a generalised linear model (GLM). The
method to estimate α had been used before in Chapter 2, although it had to be
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adjusted because of the use of 100 reconstructions. A similar method was used to
estimate β (see Appendix 3B). The results consisted of one estimate for logβ with
variance and one estimate for logα with variance, for the week or weeks of interest.
These were used to test whether the parameters were different in the successive
weeks and for construction of confidence intervals. The estimates and variances
were also used to estimate logR0 and its variance:
logR0 = logβ - logα
var(logR0) = var(logβ) + var(logα),
from which an estimate and a 95% confidence interval for R0 were derived. Note
that the cov(logβ, logα) is assumed to be 0. Because cov(logβ, logα) will not be
negative, – a larger α will lead to shorter infectious periods, which has to be
compensated by a larger β to obtain the same number of contact infections –
var(logR0) will be overestimated. Overestimation results in too wide confidence
intervals for R0.
3.2.3. Vaccination and outbreak size
As mentioned before, it is important to know if the vaccines are able to sufficiently
reduce the outbreak size. Therefore, simulations were conducted in which one pig in
a group of 100 pigs was infected by CSFV and virus transmission occurred
according to the SIR model with the estimated parameters β and α. The parameters
were allowed to change if the estimated values changed per week after vaccination.
A comparison was made between an unvaccinated group and groups completely
protected by either vaccine A or B. In addition it was examined to what extent the
outbreak sizes will be reduced if virus would enter a herd only 7 days after
vaccination, when the vaccines are not yet completely protective.
The simulations were carried out in Mathematica® (Wolfram, 1999). For each of
the five different situations, 1000 simulations were performed. The situations were
compared with the number of pigs that were ultimately infected during the
simulation, which is the final size of the outbreak.
3.3. Results
3.3.1. The final size method
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The data of all transmission trials are listed in Table 3.2 and were used for the test
with H0: R0,V = R0,C. The resulting P-values are shown in Table 3.2 as well. CSFV
transmission was significantly reduced in groups A7, A14, and A21, however not in
group A10. Transmission was also significantly reduced in group B21.
Table 3.2. The final size method: data and results.
Trial s0 a i0 b st c # c.i. d P e
C - Germany 5 5 0
C - Denmark f 7 3 0
C - France f 6 4 0
18 -
A7 - Spain g 4 6 0
A7 - Italy 5 5 5 4 <0.05
A10 - Spain h 4 5 2
A10 - Italy 5 5 0 7 0.11
A14 - Denmark 5 5 3
A14 - France 5 5 3 4 <0.05
A21 - Denmark 5 5 4
A21 - France 5 5 5 1 <0.05
B7 - Spain 5 5 0
B7 - Italy h 4 5 2 7 0.11
B10 - Spain 5 5 0
B10 - Italy 5 5 1 9 0.23
B14 - Denmark 5 5 0
B14 - France 5 5 0 10 1
B21 - Denmark 5 5 1
B21 - France 5 5 5 4 <0.05
a The number of susceptible animals at the start of the trial
b The number of infected animals at the start of the trial
c The number of susceptible animals at the end of the trial
d The total number of contact infection in the treatment group
e The P-value of the final size test for testing against group C
f Because in these trials one and two pigs were only viraemic at the time of the other
contact pigs, it was assumed that the inoculation had been unsuccessful and the pigs were
regarded as contact pigs
g In this trial, one animal was viraemic at day 11, just like the challenged animals, and has
therefore been treated as a challenged animal
h In these trials, one pig had died before the challenge day
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3.3.2. The entire course method
First, the parameters µ and σ2 of the distribution of the challenge-seropositivity
interval were determined for both Erns ELISAs. The challenged animals were found
to seroconvert by ELISA A in the following time intervals after challenge:
8 – 10 (3×), 9 – 11 (8×), 10 – 12 (7×), 12 – 14 (2×), 12 – 15, 14 – 16, 14 – 21, 15
– 18, 21 – 25, 21 – 28, 28 – 35 (4×), 35 – 42 (5×),
from which µA was estimated at 2.73 and σA2 at 0.279. With the vaccine B ELISA,
the time intervals of seroconversion were found to be
6 – 8, 8 – 10 (9×), 9 – 12, 10 – 12 (12×), 12 – 14 (7×), 12 – 15 (3×), 12 – 17 (4×),
14 – 21 (2×), 17 – 23 (3×), 18 – 22, 21 – 28,
from which µB was estimated at 2.49 and σB2 at 0.0635.
The data for the entire course method are listed in Table 3.3 for all groups A, in
Table 3.4 for all groups B, and in Table 3.5 for group C. Table 3.6 lists the estimates
of β and α from the vaccine-A trials and from the group-C trials and Table 3.7 lists
the estimates from the vaccine-B trials and the group-C trials.
The β estimated from group C was 0.65 (95% CI: 0.40 – 1.1), whereas the α was
estimated at 0.065 (95% CI: 0.045 – 0.096). The resulting R0 in unvaccinated pigs
was 9.9 (95% CI: 5.3 – 18).
For vaccine A (Table 3.6), the transmission parameter β did not differ
significantly between time intervals. Consequently, all data were pooled and β was
estimated for the whole period after vaccination, which led to an estimate of
0.29 (95% CI: 0.17 – 0.48), which was significantly lower than the β of group C.
Recovery parameter α was estimated in the same time intervals as β. The α
appeared to increase weekly until at least the fourth week after vaccination. From
the fifth week onwards, only one data point was available, with Tk = 0. Therefore, α
was re-estimated for the whole period from 21 days after vaccination at
6.1 (95% CI: 2.4 – 16), which was significantly higher than the α of group C. As
explained in section 2.2.3, the basic reproduction ratio R0 was only estimated with
constant β and α, which was 21 days after vaccination: R0 was
0.047 (95% CI: 0.016 – 0.14). Thus, vaccine A significantly reduced R0, which
reached a value significantly smaller than 1.
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Table 3.3. Reconstruction of the transmission trials of group A.
Trial Time of
infectionb
(daysa)
Start of
infectious
periodc
(daysa)
End of
infectious
periodd
(daysa)
Trial Time of
infectionb
(daysa)
Start of
infectious
periodc
(daysa)
End of
infectious
periodd
(daysa)
7 9 – 11 24 14 18 – 20 20 – 22
7 9 – 11 15 – 17 14 - -
7 9 – 11 17 – 19 14 - -
7 9 – 11 34 14 18 – 20 20 – 22
7 9 – 11 31 14 - h - h
(-3) 17 – 19 21 – 28 - - -
(-3) 17 – 19 28 – 35 - - -
(-3) 17 – 19 21 – 28 - - -
7 e 9 – 11 21 – 28 49 – 56 - h - h
Sp
ai
n 
– 
A
7
(-3) 17 – 19 19 – 21
D
en
m
ar
k 
– 
A
14
42 – 49 - -
7 14 – 16 21 – 25 14 - -
7 14 – 16 22 14 - -
7 16 – 18 25 – 28 14 - -
7 14 – 16 25 – 28 14 18 – 20 i 18 – 20 i
7 14 – 16 18 – 21 14 - -
- - - - - -
- - - - - -
- - - 42 – 49 - -
- - - - - -
Ita
ly
 –
 A
7
- - -
Fr
an
ce
 –
 A
14
42 – 49 - -
10 12 – 14 20 – 22 21 27 – 29 h 29 – 31 h
10 12 – 14 22 – 24 21 - h - h
10 12 – 14 22 – 24 21 - -
10 10 – 12 14 – 16 21 - h  h-
10 12 – 14 18 – 20 21 - -
(-3) 16 – 18 18 – 20 - - -
(-3) 18 – 20 22 – 24 - - h - h
- - - - - -
- - - - - h - h
Sp
ai
n 
– 
A
10
- f - f - f
D
en
m
ar
k 
– 
A
21
56 – 63 - -
10 17 – 19 28 – 31 21 - -
10 19 – 21 28 – 31 21 - -
10 17 – 19 26 – 28 g 21 - -
10 19 – 21 31 – 35 21 - -
10 19 – 21 28 – 31 21 - -
28 – 31 - - - - -
38 – 46 - - - - -
(-8) 26 – 28 32 - - -
26 – 28 - - - - -
Ita
ly
 –
 A
10
31 – 35 - -
Fr
an
ce
 –
 A
21
- - -
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For vaccine B (Table 3.7), β did not change from week to week after vaccination
either, so β was ultimately estimated at 0.34 (95% CI: 0.23 – 0.49). This differed
significantly from the non-vaccination β and was almost equal to the β with vaccine
A. The course of α looked similar for both vaccines as well. Unlike the trials with
vaccine A, the trials with vaccine B did contain enough data for the time after the
fourth week, from which a further increase of α was not observed. After pooling the
last two time intervals, the α after 21 days was estimated at 0.82 (95% CI: 0.51 –
1.3), which was significantly different from the non-vaccination α, and also from the
α with vaccine A. The resulting R0 was 0.41 (95% CI: 0.22 – 0.75), which was
significantly different from the unvaccinated group C, and also from vaccine A.
Although the two vaccines differed with respect to α and R0, they both let R0
significantly decrease to a value below 1.
3.3.3. Vaccination and outbreak size
The outbreak simulations in a non-vaccinated population resulted in either small or
large outbreaks: 90 of the 1000 simulations resulted in a final size of 1 or 2 infected
animals, whereas in 910 simulations the final size was 99 or 100. For the vaccinated
groups there was no distinction between small and large outbreaks possible: the
median and 95% confidence intervals are shown in Table 3.8.
Caption to Table 3.3.
a Days since vaccination
b Single positive numbers are challenge times; negative numbers between brackets are the
latent periods, to be subtracted from the start of the infectious period to obtain the infection
times; double numbers are the intervals in which the seropositivity started; dashes are for
uninfected animals
c Double numbers are the intervals in which the infectious periods started; dashes are for
animals that were not infectious
d Single numbers are the times of death and hence the ends of the infectiousness; double
numbers are the intervals in which the infectious period ended
e This animal was viraemic at day 11, just like the challenged animals, and has therefore
been treated as a challenged animal
f This animal was dead before the start of the experiment
g This animal died at day 37
h These animals had for at least one day only one virus-positive well of six replicates, which
was considered a false-positive
i This infectious period was based on fever (T > 40 °C) and was necessary to explain the
two contact infections
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Table 3.4. Reconstruction of the transmission trials of group B.
Trial Time of
infectionb
(daysa)
Start of
infectious
periodc
(daysa)
End of
infectious
periodd
(daysa)
Trial Time of
infectionb
(daysa)
Start of
infectious
periodc
(daysa)
End of
infectious
periodd
(daysa)
7 9 – 11 20 14 18 – 20 22 – 24
7 9 – 11 19 – 21 14 22 – 24 g 24 – 26 g
7 9 – 11 28 14 18 – 20 24 – 26
7 9 – 11 21 – 28 14 20 – 22 g 24 – 26 g
7 9 – 11 14 14 18 – 20 20 – 22
(-3) 11 – 13 28 – 35 (-5) 26 – 28 g* 28 – 35 g*
(-3) 17 – 19 28 – 35 (-5) 35 – 42 42 – 49
(-3) 17 – 19 21 35 – 42 - -
(-3) 17 – 19 21 – 28 42 – 49 - -
Sp
ai
n 
– 
B
7
(-3) 15 – 17 28 – 35
D
en
m
ar
k 
– 
B
14
28 – 35 - -
7 11 – 14 24 – 30 14 18 – 20 20 – 22
7 7 – 11 31 14 - -
7 7 – 11 41 14 16 – 18 20 – 22
7 11 – 14 34 14 -
7 11 – 16 22 14 - -
38 – 44 - - 35 – 42 - -
30 – 38 - - 35 – 42 - -
- - - 35 – 42 - -
- - - 35 – 42 - -
Ita
ly
 –
 B
7
-e -e -e
Fr
an
ce
 –
 B
14
28 – 31 - -
10 12 – 14 28 21 - -
10 12 – 14 24 – 31 21 25 – 27 29 – 31
10 14 – 16 22 – 24 21 - -
10 14 – 16 24 – 31 21 25 – 27 31 – 33
10 14 – 16 16 – 18 21 25 – 27 27 – 29
(-3) 16 – 18 f 31 – 38 f 49 – 56 - -
(-3) 16 – 18 f 31 – 38 f 42 – 49 - g - g
(-3) 14 – 16 28 42 – 49 - -
(-3) 22 – 24 31 – 38 33 – 35 - g - g
Sp
ai
n 
– 
B
10
(-3) 18 – 20 24 – 31
D
en
m
ar
k 
– 
B
21
- - g - g
10 14 – 17 22 – 27 21 - -
10 10 – 14 17 – 19 21 - -
10 17 – 19 27 – 41 21 - -
10 17 – 19 27 – 33 21 - -
10 10 – 14 45 21 - -
27 – 33 - - - - -
27 – 33 - - - - -
33 – 41 - - - - -
- - - - - -
Ita
ly
 –
 B
10
41 – 47 - -
Fr
an
ce
 –
 B
21
- - -
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When CSFV enters a pig unit 21 days after vaccination, the number of infected
pigs will remain very small with either vaccine. In most cases, only the initially
infected pig will be infected and sometimes, especially with vaccine B, a few more
will. Also when CSFV enters a pig unit only a week after vaccination, when α is still
increasing for another two weeks, the size of the outbreak will be considerably
reduced. With vaccine A, the upper 95% limit of the 1000 simulations reveals that
only 21 out of 100 pigs will be infected, so there is only a 2.5% chance that this will
be more. With vaccine B, the upper limit is 41 infected animals.
3.4. Discussion
This paper described an analysis of CSFV transmission trials that were carried out in
the EU to test two E2 subunit marker vaccines. With the final size method, the
reduction of CSFV transmission was tested. Virus transmission was significantly
reduced when virus was introduced 7, 14 or 21 days after vaccination with vaccine
A (produced by Bayer, Germany). Transmission was also reduced 21 days after
vaccination with vaccine B (produced by Intervet, The Netherlands). The entire
course method was used to estimate the parameters β, α, and R0 of the SIR model.
Vaccination with both vaccines reduced the transmission parameter β by about 50%.
More importantly, the vaccines increased the recovery parameter α, vaccine A even
more than vaccine B. Both vaccines reduced R0 to a value significantly below 1.
Caption to Table 3.4.
a Days since vaccination
b Single positive numbers are challenge times; negative numbers between brackets are the
latent periods, to be subtracted from the start of the infectious period to obtain the
infection times; double numbers are the intervals in which the seropositivity started;
dashes are for uninfected animals
c Double numbers are the intervals in which the infectious periods started; dashes are for
animals that were not infectious
d Single numbers are the times of death and hence the ends of the infectiousness; double
numbers are the intervals in which the infectious periods ended
e This animal was dead before the start of the experiment
f Within a series of positive samples, these animals had at least one negative sample,
which was considered false-negative
g These animals had for at least one day only one virus-positive well of six replicates,
which was considered a false-positive
g* For this animal, the one positive of six replicates was considered positive to explain the
subsequent contact infection
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The estimated β and α were used in simulations of outbreaks in a pig unit of 100
pigs. It appeared that the size of an outbreak will be greatly reduced if the pigs are
vaccinated. Already when virus enters the unit only 7 days after vaccination, the
number of animals that become infected is considerably lower than in the
unvaccinated group.
With the final size method, the implicit assumption is made that R0, and thus β
and α, are constant over time. This was probably not the case in at least some of the
Table 3.5. Reconstruction the transmission trials of group C
Trial Time of
infectionb
(daysa)
Start of
infectious
periodc (daysa)
End of
infectious
periodd (daysa)
0 2 – 4 16
0 4 – 6 22
0 4 – 6 8
0 4 – 6 25
0 4 – 6 16
(-5) 12 – 15 18
(-5) 12 – 15 57
(-5) 12 – 15 30
(-5) 12 – 15 45
G
er
m
an
y 
– 
C
(-5) 12 – 15 32
(-5) e 14 –21 29
0 4 – 6 f 12 – 14 f
(-5) e 14 – 21 30
0 4 – 6 g 31 g
0 4 – 6 43 h
(-5) 14 – 21 31
(-5) 14 – 21 28 – 35
(-5) 10 – 12 31
(-5) 12 – 14 21 – 28
D
en
m
ar
k 
– 
C
(-5) 10 – 12 f 28 – 35 f
0 6 – 8 29
(-5) e 12 – 14 14 – 16
0 4 – 6 8 – 10
0 4 – 6 26
0 2 – 4 g 14 – 16 g
(-5) 8 – 10 g 17 – 21 g
(-5) 12 – 14 14 – 16
(-5) 12 – 14 14 – 16
(-5) 12 – 14 23
Fr
an
ce
 –
 C
(-5) 12 – 14 17 – 21
a Days since start of the transmission
trial
b Single positive numbers are
challenge times; negative numbers
between brackets are the latent
periods, to be subtracted from the
start of the infectious period to
obtain the infection times
c The intervals in which the
infectious periods started
d Single numbers are the times of
death and hence the ends of the
infectiousness; double numbers are
the intervals in which the infectious
periods ended
e Because this pig was only viraemic
at the time of the other contact pigs,
it was assumed that the inoculation
had been unsuccessful and the pig
was regarded as a contact pig
f These animals had for at least one
day only one virus-positive well of
six replicates, which was considered
a false-positive
g Within a series of positive samples,
these animals had at least one
negative sample, which was
considered false-negative
h The pig was still infectious, but the
experiment stopped at this time.
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Table 3.6. Estimates and 95% confidence intervals of β, α, and R0 without vaccination
and with time after vaccination with vaccine A.
Control Day 7 – 14 Day 14 – 21 Day 21 – 28 Day 28 – ∞
β per
interval a
0.65
0.40 – 1.1
0.081
2.5 10-10 – 2.7 107
0.42
0.22 – 0.79
0.16
4.7 10-6 – 5.5 103
1.2
3.3 10-7 – 3.8 106
after
joining b
0.65
0.40 – 1.1
0.29
0.17 – 0.48
α per
interval a
0.065
0.045 – 0.094
0.098
0.063 – 0.15
0.50
0.31 – 0.79
5.5
2.1 – 14
∞ d
after
joining b
0.065
0.045 – 0.094
0.098
0.063 – 0.15
0.50
0.31 – 0.79
6.1
2.4 – 16
R0 after
joining c
9.9
5.3 – 18 ND 
e ND e 0.0470.016 – 0.14
a Estimates without vaccination and per week after vaccination
b Estimates without vaccination and per period after vaccination within which the
estimates for the subsequent weeks did not differ significantly
c Estimates without vaccination and with maximum protection by the vaccine
d Only one animal of the Denmark-A21 trial was, in some of the 100 exact
reconstructions, part of the interval and had an infectious period of 0 days.
e Not determined, for the vaccine had not reached maximum protection yet.
Table 3.7. Estimates and 95% confidence intervals of β, α, and R0 without vaccination
and with time after vaccination with vaccine B.
Control Day 7 – 14 Day 14 – 21 Day 21 – 28 Day 28 – ∞
β per
interval a
0.65
0.40 – 1.1
0.25
0.077 – 0.83
0.35
0.18 – 0.69
0.26
0.088 – 0.79
0.50
0.20 – 1.2
after
joining b
0.65
0.40 – 1.1
0.34
0.23 – 0.49
α per
interval a
0.065
0.045 – 0.094
0.069
0.046 – 0.10
0.28
0.16 – 0.46
0.86
0.48 – 1.5
0.74
0.25 – 2.2
after
joining b
0.065
0.045 – 0.094
0.069
0.046 – 0.10
0.28
0.16 – 0.46
0.82
0.51 – 1.3
R0 after
joining c
9.9
5.3 – 18 ND 
d ND d 0.410.22 – 0.75
a Estimates without vaccination and per week after vaccination
b Estimates without vaccination and per period after vaccination within which the
estimates for the subsequent weeks did not differ significantly
c Estimates without vaccination and with maximum protection by the vaccine
d Not determined, for the vaccine had not reached maximum protection yet.
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EU transmission trials,
which makes it important
to discuss the meaning of
the obtained P-values. A
P-value larger than 0.05
(groups A10, B7, B10,
and B14) would usually
mean that virus
transmission was not
significantly reduced in
the regarded groups.
Because it is known from
groups A21 and B21 that
transmission is
significantly reduced
after 21 days, most of the transmission in groups A10, B7, B10, and B14 must have
taken place in the initial stage of the trials. Thus, if P > 0.05, the vaccine is not
shown to be effective after the regarded vaccination-challenge interval. On the other
hand, if the P-value is smaller than 0.05 (groups A7, A14, A21, and B21), it is not
certain that the vaccine reduced transmission immediately after the regarded
interval. It can only be concluded that the vaccine was effective soon enough to
prevent much virus transmission. In group A7, protection was probably insufficient
in the first days, because otherwise group A10 should have shown a significant
reduction as well. In groups A14, A21, and B21, immediate reduction of
transmission is very likely if the results of the entire course method are considered:
R0 was probably smaller than 1 during these trials.
A second implicit assumption was that the specificity and the sensitivity of the
Erns-ELISAs were 100%, while they were 92% (sp.) and 74% (se.) for Erns ELISA A,
and 71% (sp.) and 94% (se.) for Erns ELISA B (De Smit et al., 2000b; Floegel
Niesmann, 2001). Due to the low specificity, observed contact infections in the
vaccine groups might have been false-positive. Then, the effectiveness of the
vaccines was underestimated in the final size analysis. By opposite reasons, the low
sensitivity might have caused an overestimation of the vaccines’ effects, but this is
not likely because of the multiple tests on each animal. The effects of imperfect tests
on the results of the entire course method are more complicated. If a too lowly
sensitive test misses a contact infection, β is obviously underestimated, but so is α,
since the unobserved infected animal was not observed by viraemia either and
consequently had a 0 days infectious period. Since β is estimated by less data than
α, the estimate of β is probably more sensitive to an incorrect test result. Hence, a
Table 3.8. Results of the simulations of CSFV outbreaks
in a pig unit with 100 pigs. The outbreaks started with 1
infectious pig.
Vaccine Interval between
vaccination and
virus entry
Final size 95% CI
No vaccine -- a a
Vaccine A 7 days 5 1 – 21
Vaccine A 21 days 1 1 – 2
Vaccine B 7 days 11 1 – 41
Vaccine B 21 days 1 1 – 6
a Without vaccination, either small outbreaks of 1 or 2
(90 of 1000 simulations) or large outbreaks of 99 or 100
infected animals (910 of 1000 simulations) occurred.
E2 vaccines reduce transmission
55
low sensitivity may underestimate R0. However, there is no need to question the
vaccines’ effectiveness, since R0 will still be smaller than 1 if β is underestimated
(and unchanged by vaccination) and α is not.
The next step is to see whether the difference in sensitivity can explain the
difference between the two vaccines, as suggested by (Uttenthal et al., 2001). Since
increased sensitivity would lead to a higher β and a higher α at the same time, β and
α should have higher estimates with vaccine B, if both vaccines are equally
effective. However, β is the same for both vaccines and α is higher with vaccine A
instead of B, so the difference in sensitivity cannot explain the difference in R0
between the two vaccines. Hence, the difference in R0 between the two vaccines is
probably a biological difference, although its nature remains unclear.  Speculations
have been made on the adjuvants and the quality or quantity of antigen per
vaccination dose (Depner et al., 2001).
The reason not to analyse all trials simultaneously is that they were carried out in
different laboratories. Namely, the risk of such a meta-analysis is that observed
‘treatment’ effects are not solely due to the treatment, but also to other differences.
Therefore, the consequences of the laboratory differences should be considered for
interpretation of the results. In the EU transmission experiment, three interpretation
problems could arise:
1. Comparison of groups A7, A10, B7, and B10 to group C. The conclusions from
trials A7, A10, B7, and B10 were that the vaccines were not yet sufficiently
effective before 14 (final size method) or 21 (entire course method) days after
vaccination. Hence, there is no risk of an observed ‘treatment’ effect not caused
by the treatment.
2. Comparison of groups A7, A10, B7, and B10 to groups A14, A21, B14, and
B21. The groups have not been directly compared, but used simultaneously to
estimate β and α. However, an indirect comparison was made because the 7 and
10 days groups mainly provided data for weeks 2 and 3 after vaccination, and the
14 and 21 days groups for weeks 4 and 5. It might have led to a wrong
conclusion about the course of β over time, but will not have affected the
conclusions that R0 was smaller than 1 after 21 days or the actual estimates of R0.
3. The use of the German group-C trial. Since it was the only trial carried out in
Germany, Uttenthal et al. (2001) did not use this trial in their analysis at all. The
reason to include the trial in our analysis after all was that the results were very
similar to the other two trials of group C, and to all control trials of other CSFV
transmission experiments as well (Chapter 4; Bouma et al., 2000; Laevens et al.,
1998; Laevens et al., 1999).
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The final assumption that needs attention is that viraemia is the indicator for
infectiousness, which had been assumed in the analysis of other transmission
experiments as well (Chapter 4; Laevens et al., 1998; Laevens et al., 1999). A
problem with the assumption is that virus excretion might also occur while viraemia
is not observed, though possibly at lower levels. However, that will be a problem
with any assumption and is related to the assumption of constant infectiousness in
the SIR model. Here, viraemia is used to indicate infectiousness, because viraemia is
a sign of virus replication and it is likely that virus excretion can occur when virus is
replicating within the animal.
Uttenthal et al. (2001) analysed the same experiment and used the Fischer’s
exact test to show a difference between the two vaccines in the number of contact
infections, especially after 14 days. Qualitative data inspection led to the conclusion
that the vaccines reduced virus shedding from 14 days after vaccination, but that no
complete protection was achieved. No conclusion could be made on whether the
protection would be sufficient. Both analysis methods in our paper, the final size
method as well as the entire course method, made use of the SIR model of virus
transmission between animals. The effect of the vaccines was investigated by
obtaining inference on the parameters of the SIR model, i.e. β, α, and R0, either by
testing whether treatment groups differ or by directly estimating the parameters. The
advantage of using the parameters of the SIR model is that it is easy to extrapolate
the results to larger populations, which was shown by the simulations.
Vaccine A was also tested by Bouma et al. (2000), who showed that in SPF pigs,
transmission was already significantly reduced 10 days after vaccination. After 14
days, R0 was significantly smaller than 1. The later onset of protection in the EU
trials might be explained by the use of conventional pigs, i.e. non-SPF pigs. Also,
the heterogeneity due to the different laboratories might have reduced the power of
the statistical tests and hence delayed finding a significant reduction in transmission.
Vaccine B was also tested by Dewulf et al., who studied horizontal transmission
between weaner pigs (Dewulf et al., 2000) and sows (Dewulf et al., 2001), but only
vaccinated the contact pigs and not the challenged pigs. Their conclusion was that
the vaccine did not prevent contact infection, which is in accordance with our
findings that the largest effect of the vaccines lies in the increase of α, and not in the
decrease of β.
The decision to use vaccination as an emergency measure during a CSFV
epidemic will depend on many factors. Policy makers will have to weigh
epidemiological, economic, and ethical arguments, brought up by the European
Union legislation, the pig industry, and the public opinion. Important aspect of the
discussion will always be the effectiveness of a vaccination campaign. The ultimate
effect of emergency vaccination should be that a CSFV epidemic will come quickly
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to an end, with less herds affected. However, it cannot be predicted directly from the
results of the analyses how fast an epidemic may stop and how many herds may be
infected. Extrapolation of the between-animal transmission to between-herd
transmission, e.g. by means of mathematical modelling, is needed. What can be
concluded, however, is that virus transmission between animals will be sufficiently
reduced three weeks after vaccination with either marker vaccine. Already when
virus enters a herd only one week after vaccination, the size of the outbreak will be
much smaller than without vaccination. Hence, from the epidemiological point of
view, emergency vaccination looks very promising.
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Appendix 3A
The distribution parameters µA and σA2 for the Erns-ELISA A, and µB and σB2 for
ELISA B were estimated from the serological data of the challenged animals.
Because the animals in group C had been tested with both ELISAs, they were used
for estimation of both µA and σA2, and µB and σB2. Animals that had not become
seropositive during the trials were omitted, because it concerns a distribution given
that the animal becomes seropositive within the duration of the trials.
If the animal is tested with Erns-ELISA A, the probability that the random
variable Tseropos. falls within interval (t1, t2) is
( )( ) ( )∫=∈ 2
1
2,21.
,
t
t
seropos dttPDFttTP
AA σµ ,
in which ( )tPDF
AA
2,σµ  is the probability density function of the lognormal
distribution with mean µA and variance σA2, and t is the time since challenge. Hence,
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the data of all challenged and tested animals k were used to construct the log-
likelihood function of µA and σA2:
( ) ( )∑ ∫ 


=
k
t
t
AA
k
k
AA
dttPDFL
,2
,1
2,
2 log, σµσµ (3.1)
Maximising Eq. (3.1) for the dataset of Erns-test A revealed the estimates for µA and
σA2. Estimates for µB and σB2 were obtained analogously.
Appendix 3B
3B.1. Estimation of β
The method for estimation of β could be used for any desired time interval of the
transmission trials. Within the interval under consideration, it was assumed that β
was a constant parameter.
For estimation of β, a survival analysis was used. Survival analysis makes use of
a hazard function h(t,β):
( ) ( ) ( )( )t
ttith
animals # total
animals infectious #, βββ =⋅= ,
which represents the pressure which the susceptible animals are subject to until they
are infected. Each transmission trial had a different h(t,β), where i(t) is the
infectiousness function of the trial.
To estimate β in a specific time interval, each susceptible animal that had been
subject to one of the h(t,β) within that interval made up one record. For example, if
we consider the week from day 14 until day 21 with vaccine A, the dataset consisted
of all animals from the trials of treatment groups A7, A10, and A14 that had still
been susceptible at day 14 after vaccination. Each record k consisted of two data, yk
and tk. The yk denoted whether the tk was truncated: yk was equal to 1 if animal k had
been infected within the considered time interval, otherwise it was 0. The tk was
either equal to the time of infection of the animal (if yk = 1) or to the end of the time
interval (if yk = 0).
If the time interval started at time tstart, the accumulated infectiousness Ik for each
animal k at time tk was calculated as
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t
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in which ik(t) was the infectiousness function of the trial which animal k had been
part of. Now the probability of observing (yk, tk) was
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From this probability, the likelihood function for β could be constructed as follows:
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The kernel of this likelihood is the same as it would be with a set of n observations
yk, each having an independent Poisson distribution with mean βIk (see Aitkin et al.,
1989). Therefore, the analysis was performed with a generalised linear model
(GLM), where yk denoted the response variate, logIk the offset, and the model was
fitted with a log LINK function and a Poisson distribution. The output was an
estimate of logβ and its estimated variance. The GLM was programmed in
Mathematica® (Wolfram, 1999).
The 100 exact reconstructions of each transmission trial resulted in 100 estimates
for β for each considered time interval. The average of the 100 estimates was
considered as the final maximum likelihood estimate. The variance of the final
maximum likelihood estimator consisted of two parts, viz. the average of the 100
estimated variances and the variance of the 100 estimates (Rao, 1973):
( )( ) ( )( )[ ] ( )( )[ ]ϑϑϑϑϑ ϑϑϑ βββ ˆvarˆvarˆvar EE += ,
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in which ϑ represents the vector of all data (the infection times, the starting and
ending times of the infectious periods, and the times of death of the animals) and
( )ϑβˆ  is the estimator of β as a function of the data ϑ.
3B.2. Estimation of α
As with the estimation of β, the method for estimating α can be used for any desired
time interval. The α of the considered time interval is the recovery rate of each
animal infected within the time interval. The estimation method for α was a survival
analysis as well. The hazard function h(t,α) of recovery was
h(t,α) = α
and was therefore independent of time and transmission trial.
Each animal that became infected (not infectious) within the time interval under
consideration, made up one record. Each record k consisted of two data, yk and Tk.
The yk was 1 if the animal had recovered before the end of the experiment, and was
0 otherwise. The Tk was the length of the infectious period. A likelihood function
could be constructed similarly to the likelihood function for β, and α could be
estimated by use of a GLM with a log LINK function and a Poisson distribution, and
with yk as the response variate and logTk as the offset. An estimate for logα was
obtained, with the variance of its estimator. In Chapter 2, the same method had been
used for estimation of α.
A final maximum likelihood estimate for logα was obtained by averaging the
100 estimates from all exactly reconstructed transmission trials. A variance of the
estimator of logα was determined similarly to that of logβ, by adding the average
variance of the 100 estimates to the variance of the 100 estimates.
Chapter 4
Influence of maternal antibodies on efficacy
of a subunit vaccine: transmission of
classical swine fever virus between pigs
vaccinated at two weeks of age
D. Klinkenberg, R.J.M. Moormann, A.J. de Smit, A. Bouma, M.C.M. de Jong
Reprinted from Vaccine, Vol 20, Pages 3005-3013, Copyright (2002), with
permission from Elsevier

Vaccination of maternally immune piglets
63
Abstract
This study shows the effectiveness of vaccination with an E2 subunit vaccine against
classical swine fever in two-week old piglets. Half of the piglets were carrying
maternally derived antibodies at the time of vaccination. Three and six months later,
antibody levels were compared between the two treatments. Moreover, reduction of
virus transmission was investigated at three and six months by doing transmission
experiments. The vaccine was found to be capable of reducing virus transmission
significantly at both time intervals. Maternal immunity reduced vaccination-induced
antibody levels after three and six months and possibly led to a less effective
protection against virus transmission after six months.
4.1. Introduction
Classical swine fever (CSF) is a contagious pig disease caused by classical swine
fever virus (CSFV) (Dahle and Liess, 1992; Taylor, 1995; Terpstra, 1987).
Occasional epidemics of CSFV in domestic pigs can cause huge problems, as
exemplified by the Dutch epidemic in 1997/1998. The epidemic caused the killing
of over 12 million pigs and a loss of US$ 2.3 billion (Meuwissen et al., 1999;
Stegeman et al., 2000). New epidemics might occur in the future as re-introduction
of the virus in the domestic pig population is a constant threat (Edwards et al., 2000;
Moennig, 2000). Although preventive slaughter of pig herds that had been at risk for
infection was a major control measure in the Dutch epidemic (Stegeman et al.,
1999b), in future epidemics, vaccination might be a better option for ethical reasons
(Terpstra et al., 2000). Emergency vaccinations during CSF epidemics are allowed
by the EU (Anonymous, 1980), but have not been applied yet. This is, because with
the hitherto used vaccines and diagnostic tests infection of vaccinated pigs cannot be
detected, so that emergency vaccinations would result in prolonged trade bans by
other countries and are therefore economically not profitable (Terpstra et al., 2000).
This problem could be overcome by a marker vaccine against CSFV with an
accompanying diagnostic test to detect infection in vaccinated animals, provided
that such a vaccine would be internationally accepted. One such marker vaccine is
based on the glycoprotein E2 of the virus, produced in an insect cell-baculovirus
expression system (Hulst et al., 1993; Moormann et al., 2000). Several experiments
have shown that this vaccine can prevent clinical signs in and virus transmission
between animals (Bouma et al., 2000; Bouma et al., 1999; Hulst et al., 1993). In SPF
(specified pathogen free) pigs, transmission appeared to be significantly lower if
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infection occurred at 10 days after vaccination (Bouma et al., 2000). In conventional
pigs, transmission appeared to be significantly lower only after 14 days. Estimations
of the basic reproduction ratio R0, i.e., the average number of secondary infections
caused by one infectious individual in a fully susceptible population, appeared to
decrease from 6.8 without vaccination to 0.36 three weeks after vaccination
(Klinkenberg, unpublished results). Stochastic simulations of a CSF epidemic with
vaccination based on the 1997-1998 epidemic in the Netherlands showed that
vaccination might lead to a reduction of the magnitude and the costs of the epidemic
(Mangen et al., 2001).
If, in case of application of the vaccine in emergency situations, young pigs are
immunised in the first weeks after birth, two complications could arise. First, if the
sow has been vaccinated, its piglets receive maternally derived antibodies (MDA)
via the colostrum, which may interfere with the immune response to the vaccine.
MDA have been shown to affect antibody responses to non-live vaccines (Siegrist,
2001) and to the C-strain vaccine against CSF, a modified live vaccine (Precausta et
al., 1978). Also, the potential of MDA-related reduction of vaccine efficacy in
affecting transmission has been observed in experiments with vaccination against
pseudorabies virus (Bouma et al., 1997). Second, the efficacy of the vaccine will
possibly decrease as the piglets get older. Decrease of antibody titre over time
occurs in some pigs vaccinated with the E2 vaccine (De Smit et al., 2001a), which
might result in a finishing pig population with insufficiently protected pigs, allowing
virus transmission within a herd and to other herds. The aim of the research
described in this paper was to determine whether vaccination of piglets at two weeks
of age, with or without presence of MDA, reduced transmission of CSFV three and
six months later.
4.2. Materials and Methods
4.2.1. Experimental design
The whole experiment consisted of six different transmission trials, in which
transmission of CSFV was investigated. Each of these transmission trials was
conducted with a group of ten animals with the same vaccination history and age.
Groups C and D were born of twice vaccinated sows and were vaccinated
themselves at the age of two weeks. Groups E and F were born of naive sows and
were vaccinated at the age of two weeks. Finally, groups G and H were born of
naive sows and were not vaccinated. The transmission trials with groups C, E, and G
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started when the animals were at the age of about 3.5 months, whereas the trials with
groups D, F, and H started three months later, with animals of about 6.5 months old.
4.2.2. Animals and vaccination
Six pregnant sows from the conventional pig herd of the Veterinary Faculty in
Utrecht were transported to ID-Lelystad, where the whole experiment was carried
out. The sows were free of antibodies against pestiviruses. Three of the sows
received a double dose (4 ml.) of E2 marker vaccine (16 µg/ml inactivated E2
antigen in a Double Oil Emulsion adjuvant), intramuscularly (i.m.) behind the ear, at
day 70 of pregnancy. The same sows were vaccinated a second time, four weeks
later, with a single dose (2 ml) i.m. The other three sows were not vaccinated, but
instead they were given PBS twice, 4 and 2 ml i.m.
After farrowing, twenty piglets from the sows in group A were randomly (by
random stratification by litter, sex, and weight) allotted to groups C and D. Twenty
piglets from the sows in group B were randomly allotted to E and F. Twenty piglets
born of non-vaccinated sows were obtained from the pig herd of the Veterinary
Faculty and were allotted to groups G and H. Groups C, D, E, and F were vaccinated
once with 2 ml i.m. in the neck at two weeks of age. Groups G and H remained
untreated.
About three months post-vaccination, when the animals were 3 to 3.5 months of
age (depending on the litter they came from), groups C, E, and G were transported to
the high containment unit of ID-Lelystad. About six months post-vaccination,
groups D, F, and H were transported to the high containment unit. All groups were
housed separately and the pigs were allowed to acclimatise for one week, before the
transmission trials started. During the trials, they were fed on complete foodpellets
(Hope Farms) twice a day and were free to drink water from a nipple ad libitum.
4.2.3. Transmission trials
The transmission trials (for general information, see Kroese and De Jong, 2001)
lasted six weeks. In each trial, five of the ten pigs were separated from the others
and inoculated intranasally with 105 TCID50 of CSF strain CSF277, a field isolate
from Germany (Paderborn) (Greiser Wilke et al., 1998) and used at passage level 5.
After 24 hours, the remaining five pigs per trial were placed with the inoculated
animals as contact animals. Six weeks later, all pigs that had not died during the trial
were killed for post-mortem examination.
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4.2.4. Clinical observations
During the transmission trials, the pigs were observed clinically every day. In
addition, rectal body temperatures were assessed daily in the first three weeks,
which was prolonged in group G (no vaccination, 3 months) because some animals
still had fever after three weeks. Fever was defined as a body temperature of at least
40.5ºC.
4.2.5. Sampling
EDTA-blood samples from all the pigs were collected on days 0, 2, 4, 7, 9, 11, 14,
16, 18, 21, 28, and 35 after inoculation. From these blood samples peripheral blood
leukocytes were extracted as described in De Smit et al. (2001b), with one
difference: the leukocytes were resuspended in a K1000 medium with 2% antibiotic
stock before storage at –70°C. Oral swabs were taken on days 0, 2, 4, 7, 9, 11, 14,
16, and 18 after inoculation to monitor viral excretion. The samples were stored at –
70ºC until they were tested collectively.
Serum blood samples of all the pigs were taken just before vaccination, just
before inoculation and during the transmission experiments at weekly intervals until
death or euthanasia. Serum samples of the vaccinated dams were taken four weeks
after farrowing. Samples were stored at –20°C until testing at the end of the
experiment.
At post-mortem examination, tissue samples were collected from tonsil, spleen,
kidney, and ileum, for a direct immunofluorescence test for the presence of viral
antigen.
4.2.6. Testing
The EDTA-blood samples were used to monitor the leukocytes and thrombocytes in
the blood. Cell counts were performed with a Medonic® CA cell counter: a decrease
of the numbers of leukocytes (leukopenia) or thrombocytes (thrombocytopenia) is a
typical sign of CSF (Dahle and Liess, 1992; Taylor, 1995). Leukopenia and
thrombocytopenia were defined as cell and platelet counts that were considerably
lower (1 day < half of the maximum value of the first week’s counts [days 0, 2, and
4 after challenge]).
Presence of virus in the leukocyte samples and oral swabs was tested by virus
isolation (De Smit et al., 2001b; Wensvoort et al., 1986). Antigen detection in the
post-mortem tissue samples was checked in an immunofluorescence test (IFT,
Ressang and Den Boer, 1967).
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The serum samples were tested for antibodies by two ELISAs and by a
neutralising peroxidase-linked assay (NPLA). The ELISAs were the Ceditest® E2-
ELISA (Colijn et al., 1997), which detects antibodies against the E2-vaccine and the
corresponding epitope on the CSFV; and the Ceditest® Erns-ELISA (De Smit et al.,
2000b), which detects antibodies against the Erns epitope on the CSFV only, and is
therefore the test that distinguishes between vaccinated and infected animals. The
NPLA (Terpstra et al., 1984) determines the antibody titre against the whole virus.
The antibody titre was expressed as the reciprocal of the highest dilution that
neutralised all virus present.
4.2.7. Data analysis
The vaccine-induced antibody (VIA) titres were examined in three steps to
investigate the effect of maternal immunity on vaccination effectiveness. In the first
step, it was tested whether the MDA titres at two weeks of age differed between the
piglets (groups C and D) of the three mother sows. For this, a Kruskal-Wallis test
(Sokal and Rohlf, 1981) was used. In the second step, it was tested whether the
MDA titres at two weeks of age were related with the VIA titres at three or six
months of age, before the transmission experiments started (groups C and D). This
was done with a two-sided Spearman’s rank correlation test (Sokal and Rohlf,
1981). In the third step, it was tested whether the VIA titres in the MDA+-vaccinated
animals differed from the titres of the MDA–-vaccinated animals. A two-sided
Mann-Whitney U test (Sokal and Rohlf, 1981) was used to test group C versus E
(three months post vaccination) and group D versus F (6 months post vaccination).
The effect of vaccination on the transmission of CSFV was analysed with the
statistical test of Kroese and De Jong (2001). This method, which is based on the
stochastic SIR model that describes the transmission dynamics of infectious diseases
between individuals, compares treatments pairwise with respect to their effect on
virus transmission. The test statistic that is needed for this test, is the difference in
the numbers of contact infections between the two treatment groups, where a contact
infection is a contact animal that got infected during the trial. The test calculates the
probability (P) of the observed difference in the numbers of contact infections,
under the null-hypothesis: R0,control = R0,vaccine. If P is smaller than 0.05, the groups
differ significantly with respect to virus transmission.
In this experiment, group C was tested against G, group E against G, group D
against H, and group F against H, in each case a vaccinated group against a control
group. A significant difference would lead to the conclusion that the vaccine
protects against CSFV transmission. For each group, the number of contact
infections had to be determined. A contact animal was considered a contact infection
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if it had been positive at least once in the IFT, the virus isolation from leukocytes, or
the Erns ELISA.
Basic reproduction ratios (R0s) were estimated in each group using two methods.
The first is a maximum likelihood method based on the number of initially
infectious animals (I0) and the number of ultimately infected animals (It) (final size
method (Kroese and De Jong, 2001)). The second is a maximum likelihood method
with Generalised Linear Models (GLM), based on the exact course of the local
epidemic within the group (GLM method (Chapter 2)). For the GLM method, the
periods during which the animals were infectious towards other animals had to be
determined. This was done by assuming that animals are infectious when they are
viraemic, which made it possible to reconstruct the course of each experiment. Both
estimation methods were used, because on the one hand the final size method needs
no assumptions on the course of the infectiousness of the individual animals and can
therefore be used with little data, but on the other hand the GLM method, which
needs more data, gives narrower confidence intervals. If the confidence intervals
obtained did not include the value 1 but only values smaller (larger) than 1, it could
be concluded that R0 was significantly smaller (larger) than 1.
4.3. Results
4.3.1. MDA and VIA titres
The MDA titres at the time of vaccination of groups C and D are shown in Table
4.1, as well as the VIA titres at the starting time of the transmission trials of groups
C, D, E, and F. It appeared that there was a significant difference between the three
sows in their piglets’ MDA titres (P < 0.01): a lower antibody titre in the sow seems
to lead to a lower titre in its piglets. The MDA titre is not related to the VIA titre in
the same pig, neither at three months (P = 0.21) nor at six months (P = 0.67).
However, MDA+-vaccinated pigs do differ from MDA–-vaccinated pigs with respect
to their antibody titres, after three months (P < 0.01) as well as after six months (P <
0.01).
4.3.2. Description of the trials
Figure 4.1 shows the data of oral swab and leukocyte virus isolation, IFT, and Erns-
ELISA. Each trial is described separately and the numbers of the animals refer to
Figure 4.1.
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Table 4.1. Maternal antibody titres at the day of vaccination and vaccine-induced
antibody titres at the day of the start of the transmission trials. The titres are expressed as
the 2log(titre/10).
Animal age Animal ageAnimal noa
2 weeksb 3 monthsc 6 monthsc
Animal no
3 monthsd 6 monthsd
1 (I) 8 6.5 11 8.5
2 (I) 8.5 <0e 12 7
3 (I) 7.5 7 13 8
4 (I) 7.5 6 14 11
5 (I) 7.5 7 15 10.5
6 (I) 7.5 7 16 4
7 (II) 6 7 17 7.5
8 (II) 7 7 18 9
9 (III) 4.5 6 19 7.5
G
ro
up
 C
10 (III) 5 7.5
N
ot
 d
et
er
m
in
ed
G
ro
up
 E
20 9.5
N
ot
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et
er
m
in
ed
31 (I) 9 8 41 9
32 (I) 6.5 5.5 42 7.5
33 (I) 7.5 6.5 43 8
34 (I) 8.5 6.5 44 7
35 (I) 9.5 7.5 45 8
36 (I) 8.5 4 46 7
37 (II) 6.5 5.5 47 8.5
38 (III) 5 6 48 7.5
39 (III) 5 7 49 9
G
ro
up
 D
40 (III) 5.5
N
ot
 d
et
er
m
in
ed
8
G
ro
up
 F
50
N
ot
 d
et
er
m
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ed
9
a Between brackets are the numbers of the dams, which had the following antibody titres
4 weeks post-farrowing: (I) 6.5, (II) 5.5, (III) 2.5.
b The maternal antibody titres. There was a significant difference in antibody titres
between the piglets of the three sows (P < 0.01).
c The vaccine-induced antibody titres in the MDA+-vaccinated animals at the start of the
transmission experiments. There was no significant relation between the maternal titres at
two weeks and the vaccine-induced titres at three months (P = 0.21) or at six months (P =
0.67).
d The vaccine-induced antibody titres in the MDA–-vaccinated animals at the start of the
transmission trials. There was a significant effect of maternal immunity on the vaccine-
induced titre at three months (P < 0.01) and at six months (P < 0.01).
e During the transmission trial, the titre of this animal was comparable to the titres of the
animals with the same treatment (nos. 1, 3, 4, 5).
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Animal Days since inoculation
 no   c/i Vacc 0 2 4 7 9 11 14 16 18 21 28 35
Erns IFT
1 c – – – – – – – – – – – – – – –
2 c – – – – – – – – – – – – – – –
3 c – – – – – – – – – – – – – – –
4 c – – – – – – – – – – – – – – –
5 c – – – – – – – – – – – – – – –
6 i – – – – – – – – – – + – – – –
7 i – – – – – – – – – – – – – – –
8 i – – – – – – – – – – + – – – –
9 i – – – – – – – – – – + – – – –
Group C
MDA+
3 months
10 i – – – – – – – – – – + – – – –
11 c – – – – – – – – – – – – – – –
12 c – – – – – – – – – – – – – – –
13 c – – – – – – – – – – – – – – –
14 c – – – – – – – – – – – – – – –
15 c – – – – – – – – – – – – – – –
16 i – – – – – – – – – – + – – – –
17 i – – – – – – – – – – + – – – –
18 i – – – – – – – – – – + – – – –
19 i – – – – – – – – – – + – – – –
Group E
MDA–
3 months
20 i – – – – – – – – – – + – – – –
21 c – – – – – – – – – – + – – – –
22 c – – – – – – – + + – x + – – – –
23 c – – – – – – – – + – + – – – –
24 c – – – – – – – + + + + + + + +
25 c – – – – – – – – + + + + + + +
26 i – – – – – + + + + + x + + + + +
27 i – – – – – – – – – – + – – – –
28 i – – – – – – + + – + x + + + + +
29 i – – – – – – + – – – + – – – –
Group G
control
3 months
30 i – – – + + – – – – – + – – – –
31 c – – – – – – – – – – – – – – –
32 c – – – – – – – – – – – – – – –
33 c – – – – – – – – – – – – – – –
34 c – – – – – – – – – – + – – – –
35 c – – – – – – – – – – – – – – –
36 i – – – – – – – – – – + – – – –
37 i – – – – – – – – – – + – – – –
38 i – – – – – – – – – – + – – – –
39 i – – – – – – – – – – + – – – –
Group D
MDA+
6 months
40 i – – – – – – – – – – + – – – –
41 c – – – – – – – – – – – – – – –
42 c – – – – – – – – – – – – – – –
43 c – – – – – – – – – – – – – – –
44 c – – – – – – – – – – – – – – –
45 c – – – – – – – – – – – – – – –
46 i – – – – – – – – – – + – – – –
47 i – – – – – – – – – – – – – – –
48 i – – – – – – – – – – + – – – –
49 i – – – – – – – – – – + – – – –
Group F
MDA–
6 months
50 i – – – – – – – – – – + – – – –
51 c – – – – – – – – – – + – – – –
52 c – – – – – – – – – – + – – – –
53 c – – – – – – – – – – + – – – –
54 c – – – – – – – – – – + – – – –
55 c – – – – – – – – – – + – – – –
56 i – – – – – + + – – – x + + – + +
57 i – – – – – + – – – – + – – – –
58 i – – – – – + – – – – + – – – –
59 i – – – – – + – – – – + – – – –
Group H
control
6 months
60 i – – – – – – – – – – + – – – –
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4.3.2.1. Group C: vaccination when MDA+, transmission experiment after 3 months
No clinical signs developed in group C, and only inoculated animal 10 had two days
of fever (41.2ºC and 41.3ºC after 7 and 8 days, respectively). Leukopenia developed
in inoculated pigs 6 and 9, and thrombocytopenia in contact pig 4. All organs were
virus negative, as were the oral swabs. Four inoculated animals showed one day of
viraemia and these animals were also Erns-positive at some time. NPLA showed an
increase in antibody titre of all inoculated animals except no. 7. All the tests on this
animal were negative so we assumed that the inoculation had not been successful.
Therefore, the animal was considered susceptible in the statistical analysis. The
number of contact infections was 0.
4.3.2.2. Group E: vaccination when MDA–, transmission experiment after 3 months
None of the pigs in group E showed clinical signs. Leukopenia was detected in four
inoculated pigs (nos. 16, 17, 19, 20). Two inoculated pigs exhibited one day of
viraemia, while IFT and oral swabs were negative for all animals during the entire
experiment. All inoculated animals were Erns-positive. The number of contact
infections was 0.
4.3.2.3. Group G: control (MDA–, no vaccination), transmission experiment after 3
months
All pigs of group G developed clinical signs ranging from dullness to diarrhoea and
crippling. All animals got fever, the maximum temperature ranging between 40.7°C
and 42.0°C. Two inoculated and two contact animals (nos. 22, 24, 26, 28) were
killed during the experiment when moribund. All tested organs of three of these
animals and of one other contact animal were IFT-positive. All animals developed
← Figure 1. Course of the experiment in all trials. Each row represents one animal,
identified by a number and either an ‘i’, if it was an inoculated animal, or a ‘c’, if it was a
contact animal. Day ‘Vacc’ is the day of vaccination, or, in the case of groups G and H,
14 days before day 0. Indicated are for each day the data of the virus isolation from the
oral swabs (+/– at individual days; empty fields on days without sampling), and the data
of the virus isolation from the EDTA blood samples (shaded areas denote viraemia, no
shading means negative test result unless the animal had died). The last two columns
show the data of the Erns-ELISA (+ if the animal had been positive at least once), and the
data of the IFT (the four +/ –-signs denote the IFT results from tonsil, kidney, spleen, and
ileum, respectively). ‘x’, day as from which the animal was dead (might have died at a
day not indicated in the figure).
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leukopenia, and all pigs but one (no. 27) got thrombocytopenia as well. The oral
swabs of four inoculated and four contact animals were virus-positive at least one
day. All the pigs had developed viraemia and were positive in the Erns-ELISA. The
number of contact infections was 5.
4.3.2.4. Group D: vaccination when MDA+, transmission experiment after 6 months
No clinical signs were observed in group D. Thrombocytopenia appeared to have
developed in three contact animals (nos. 31-33), and leukopenia was observed in the
five inoculated pigs. All oral swabs were negative, no viraemia was seen and all
organs were negative in the IFT. All inoculated animals appeared to have Erns-
antibodies, and one contact animal was Erns-ELISA positive (no. 34). Antibody titres
increased after inoculation in all inoculated pigs. The number of contact infections
was 1.
4.3.2.5. Group F: vaccination when MDA–, transmission experiment after 6 months
The pigs in group F had no clinical signs. The two inoculated pigs 47 and 48
developed thrombocytopenia; no. 48 also showed leukopenia. Oral swabs and
leukocyte virus isolation were always negative and only four of the inoculated pigs
were Erns-positive. Because the fifth, Erns-negative, pig (no. 47) did show a large
increase in antibody titre, as observed in the NPLA test, inoculation was assumed to
have been successful in this animal. The number of contact infections was 0.
4.3.2.6. Group H: control (MDA–, no vaccination), transmission experiment after 6
months
Four inoculated and four contact pigs (nos. 52-56, 58-60) developed clinical signs,
mostly dullness and anorexia. Four inoculated pigs (nos. 56, 58-60) also got fever,
the maximum temperature ranging between 40.5°C and 41.3°C. One inoculated
moribund animal was killed during the experiment. This was the only animal that
tested IFT-positive in all organs but the kidney. Two inoculated pigs and one contact
pig (nos. 51, 56, 59) developed thrombocytopenia; three inoculated and all contact
pigs (nos. 51-57, 59) showed leukopenia. Only four inoculated animals had positive
oral swabs, but all ten pigs were viraemic for one or more days. All pigs were Erns-
positive. The number of contact infections was 5.
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4.3.3. Analysis of the transmission experiments
Table 2 presents the results of the statistical evaluation of the transmission
experiments. First, the difference in the number of contact infections between the
vaccinated groups (C, D, E, F) and the control groups (G, H) was used to test
whether vaccination reduced CSFV transmission. The transmission was reduced in
the groups C, E, and F (P < 0.05), but not in group D. Therefore, it is concluded that
transmission was not significantly reduced 6 months after vaccination in MDA+
pigs.
Second, the reproduction ratio R0 in the different groups was estimated. The final
size method estimated R0 in all four vaccinated groups (C, D, E, F) to be below 1,
and in both control groups (G, H) above 1. However, none of these R0s significantly
differed from 1. The GLM method could only be properly used in the control groups
G and H, since in the vaccine groups not enough infectiousness — viraemia was
assumed to denote infectiousness — was available. R0 appeared to be significantly
above 1 in both control groups (P < 0.01). The GLM method estimated R0 after six
Table 4.2. Final size results and statistical analysis of the transmission trials.
Treatmenta Final sizeb P-valuec final size methodd GLM methodeGroup
MDA vacc time lag I0 It R0 95% CI R0 95% CI
C + + 3 4 4 0.017 0.0 (0.0 - 2.5) NDg NDg
D + + 6 5 6 0.053 0.38 (0.020 - 3.2) NDg NDg
E – + 3 5 5 0.013 0.0 (0.0 - 2.2) NDg NDg
F – + 6 5 5 0.013 0.0 (0.0 - 2.2) NDg NDg
G – – 3 5 10 NDf ∞ (0.68 - ∞) 16 (5.0 - 51)
H – – 6 5 10 NDf ∞ (0.68 - ∞) 4.0 (1.4 - 12)
a Summary of the treatment of the groups: MDA, presence of MDA at the time of
vaccination; vacc, vaccination at two weeks of age; time lag, time lag between
vaccination and start of the transmission trial.
b The final size results of the transmission trials: I0, number of successfully virus-
inoculated animals; It, number of animals ultimately infected.
c P-value of the final size-based test with H0: R0,vaccine = R0,control (Kroese and De Jong,
2001). Groups C and E are tested against G, groups D and F are tested against H.
d R0 estimations and 95% CI with the final size method as described in Kroese and De
Jong (2001).
e R0 estimations and 95% CI with the GLM method as described in Chapter 2.
f Not determined, because these are the control groups.
g Not determined, because of lack of data.
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months (group H) smaller than R0 after three months (group G), but this difference
was not statistically significant.
4.4. Discussion
The objective of this study was to determine whether vaccination of piglets at two
weeks of age, reduced transmission of CSFV three and six months later. Because
maternal immunity might affect the vaccine effectiveness in young pigs, vaccination
of MDA+ pigs has been compared with vaccination of MDA– pigs.
First, the antibody titres of the pigs were examined in order to test the effect of
MDA on the VIA titres. It was shown that the presence of MDA at the time of
vaccination led to lower VIA titres (Table 1). The titres of pigs from vaccinated
sows (averages of the 2log(titre/10): 6.1 after three months; 6.5 after six months)
were significantly lower than the titre of pigs from unvaccinated sows (averages: 8.3
after three months; 8.1 after six months). This effect has also been observed with the
C-strain vaccine, a modified live CSF vaccine (Precausta et al., 1983; Terpstra and
Tielen, 1976) and is probably caused by neutralisation of the vaccine by the MDA.
Neutralisation of the vaccine by MDA would also be expected to lead to different
vaccine responses between MDA+ pigs, i.e., a negative correlation between the
MDA titre and the VIA titre in the same pig. Such a negative correlation could lead
to a very heterogeneously protected pig population, with subgroups of poorly
protected pigs within which CSFV can circulate (R0 > 1 within subgroups). A
negative correlation could, however, not be shown in this experiment (Table 1),
although it has been described with the C-strain vaccine (Precausta et al., 1978;
Terpstra and Tielen, 1976). The difference can possibly be explained by the different
natures of the E2 vaccine and the C-strain vaccine, the latter of which is suggested to
have a relatively high sensitivity of the vaccination response to the presence of
maternal antibodies (Precausta et al., 1978). More likely, however, is that there is an
effect of the MDA titre on the VIA titre, but that this could not be shown with only
ten animals per time interval. In any case, since there is no very clear-cut effect,
vaccination of MDA+ pigs is not expected to lead to subgroups of poorly protected
pigs.
A question may be raised concerning the level of the antibodies at three or six
months, whether this may still consist of MDA, which would mean that the VIA
titres are in fact even more reduced in MDA+-vaccinated pigs than already shown.
This is, however, rather unlikely, since the MDA titres reach a minimum level from
about 10 weeks of age onwards (Precausta et al. (1978, 1983); Soos et al. (2001);
Terpstra and Tielen (1976) for the C-strain vaccine; Lipowski et al. (2000) for the
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E2-vaccine). Moreover, MDA of piglets from sows with the same treatment as in
this paper had titres below the detection limit at an age of 84 days (Moormann,
unpublished results).
Second, the effectiveness of vaccination with respect to virus transmission was
investigated. This was done three and six months post-vaccination, in MDA+-
vaccinated as well as MDA–-vaccinated animals. The experiments indicate that, after
vaccination at a very young age, the reduction of transmission of CSFV will still be
significant at slaughter age, at least if the piglets were MDA–. In the case of the
vaccination of MDA+ piglets, a statistically significant reduction of transmission
after six months could not be proved (group D). Because of the apparently reduced
protection and the lower antibody titres in MDA+-vaccinated pigs after six months,
there seems to be a relation between antibody titre and virus transmission. Although
the relation cannot be excluded, it is not certain either: the antibody titres in the
MDA+ group C were lower than in the MDA– group E three months after
vaccination, but virus transmission was significantly reduced in both groups C and
E. Moreover, the conclusion that maternal immunity at the time of vaccination
hampers the reduction of CSFV transmission six months after vaccination, would be
too definite for two reasons. The first is that the power of the statistical test was only
33%, with one vaccine group (if R0 = 0.38 as estimated) and one control group (if
R0 = 4.0 as estimated). The second reason is that the method of counting contact
infections is rather conservative. The statistical method used to test the reduction of
transmission in the vaccinated groups assumes equal infectivity of all infected pigs,
whether inoculated or contact infected. Whether the contact infection in group D is a
true contact infection in terms of this assumption, is questionable, since it was only
once positive in the Erns ELISA and never in any other test, including cell counts and
temperature measurements. An interesting observation was that, in the control
groups, R0 after six months was estimated to be smaller than R0 after three months.
Although this was not a significant result, it is in accordance with estimations from
other experiments with CSFV, where R0 did differ significantly between weaner pigs
(6 weeks) and slaughter pigs (6 months) (Chapter 2).
The results of the presented experiment, together with the results of earlier
transmission experiments in E2 vaccinated animals (Bouma et al., 2000), give
confidence in the effectiveness of emergency vaccination as a control measure
during CSF epidemics. CSFV transmission appears to be significantly reduced
during the entire economic life of finishing pigs, when they are vaccinated once at a
young age. R0 appears to be smaller than 1, so that no major outbreaks can occur. A
point of concern is the possible negative effect of maternal immunity on the vaccine
effectiveness. For the development of control strategies, it might be considered to
avoid the risk of having vaccinated pigs that become susceptible again. This can be
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done, e.g., by vaccinating at a later age, or by not vaccinating sows at all. In the case
of the C-strain vaccine, age at vaccination appeared to be of importance for the size
of the MDA-caused inhibitory effect on VIA development (Precausta et al., 1983).
Not vaccinating sows may sound unlogical at first, but if all other pigs within the
herd are vaccinated, herd immunity may remain secured. Another advantage is that,
if persistently infected piglets would be born (piglets which shed CSFV without
getting diseased, (Van Oirschot and Terpstra, 1977)), the very young unprotected
piglets and the sows can have a ‘signalling’ function by showing clinical signs after
infection by the persistently infected piglets. The vaccine, namely, does not fully
prevent birth of these piglets (Depner et al., 2001; Dewulf et al., 2001).
Further investigations into effectiveness of different control scenarios can be
done by means of mathematical modelling virus spread between herds. The specific
design of transmission trials, with homogeneous groups of animals instead of
vaccinated infectious animals and unvaccinated sentinels, make it easier to
extrapolate the data to the field situation with mathematical models. That is, because
the actual effectiveness of vaccination of pig herds is reflected by the vaccine’s
effectiveness on susceptibility and infectivity together. Moreover, the vaccine can be
judged in terms of the reproduction ratio R0, which facilitates the interpretation of its
effect on transmission within pig herds.
In this particular experiment we used conventional pigs instead of SPF pigs. The
advantage of SPF animals would be that the animals are probably more similar
leading to less variance in the results and a higher power of the experiment.
Therefore, using SPF animals to evaluate vaccine efficacy can be very effective.
However, a major disadvantage is that conclusions drawn from experiments with
SPF animals do not necessarily apply to conventional animals, as is suggested by
Van Nes et al. (2001) in the case of PRV transmission between pigs. More
significant results in different settings augment the robustness of the conclusion that
the vaccine is indeed capable of reducing transmission.
An important factor of a marker vaccine is the quality of its accompanying
diagnostic test. The accompanying test of the E2 vaccine is the Erns ELISA and in
this experiment two animals (in groups C and F) were not found positive in the Erns
ELISA after inoculation. One of these pigs (in group C) had no increase in CSFV
antibody titre and did not show any other sign of CSFV infection, so we assumed
that inoculation had not caused infection. The animal was considered susceptible in
the statistical analysis. Considering it infectious would, however, not have altered
the conclusion that virus transmission was significantly reduced in group C. The
other inoculated Erns-negative animal did show an antibody (booster) response,
which means that the Erns ELISA result was false-negative. Occurrence of false-
negativity is in accordance with experiments for determination of the Erns ELISA test
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characteristics, in which the sensitivity was estimated at about 74% (De Smit et al.,
2000b; Floegel Niesmann, 2001). False-negative in this case means that the Erns
ELISA was unable to detect antibodies in an animal that had been in contact with
the virus. In principle, every test will suffer from this inability to some degree if the
amount of virus that the animal had been in contact with is small enough. However,
it is undesirable for a test to score an animal false-negative, when it is a risk in terms
of infectiousness. It is unlikely that false-negatives for the Erns ELISA are very
infectious since even Erns-positive (vaccinated) animals were hardly able to transmit
virus to contact animals, which has been seen in the experiments presented in this
paper and in the experiments of Bouma et al. (2000).
Acknowledgements
We owe much gratitude to H. Rutgers, A. Timmerman and co-workers for the care
of the animals and to W. Hoogers, L. Mastenbroek, M. Koopmans, and E. de
Kluijver for their technical assistance. We thank three anonymous referees for
helpful comments on the manuscript. This research project was supported by Bayer
Animal Health Division, Germany, and STW (Technology Foundation), Utrecht,
The Netherlands.

Chapter 5
Quantification of the effect of control
strategies on classical swine fever epidemics
D. Klinkenberg , A. Everts-van der Wind, E.A.M. Graat, M.C.M. de Jong
Submitted to Mathematical Biosciences

Effect of control strategies
81
Abstract
Emergency vaccination during an epidemic of Classical Swine Fever Virus (CSFV)
has become a serious option because of the ethical problems of strategies with
massive culling and the availability of a marker vaccine that reduces virus
transmission. Here we present a model of between-herd CSFV transmission, which
quantifies the effect of control strategies with and without vaccination. We estimate
the model parameters from data of the Dutch CSFV epidemic of 1997/1998. With
the model, a set of control strategies is compared, consisting of five control
measures in several combinations. Consequently, the following general requirements
of successful strategies can be formulated. First, to achieve extinction of a CSFV
epidemic, transmission through transport should be prevented and the indirect virus
transmission, i.e. all transmission not through animal contacts, should at least be
halved, either by vaccination or by culling of the susceptible pig population. Second,
to minimise the size and duration of an epidemic, the extinction requirements should
be met quickly and indirect virus transmission should be reduced by far more than a
half. Although the origin of the model parameters let the requirements in fact be
only applicable for the southeastern part of the Netherlands, it is argued that
epidemics in other areas will not need stricter control strategies.
5.1. Introduction
Classical swine fever (CSF) is a viral disease of swine (Taylor, 1995). The entry of
classical swine fever virus (CSFV) into populations of non-vaccinated domestic pigs
can cause large epidemics. Nonetheless, the domestic pig population of the
European Union (EU) is not preventively vaccinated against CSFV, because
importing countries do not accept vaccinated pigs (Anonymous, 1980). They
consider vaccinated pigs as infected, which is due to the fact that most antibody tests
react positively in vaccinated animals. This problem was to be solved with the Erns-
antibody ELISA, designed to be used with the E2 subunit marker vaccine which
only evokes antibodies against the E2 subunit and not against Erns. However, the Erns
ELISA has a sensitivity of only 75% (Depner et al., 2001).
In 1997, a CSFV entry into the Netherlands led to a large epidemic (hereafter
called the Dutch CSFV epidemic), which lasted 1.5 years and in which 429 herds
were infected (Elbers et al., 1999). In part the epidemic was so large and long-
lasting because the initial set of control measures, as prescribed by the EU, was
insufficient to bring the basic reproduction ratio between herds, Rh, to a value below
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1. Additional control measures appeared necessary, among which preventive
slaughter of herds with traced contacts with infected herds or in close vicinity of
infected herds (Stegeman et al., 1999b). Preventive slaughter, however, has major
disadvantages, because the killing of healthy pigs, if not for consumption, is
economically and ethically undesirable (Terpstra et al., 2000).
Future introductions of CSFV should therefore be followed by an alternative
control strategy, without preventive killing but with the effect of reducing Rh
sufficiently to end the epidemic quickly. A future strategy might include emergency
vaccination, e.g. with an E2 subunit vaccine, which reduces the basic reproduction
ratio between individual pigs to below 1 (Bouma et al., 2000; Chapter 3).
Vaccination of the entire pig population will therefore certainly lead to extinction of
a CSF epidemic. However, the economic consequences might be far-reaching since
importing countries will not resume import of live pigs and pig products as long as
the entire population is not CSFV-free. If importing countries do not accept a
sensitivity of 75% to prove virus-freedom, all vaccinated animals will have to be
removed before resuming export. If sufficiently effective, it would be preferable to
use strategies with only partial vaccination, e.g. only vaccination of fattening pigs.
These could already be replaced by unvaccinated piglets before the end of the
epidemic.
Considerations like these make it desirable to know the requirements of a good
control strategy. To determine these requirements, the effects of various control
strategies should be quantified. Nielen et al. (1999) and Mangen et al. (2001) studied
the epidemiological and economic effects of a number of control strategies, in part
defined by the reaction of trading partners — whether they will or will not import
vaccinated pigs. In both these studies, simulation models with a very detailed
structure were used. The models, for example, were spatially explicit and simulated
every single contact between farms. The approach enabled the authors to make
detailed economic analyses, but leads to questions regarding the reliability of the
exact outcomes since many parameter values had to be chosen without data.
Moreover, a general insight into the requirements of a good control strategy cannot
be obtained. This points out the need for a quantitative analysis of control strategies
with reliable parameter estimates from epidemic data.
In this paper, we present a mathematical model of CSFV transmission between
pig herds. We use the model to link data on CSFV transmission and assumptions on
the effect of control measures. In section 2, the model structure is presented. In
section 3, the model is used to construct likelihood functions, which are used to
estimate the model parameters from data of the 1997/1998 CSFV epidemic in the
Netherlands. Section 4 describes how five control measures are incorporated into the
model. In section 5, the estimated parameters are used to quantify the effects of the
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five control measures, which are applied in all possible combinations. From the
analysis, general requirements for good control strategies are deduced. Finally, in
section 6 the results are interpreted and discussed in relation to previous
publications, model assumptions, and the future of CSFV control.
5.2. Model structure
The model describes the transmission of CSFV between pig herds in the
Netherlands. In the basic model, the set of EU control measures is applied, as was
applied in the first ten weeks of the Dutch CSFV epidemic (Stegeman et al., 1999b).
The most important control measures are the culling of infected herds, a transport
prohibition, the tracing and testing of infectious contacts, and the implementation of
hygiene measures and surveillance in the affected area. In the basic model, however,
the complete transport prohibition is relaxed and animal transport from multiplier to
finishing herds and from finishing herds to the slaughterhouse is permitted. This
relaxation causes heterogeneity in the contact pattern, and therefore two herd types
are distinguished in the model, multiplier herds and finishing herds. Multiplier herds
contain sows and produce 23 piglets per sow per year (Siva software, 2001), which
are transported to the finishing herds at an age of ten weeks. This leads to a piglet to
sow ratio of (23⋅10⋅7):365 = 1610:365 within multiplier herds. The pigs remain 100
days on the finishing herds, until slaughter.
The virus transmission between pig herds is modelled as a branching process of
infected herds, which means that the number of available susceptible herds to be
infected is not limiting. Immediately after infection, virus spreads within the herd.
The herd gives rise to new infected herds by a Poisson process with a variable rate
proportional to the number of infectious animals within the herd. The infection
process stops when infection of the herd is detected, as detection is immediately
followed by culling of the herd. Although virus entry into a herd can result in a
minor outbreak, only major outbreaks within herds are modelled since these are the
most important for further virus transmission between herds. For an overview of all
model parameters, variables, and functions, see Appendix 5A.
5.2.1. Within-herd transmission
Virus transmission within a herd starts with one infectious pig, immediately after
infection of the herd. We assume that this is followed by a linear birth-death process
(Cox and Miller, 1965) of infected pigs, independent of herd type. In
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epidemiological terms, birth would be equivalent to infection and death to recovery.
The linear birth-death process is described by
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tdp
iii
i µλµλ (5.1.3)
in which pi(t) is the probability of having i infectious pigs at time t, λ is the per
capita infection rate and µ is the recovery rate (Cox and Miller, 1965).
The solution to this set of differential equations with initial conditions 1)0(1 =p
and 10)0( ≠∀= ipi  is given by (after Cox and Miller (1965), p. 166)
( )
( ) 1exp
1exp)(0 −⋅
−=
rtR
rttp (5.2.1)
( )( )( ) 1000 )()(1)(1)( −−−= ii tRptRptptp , (5.2.2)
in which r = λ - µ, the mean exponential growth rate of the number of infectious
pigs, and R = λ/µ, the basic reproduction ratio between animals. In the model, R is
assumed to exceed 1 (and hence, r > 0), otherwise no major outbreaks can occur
within herds.
We now define the stochastic variable I(t)1 as the number of infected animals at
time t since infection of the herd and conditioned on non-extinction, as the model
only takes major outbreaks in herds into account:
( )( ) ( )( ) ( )( ) ( )( ) 1000 11
−−=−==
ii tRptRp
tp
tp
itIP . (5.3)
                                                          
1 Throughout the paper, upper case letters denote stochastic variables, whereas lower
case letters denote parameters or ordinary variables. Note that r and R are two
different model parameters.
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 By letting t→∞, a continuous approximation to the discrete distribution for I(t) can
be made (see Appendix 5B):
( )rtHtI exp)( = , in which (5.4.1)
( ) 

 −−−=≅ h
R
R
R
RhpdfH 1exp1 . (5.4.2)
The approximation (5.4) is used instead of the real solution (5.2) to keep the model
more manageable. In short, the within-herd transmission of CSFV is described by a
deterministic exponential curve of which the height is random and has an
exponential distribution.
5.2.2. Herd detection
Infected herds can be detected at any time after they are infected. Detection of
infected herds takes place by a Poisson process with an increasing rate
( )rtHtI exp)( αα = . The first realisation is the detection time. Parameter α is the
detection rate per infectious pig. After detection of a herd, it is immediately culled
and cannot give rise to new infected herds anymore.
5.2.3. Between-herd transmission: indirect contacts
Each infectious herd can transmit the virus to susceptible herds via indirect contacts,
i.e. all potentially infectious contacts except transport of infectious pigs.
Transmission takes place by a Poisson process, thereby giving rise to new infectious
herds with increasing transmission rates ( )rtHtI ff exp)( ββ =  for infecting
finishing herds and ( )rtHtI mm exp)( ββ =  for infecting multiplier herds, where t is
the time since infection of the infectious (source) herd. The type of source herd is
assumed irrelevant. Parameters βf and βm are the transmission rates per infectious
pig per indirect contact per day. The sum βind = βf + βm is the total rate by which an
infectious animal in an infectious herd gives rise to new infectious herds through
indirect contacts.
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5.2.4. Between-herd transmission: transport contacts
Infectious herds can also transmit virus through transport of live pigs. In the model,
this mode of transmission is restricted to multiplier herds infecting finishing herds.
For simplicity, the assumption is made that this occurs analogously to the indirect-
contact transmission, viz. by a Poisson process with rate ( )rtHtI trtr exp)( ββ = , in
which βtr is the transmission rate per infectious pig for transport contacts.
5.3. Parameter estimations
The described model contains six parameters: (1) r, the exponential growth
parameter for the number of infectious pigs on a farm; (2) R, the basic reproduction
ratio between animals on a farm, which describes the height of the exponential
infectious curve within farms. The pair (r, R) is a reparametrisation of the parameter
pair (λ, µ) of the within-herd transmission model: r = λ – µ and R = λ/µ; (3) α, the
detection parameter, which denotes the rate of herd detection per infectious pig on a
farm; (4) βind, the between-herd transmission parameter that denotes the rate at
which one infectious pig infects other herds by indirect herd contacts. The indirect
transmission is split into two types, for the transmission to finishing herds and to
multiplier herds, which are denoted by the parameters βf and βm, respectively. The
values of βf and βm can be derived from their sum βind and from their ratio: (5) the β-
f:βm ratio, which determines the division of βind into βf and βm; (6) βtr, the between-
herd transmission parameter for transport contacts.
5.3.1. Methods
5.3.1.1. Estimation of r, R, α, and βind
The first four parameters r, R, α, and βind have been estimated simultaneously by
using data from the 1997/1998 epidemic in the Netherlands under the assumption
that the data had arisen according to the described mathematical model. From the
data, three stochastic processes could be distinguished and the log-likelihood
functions L1(r, R), L2(r, R, α), and L3(r, R, α, βind) for these processes were
formulated. The sum of these log-likelihood functions
L(r, R, α, βind) = L1(r, R) + L2(r, R, α) + L3(r, R, α, βind) has been maximised
numerically in Mathematica® (Wolfram, 1999) for the four parameters
simultaneously to obtain the maximum likelihood estimates.
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The combined likelihood function has also been used to derive a distribution of
the estimators. Since α and βind are positive by definition and r must be positive to
enable within-herd transmission, it was assumed that the estimators for r, α, and βind
were lognormally distributed. Since R > 1 to enable within herd transmission2, it was
assumed that the estimator for R-1 was lognormally distributed. A covariance matrix
for logr, log(R-1), logα, and logβind was obtained numerically in Mathematica®
(Wolfram, 1999) by calculating
( ) ( )( )
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( )( )
( )( ) ( )
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The goodness-of-fit of the model to the parameters has been tested for each
likelihood equation separately, by calculation of the Pearson χ2 statistic
( )( )
( )( )( )∑= 


 −= n
i i
iii
YE
YEy
1
2
2
var
χ ,
in which n is the number of records, yi the ith observation, E(Yi) the expected value
of the ith observation, and var(E(Yi)) the estimated variance of the ith observation.
The statistic is χ2-distributed with n – p degrees of freedom, where p is the number
of parameters estimated with the regarded likelihood equation.
5.3.1.2. Log-likelihood function L1(r, R)
The first log-likelihood function described the detection of infected animals in a
random sample of animals as a function of time since infection of the herd. The
function provided information on the within-herd transmission parameters r and R.
                                                          
2 Note that a basic reproduction ratio larger than 1 implies a net exponential
increase: R > 1 ⇔ r > 0 (Diekmann and Heesterbeek, 2000).
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Table 5.1. The dataset for L1(r,R). Each row represents the record of one herd.
tdet (days) a ntot b ntest c npos d E(Npos) e
12 3905 394 0 0.06
13 578 60 0 0.08
14 789 143 0 0.16
14 739 145 0 0.17
14 633 134 0 0.19
16 1598 226 0 0.18
18 2436 186 0 0.14
18 247 27 1 0.20
20 1888 216 0 0.16
20 1430 102 0 0.18
20 551 63 0 0.28
20 282 18 0 0.28
22 594 117 0 0.67
23 447 111 0 0.98
25 2400 137 0 0.30
25 1949 128 0 0.35
26 506 506 3 6.13
29 2624 361 9 1.24
29 1045 138 0 1.29
29 350 49 0 1.32
30 2510 188 0 0.79
30 2236 164 0 0.81
30 88 12 3 1.47
33 1885 238 2 2.07
36 585 83 2 3.51
38 1497 238 12 5.10
39 422 36 3 3.08
41 711 103 17 6.47
42 3657 132 3 1.76
42 1582 147 6 4.53
51 2998 229 8 4.13
52 321 42 6 6.70
a The time interval between infection and detection
b The number of animals in the herd
c The number of tested samples
d The number of positive samples
e The expected number of positive samples according to the model and the parameter
estimates.
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Of a set of 82 herds of the 1997/1998 epidemic of CSF in the Netherlands, the
exact day of virus introduction is known from tracing (Stegeman et al., 1999b). Of
this set of herds, those 32 finishing herds were selected, in which blood samples
from animals throughout the herd had been taken to test for seroconversion. Of each
of these herds, the known data were: the time between infection and detection tdet,
the total number of animals ntot, the number of sampled and tested animals ntest, and
the number of animals tested seropositive npos (Table 5.1).
We assumed a perfect serological test with a sensitivity and a specificity of 1.
Then, for each record, the number of seropositive animals npos was a realisation of a
random draw of ntest animals out of a population of ntot animals with Nser true
seropositives; the stochastic variable Npos was therefore hypergeometrically
distributed:
( )pospos nNP =
( )∑−+
= 

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         (5.6)
The number of true seropositives Nser, of which the distribution had to be determined
to use equation (5.6), was the accumulated number of animals infected 18.45 days
before tdet, 18.45 days being the average time until seropositivity of an individual
animal (Stegeman et al., 1999b). The number of true seropositives Nser consisted of
the number of animals that had been infected at rate λI(t) by within-herd
transmission plus the number of initially infected animals, which was the height H
of the infectious curve at the time of infection of the herd:
( ) ( )( )45.18exp
1
45.18
0
−−≈−+= ∫ det
t
ser trHR
RdIHN
det ττλ . (5.7)
Eq. (5.7) was used to derive the probability P(Nser = nser), by approximating the
continuous exponential distribution for Nser by a discrete geometrical distribution:
( )
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in which 

 −−− h
R
R
R
R 1exp1  is the probability density function (pdf) for the height
of the infectious curve H, and ( )( )45.18exp1exp1
2
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 

 −−−= dettrR
Rπ . By
taking the logarithm of Eq. (5.6) and summing over all 32 observations, the function
L1(r, R) was obtained.
5.3.1.3. Log-likelihood function L2(r, R, α)
The second log-likelihood function described the detection of infected herds. It
mainly provided information on the detection parameter α. However, as detection
depends on the within-herd dynamics, also the within-herd transmission parameters
r and R were involved.
For 82 of the 429 herds of the Dutch CSF epidemic, the day of virus introduction
is known. We used the interval in days between infection and detection as the
detection times tdet of these 82 herds (Stegeman et al., 1999b):
10(2×), 12, 13, 14(3×), 16(3×), 18(3×), 20(4×), 21(2×), 22(3×), 23, 24(3×), 25(2×),
26(2×), 27(2×), 28, 29(6×), 30(4×), 33(3×), 34(2×), 35, 36, 37(2×), 38(4×), 39,
41(2×), 42(6×), 43, 44, 45, 47(2×), 48(3×), 49(2×), 50, 51, 52, 55, 56, 57(2×)
The detection times were considered as random draws from a probability
distribution of the stochastic variable Tdet, which could be expressed in terms of the
parameters r, R, and α and became, integrated over all possible values of H:
( )( )∫∞ 

 −−−
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In Eq. (5.9), αhexp(rtdet) is
the detection rate at time tdet,
exp(-αh(exp(rtdet)-1)/r) is the
probability that the herd has
not been detected until tdet,
and 

 −−− h
R
R
R
R 1
exp
1  is
the pdf for H. By summing
the logarithm of Eq. (5.9)
over the 82 observations, the
function L2(r, R, α) was
acquired.
5.3.1.4. Log-likelihood
function L3(r, R, α, βind)
The third log-likelihood
function described the CSFV transmission between herds. Although it mainly
provided information on transmission parameter βind, also the parameters r, R, and α
were included, since these parameters together determine the average number of
infectious animals within an infectious herd.
After the first detection of the Dutch CSFV epidemic, the compulsory set of EU
measures came into force for 10 weeks. Of each week, the number of infectious
herds j and the number of new infections c had been reconstructed by Stegeman et
al. (1999a) (Table 5.2). According to the model, the numbers of new infections per
week C were regarded as random draws from Poisson distributions of which the
parameters depended on the number of infectious herds j and on r, R, α, and βind:
( ) ( ) jRrCE ind ανβ ,,= . (5.10)
Since βind is the average number of herds infected per infectious animal per day, the
function ν(r,R,α) had to convert one infectious herd into a number of infectious
‘animal days’. Therefore, ν(r,R,α) is the expected number of infectious ‘animal
days’ per herd divided by the expected number of weeks from infection to detection
of a herd:
Table 5.2. The dataset for L3(r,R,α,βind). Each
row represents the record of one week.
j a c b E(C) c
22.9 9 8.4
27.2 16 10.0
30.3 10 11.2
35.9 12 13.2
41.2 12 15.2
50.1 17 18.5
55.6 20 20.5
59.0 20 21.8
67.5 27 24.9
68.6 26 25.3
a The average number of infectious herds
b The number of new infections
c The expected number of new infections
according to the model and the parameter
estimates.
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In Eq. (5.11), the numerator is equal to
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where hexp(rt) is the infectiousness at time t, ( )( )
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hα  the probability
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In Eq. (5.11), the denominator, i.e. the expected number of weeks that a herd is
infectious, is
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in which ( )( )

 −− 1expexp rt
r
hrth αα  is the pdf for the detection time and


 −−− h
R
R
R
R 1exp1  the pdf for H. The division by 7 is to convert the expected
number of days to the expected number of weeks.
This results in the probability of observing c new cases in a week being
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Summing the logarithms of Eq. (5.13) over the ten weekly intervals resulted in the
function L3(r, R, α, βind).
5.3.1.5. The ratio βf:βm
The fifth model parameter is the ratio βf:βm, which is the ratio by which infectious
herds of both types infect finishing and multiplier herds, respectively. For estimation
of the ratio, the 429 infected herds of the Dutch CSFV epidemic were subdivided
into three groups, according to the ratio of finishing pigs and sows in the herds. In a
perfectly closed herd that does not sell or buy piglets, the ratio between the number
of finishing pigs (each sow produces 23 piglets a year, which are all living as a
finishing pig for 100 days) and the number of sows (each living 365 days a year)
would be 23⋅100/365 ≈ 6.3. Therefore, the groups were subdivided as follows: net
piglet producers (finishing pig to sow ratio < 5.0), net piglet receivers (finishing pig
to sow ratio > 7.5), and a third group (finishing pig to sow ratio between 5.0 and 7.5,
breeding herds which supply gilts to herds with sows, and herds with unknown
animal numbers). The third group is likely to have very few transport contacts, since
only transport of piglets to finishing herds is permitted. Because infected third-group
herds do not infect other herds by transport, just like the finishing herds, the third
group has been included in the receiver group to determine the βf:βm ratio.
5.3.1.6. The parameter βtr
The parameter βtr is the parameter for transmission through transport contacts. It is
derived by first calculating the mean number of finishing herds that are infected by
one infectious multiplier herd through transport, σtr. Subsequently, the parameter βtr
is chosen such that the mean number of infections through transport per herd
according to the model will also be σtr.
The mean transport frequency of piglets from multiplier herds to finishing herds
is approximately 32/365 ≈ 1/11.4 (one transport every 11.4 days) (Mangen, 2002).
By assuming an average transmission probability of ±0.8, the frequency of
transmission through transport becomes 1/14, thus once in two weeks. The expected
number of contact infections due to transport of infectious pigs, σtr, then becomes:
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which was already derived in Eq. (5.12), apart from the division by 14.
In the model, the rate of transmission through transport is assumed to be
proportional to the number of infectious animals at the infectious multiplier herd, i.e.
equal to ( )rtHtI trtr exp)( ββ = . Therefore, with the expected total number of
contact infections through transport being σtr, βtr is equal to
trtr ασβ = . (5.15)
5.3.2. Results
The estimates for logr, log(R–1), logα , and logβind were –2.0, 0.60, –6.7, and –6.2
respectively. The covariance matrix of the estimators of these parameters was:

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Transformed to the original model parameters, the point estimates with 95%
confidence intervals are listed in Table 5.3. Table 5.3 also shows the means and 95%
confidence intervals of βtr. The 95% confidence limits of βtr are the 250th and
9751st value of the ordered range of 10,000 determined βtrs with parameters
randomly drawn from the above distribution of logr, log(R-1), logα, and logβind. To
get an idea of the level of between-herd transmission with the estimated parameters,
we have calculated the basic reproduction ratio between herds Rh as the largest
eigenvalue of the next-generation matrix (Diekmann and Heesterbeek, 2000):
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In matrix (5.17), ϕtr = 1 if transport is permitted and ϕtr = 0 if not. The estimated Rhs
with and without transport are given in Table 5.3. The Rh without transport, i.e. the
largest eigenvalue of (5.17), is equal to βind/α. Therefore, the variance of logRh can
be derived from the covariance matrix (5.16): var(logRh) = var(logβind) + var(logα) –
2covar(logβind,logα). The 95% CI for Rh with transport has been determined as for
βtr.
Subsequently, a χ2 goodness-of-fit test was carried out for the three likelihood
functions. All E(Npos,i) for L1(r, R) and E(Ci) for L3(r, R, α, βind) are given in Tables
5.1 and 5.2, respectively. The E(Tdet,i) for L2(r, R, α) were equal for all i: 32.0. The
one-sided test results are P = 0.26 (χ2 = 34.5; d.f. = 30) for L1, P = 0.55 (χ2 = 76.6;
d.f. = 79) for L2, and P = 0.55 (χ2 = 4.97; d.f. = 6) for L3. Thus, the model cannot be
rejected.
Finally, the division of the 429 infected herds of the Dutch CSF epidemic into
groups resulted in 231 net piglet producers, 105 net piglet receivers, and 93 rest
herds. By inclusion of the rest herds in the net piglet receiver group, a βf:βm ratio of
approximately 1:1 is retrieved. The ratio 1:1 was used for the model calculations.
Table 5.3. The estimates and 95% confidence intervals of the model parameters and the
basic reproduction ratios.
Parameter Estimate 95% CI
r 0.13 0.11 - 0.16
R 2.8 1.8 – 5.1
α 0.0013 0.00068 - 0.0023
βind 0.0021 0.0012 - 0.0038
βtr 0.0029 0.0016 - 0.0050 a
Rh without transport 1.7 1.4 - 2.0
Rh with transport 2.5 2.1 - 2.8 a
a These 95% CIs have been approximated by drawing 10,000 times from the parameter
estimator distribution and determining βtr and Rh for each parameter set. The 250th and
9751st values of the ordered ranges were the limits of the confidence intervals.
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5.4. Control scenarios
The effects of five different control measures have been investigated with the
described model, as well as all relevant combinations of these measures:
(A) Total transport prohibition
(B) Killing of young piglets (in combination with a breeding ban)
(C) Vaccination of all piglets (not sows) at multiplier herds, followed by recurrent
vaccination of newborn piglets
(D) Single vaccination of all pigs at finishing herds
(E) Vaccination of piglets on arrival at finishing herds
Tested control scenarios consist of combinations of these measures and are indicated
by codes referring to the above list, e.g. scenario AD holds a transport prohibition
and a single vaccination of finishing herds. All tested scenarios are listed in Table
5.4. Missing letter combinations code for scenarios that are impossible, for example,
all scenarios with control measures (A) and (E) together. To distinguish single
control measures from control scenarios, the measures are always put between
brackets, so (A) refers to a measure and A to a scenario.
The effect of control scenarios is modelled by multiplication of the transmission
rate parameters βm, βf, and βtr by the functions ϕm(t), ϕf(t), and ϕtr(t), respectively.
For each control scenario, the functions ϕ(t) are different. The control scenarios start
at t = 0. Assumptions for the functions ϕ(t) are
(1) Animals vaccinated at t = 0 are instantaneously protected, i.e. not susceptible.
Although in reality the vaccine significantly reduces transmission only after 2
weeks (Bouma et al., 2000), that is already sufficient to reduce the size of
within-herd outbreaks even if the herd is infected just after vaccination.
Protected animals cannot be infected, so the transmission rate for indirect
infectious contacts is multiplied by the fraction of unvaccinated animals on the
farm, which denotes the probability that the first animal to be infected is
unvaccinated.
(2) On a multiplier herd, the piglet to sow ratio is 1610:365, as noted before. This
means that, if there are no susceptible piglets present, ϕm(t) = 365/(1610+365) =
365/1975. When control measure (C) is applied, the vaccine is not assumed to
protect at once, because vaccination is an ongoing process, which results in the
continuous presence of yet insufficiently protected pigs. Hence, it is assumed
that piglets are protected by vaccination from the age of four weeks onwards,
namely, vaccination at two weeks of age plus two weeks for the vaccine to start
its effect. Then, ϕm(t) = (365+1610⋅4/10)/1975 = 1009/1975.
Effect of control strategies
97
(3) Transmission through transport contacts is only prevented if there is no
transport at all or if the transported piglets have been vaccinated at the
multiplier herd. In all other cases transport of pigs from infected multiplier
herds leads to major outbreaks in finishing herds with normal within-herd
transmission rates.
Table 5.4. The functions ϕ(t) for each of the tested scenarios; time t is measured in days
and t = 0 is defined as the initiation of the control scenarios.
Scenario Time interval ϕf(t) ϕm(t) ϕtr(t)
ABCD t > 0 0 365/1975 0
ABC t > 0 1 365/1975 0
ABD t > 0 0 1 0
AB t > 0 1 1 0
ACD t > 0 0 1009/1975 0
AC t > 0 1 1009/1975 0
AD t > 0 0 1 0
A t > 0 1 1 0
BCD t > 0 0 365/1975 0
CD t > 0 0 1009/1975 0
DE t > 0 0 1 1
co
ns
ta
nt
 ϕ(
t)
none t > 0 1 1 1
BC 0 < t ≤ 100 1 – t/100 365/1975 0
t > 100 0 365/1975 0
BDE 0 < t ≤ 70 0 1 – 23t/1975 1
t > 70 0 365/1975 0
BD 0 < t ≤ 70 t/100 1 – 23t/1975 1
70 < t ≤ 100 0.7 365/1975 0
100 < t ≤ 170 1.7 – t/100 365/1975 0
t > 170 0 365/1975 0
BE 0 < t ≤ 70 1 – t/100 1 – 23t/1975 1
70 < t ≤ 100 1 – t/100 365/1975 0
t > 100 0 365/1975 0
B 0 < t ≤ 70 1 1 – 23t/1975 1
70 < t ≤ 170 1.7 – t/100 365/1975 0
t > 170 0 365/1975 0
C 0 < t ≤ 100 1 – t/100 1009/1975 0
t > 100 0 1009/1975 0
D 0 < t ≤ 100 t/100 1 1
t > 100 1 1 1
E 0 < t ≤ 100 1 – t/100 1 1
ch
an
gi
ng
 ϕ(
t)
t > 100 0 1 1
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(4) Vaccination does not affect virus transmission within herds, because in most
cases the vaccinated and unvaccinated animals on a farm are separated (they are
housed within weight classes, which are approximate age classes, which in most
cases denote the vaccination status).
The functions ϕ(t) for all tested control scenarios are listed in Table 5.4. As can
be seen from Table 5.4, for some control scenarios, all ϕ(t) remain constant from t =
0. For other scenarios, however, one or more functions had to be subdivided into
time intervals, to account for the changing situation due to transport. For example,
scenario B starts with a completely susceptible population, but in 70 days all piglets
are removed from the multiplier herds and in another 100 days the finishing herds
are emptied as well. Therefore, ϕm(t) decreases linearly from 1 to 365/1975 within
70 days; ϕtr(t) = 1 until t = 70 and then becomes 0; and ϕf(t) first remains 1 for 70
days and then decreases linearly from 1 to 0 within 100 days.
5.5. Model analysis
5.5.1. Methods
5.5.1.1. Probability of extinction
A common measure to characterise transmission of an infectious agent in a
population of herds would be the basic reproduction ratio between herds Rh, the
expected number of herds infected by one infectious herd in a population of
susceptible herds. An Rh < 1 ascertains extinction of the infection, whereas an Rh > 1
denotes the possibility of major epidemics (Diekmann and Heesterbeek, 2000). For
some of the scenarios, however, Rh is not a constant value in the initial stage since
one of the functions ϕ(t) changes with time. Therefore, we chose to determine the
probability of extinction of an epidemic. The probability of extinction is directly
related to the threshold property of Rh, since extinction will occur with probability 1
if in a control scenario Rh eventually reaches a constant value < 1.
The probability of extinction heavily depends on the epidemic situation at the
time a control scenario is implemented, viz. on the number of undetected infected
herds present in the population, the types of the infected herds (multiplier or
finishing herds), and how much the infection has already spread in the herds.
Regarding the progression of infection in infectious herds, we always assume that
the herds have been infected at t = 0, implying that the entire infectious period still
has to be completed. As for the initial numbers and types of infectious herds, the
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probability of extinction has to be calculated only with one finishing herd or one
multiplier herd as a starting condition. Subsequently, the probabilities of extinction
for all other starting conditions can be calculated, because the model is a branching
process: if the probability of extinction starting with one multiplier herd is zm and the
probability starting with one finishing herd is zf, then the probability of extinction
starting with x multiplier herds and y finishing herds will be zmxzfy.
For determination of the probabilities of extinction zf and zm, two types of control
scenario could be distinguished. The first type comprised all scenarios with constant
functions ϕ(t), which were the scenarios ABCD, ABC, ABD, AB, ACD, AC, AD,
A, BCD, CD, and DE (Table 5.4). For these control scenarios, Rh could be
calculated as the largest eigenvalue of the next-generation matrix (Diekmann and
Heesterbeek, 2000):
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Matrix (5.18) is a more general form of matrix (5.17), in which ϕf(⋅) = ϕm(⋅) = 1. If
Rh < 1, then both zf and zm were equal to 1. If, on the other hand, Rh > 1, then it was
possible to determine the probability of extinction with a method based on the
properties of branching processes. In Appendix 5C, the following set of recursive
equations is derived, from which zf and zm could be solved numerically:
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In Eq. (5.19), β’f = ϕf(t) βf, β’m = ϕm(t) βm, and β’tr = ϕtr(t) βtr. For the point
estimates of zf and zm, the point estimates of βind and α were used. Confidence
intervals for zf and zm were determined by drawing 1000 times from the distribution
of parameter estimators and determining zf and zm for each set of parameters. The
25th and 976th value of the ordered range denote the limits of the 95% confidence
interval.
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The second type of control scenario had at least one of the functions ϕ(t) not
constant. However, all functions ϕ(t) in the long run did reach a constant value, so
all control scenarios ultimately reached a constant Rh. According to the ultimate
constant Rh, the second type could be divided into two subtypes. The first subtype
consisted of all control scenarios where Rh becomes smaller than 1. Control
scenarios BC, BDE, BD, BE, B, and C were of this subtype, for which zf = zm = 1.
The second subtype comprised the scenarios where Rh ultimately exceeded 1 —
scenarios D and E. For these scenarios, zf and zm had to be determined by 1000
repeated continuous time stochastic simulations (see Appendix 5D) with the model
parameters set at their estimate. Starting with one finishing or multiplier herd, each
simulation continued until either extinction or until a generation with at least 21
infectious herds was reached, the latter outcome indicating a major outbreak.
Further, to get some insight into the variation of these zf and zm values due to
uncertainty about the model parameters, for each of 1000 random draws from the
distribution of the parameter estimators, 25 model simulations were executed from
which zf or zm was estimated. The variance of these estimates was calculated from
the simulation results and consists of two parts (Rao, 1973) [for notational
convenience, we define ϑ = (r, R, α, βind)T]:
( )( ) ( )( ){ } ( )( ){ }ϑϑϑϑϑ ϑϑϑ fff ZEZEZ varvarvar += , (5.20)
in which Zf(ϑ) is the estimator of zf as a function of ϑ. The expected conditional
variance in the second right-hand side (RHS) term reflects the variation due to
stochastic effects and was equal to zf(ϑ)(1-zf(ϑ))/25. It could be approximated by( ) 251 ff zz − , in which fz  is the average ( )ϑfzˆ . The variance of the conditional
expectation in the first RHS term reflects the uncertainty about the model parameter
estimates and was estimated by subtracting the expected variance from the observed
variance by rewriting (5.20) as:
( )( ){ } ( )( ) ( ) 25/1
1000
ˆ
var
2
ff
i
iff
f zz
zz
ZE −−−≈ ∑∧ ϑϑϑϑ (5.21)
By assuming a normal distribution of the conditional expected value, an
approximate confidence interval for zf was obtained, which may serve to indicate the
effect of the uncertainty about the model parameter estimates. A confidence interval
for zm was determined analogously.
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5.5.1.2. Duration and size of the epidemic
Although the probability of extinction is very useful in deciding which control
strategies are insufficient, it does not distinguish between the scenarios in which
extinction will be reached. Therefore, all scenarios with zf = zm = 1 were compared
with respect to the duration and the size of the epidemic, i.e. the number of herds
ultimately infected. The comparison was done by continuous time stochastic
simulations of epidemics. Both duration and size of the epidemic largely depend on
the situation at the time the control measures are implemented, as did the probability
of extinction. The duration starting with one infectious herd, however, cannot so
easily be extrapolated to situations with more infectious herds. Hence, we simulated
with three starting conditions: one infectious finishing herd, one infectious
multiplier herd, and five of both types of herds. The expected size of the epidemic is
easier to extrapolate to other starting conditions, since this will always be a
multiplication factor with respect to the initial number of infectious herds. Thus, the
size of the epidemic has only been determined for the starting condition with five
infectious herds of both types.
Simulations were performed as described in Appendix 5D. For each scenario and
starting condition, 1000 simulations were done in which each simulation used
another set of model parameters, randomly drawn from the distribution of the
estimators. Of the 1000 simulations, the median time to extinction and the median
size of the epidemic were determined together with the 95% interval by taking the
25th and 976th value of the ordered ranges of times and sizes.
5.5.1.3. Further model investigations
Finally, we made some plots to explore the sensitivity of the model outcomes for the
four model parameters r, R, α, and βind, and for the calculated Rh (largest eigenvalue
of matrix (5.18)); to explore the correlation between calculated outcomes zf and zm;
and to explore the correlation between the size and duration of the simulated
epidemics.
The variation in extinction times and epidemic sizes, as obtained with the
simulations, is a combination of variation due to random effects of the stochastic
simulation and variation due to uncertainty about the parameter values. The
sensitivity plots were used to distinguish between these two sources of variation. If
the variation is mainly due to random effects, no relation between the parameters
and the outcomes can be observed. In that case, more precise estimates of the
parameters will not help to better predict the effectiveness of the control measures.
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If, on the other hand, the model outcomes are related to the parameter values, better
estimates can improve the predictions.
5.5.2. Results
Table 5.5 shows the estimated probabilities of extinction and the 95% confidence
intervals for all tested scenarios. By comparison of the effectiveness of the
strategies, we can come up with two conditions that have to be met to ensure
extinction. First, virus transmission through transport should be prevented. This can
be achieved by a transport prohibition (control measure (A)), by a breeding
prohibition (control measure (B)), or by recurrent vaccination of multiplier herds
(control measure (C)). Second, at least half of the indirect transmission should be
prevented. This can be observed from comparing the effective scenario AD, in
which the indirect transmission is reduced by 50%, and the ineffective scenario
ABC, in which the indirect transmission is still present for 59%. The second
Table 5.5. The probabilities of extinction for each of the tested scenarios if starting with
one infected finishing herd (zf) or one multiplier herd (zm); zf = zm = 1 denotes an Rh ≤ 1,
whereas zf ≤ 1.00 and zm  ≤ 1.00 denote an Rh > 1.
Scenario type a Scenario zf 95% CI zm 95% CI
constant ϕ(t) ABCD; ABD; ACD;
AD; BCD; CD 1 1      - 1 1 1      - 1
ABC 1.00 0.85 - 1 1.00 0.85 - 1
AB 0.59 0.50 - 0.71 0.59 0.50 - 0.71
AC 0.79 0.64 - 0.93 0.79 0.64 - 0.93
A 0.59 0.50 - 0.71 0.59 0.50 - 0.71
DE 0.69 0.62 - 0.75 0.46 0.40 - 0.54
none 0.50 0.43 - 0.57 0.32 0.27 - 0.37
changing ϕ(t)
Rh < 1
BC; BDE; BD; BE;
B; C 1 1      - 1 1 1      - 1
changing ϕ(t) D 0.61 0.57 - 0.64 b 0.38 0.30 - 0.46 b
Rh > 1 E 0.57 0.51 - 0.65 b 0.39 0.33 - 0.45 b
a Based on the functions ϕ(t), two scenario types are distinguished: with constant ϕ(t) and
with changing ϕ(t), the latter of which is subdivided into two subtypes: with Rh ultimately
smaller than 1 and with Rh larger than 1.
b Approximate confidence intervals as calculated with Eq. (5.21) from 1000 estimates;
each estimate was for a different parameter set, randomly drawn from the parameter
distribution, and each estimate was based on 25 model simulations.
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condition can also be explained from the estimate of Rh without transport, of which
the upper limit of the 95% confidence interval is 2.0. Reducing the indirect
transmission by a half results in an upper confidence limit of 1.0, which leads to
extinction. Prevention of transmission can be accomplished by a breeding
prohibition (control measure (B)), or by vaccination (control measures (C), (D), and
(E)).
There are three possibilities of satisfying both conditions at the same time,
namely, both control measures (A) and (D), only control measure (B), or only
control measure (C). It is important to note that the second condition is met by
control measures (B) and (C) because of the permit to transport pigs: the susceptible
finishing pigs are either not replaced at all (in case of (B)), or replaced only by
vaccinated pigs (in case of (C)). Consequently, if a transport prohibition is added as
a control measure, the scenarios become less effective (compare scenarios ABC vs.
BC, AB vs. B, and AC vs. C). This can be resolved by vaccinating the finishing
herds.
For scenario ‘none’, Figure 5.1a shows the sensitivity plots of zf and zm against
parameters r, R, βind, α, and Rh using the 1000 simulations for determining the
confidence intervals for zf and zm. For all other scenarios with zf and zm smaller than
1, the sensitivity plots look similarly and are therefore not shown. It appears that Rh
is the major determinant for both zf and zm. This is not very surprising, since the
terms of the next-generation matrix (5.18), which determines Rh, also appear in the
equations for zf and zm (5.19). Figure 5.1b shows a high correlation between the
calculated zf and zm.
Table 5.6 shows the results of the simulations of the scenarios with certain
extinction: the durations and sizes of the epidemics. In some of the simulations with
scenario AD, the random draw of the model parameters led to an Rh above 1. If
during such a simulation the number of infected herds grew so large that the
probability of a major epidemic exceeded 95%, the simulation was stopped and
duration and size of the epidemic were set to infinity. This happened in two of the
1000 simulations starting with one infectious herd and in seven of the 1000
simulations starting with ten infectious herds.
Close examination of the results in Table 5.6 reveals that there are two ways in
which the effectiveness of a scenario can be improved. The first way is by a more
severe reduction of indirect transmission between herds. This can best be seen by
comparing the scenarios ABCD, ACD, and ABD. These all have constant functions
ϕ(t), but differ in the value of ϕm(t), so they differ in the level of indirect
transmission. Rh for these three scenarios is 0.16 for ABCD, 0.43 for ACD, and 0.85
for ABD. By comparison of the results in Table 5.6, it appears that a lower Rh
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Figure 5.1. Investigation of zf and zm with respect to the distribution of the model parameters.
Each dot represents one of 1000 draws from the parameter distribution.
(a) The sensitivity plots of zm (top row) and zf (bottom row) against the four transformed
parameters logr, log(R-1), logα, and logβind, and against the derived parameter logRh.
(b) The plot of the correlation between zm and zf.
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strongly reduces both duration and size. The second way to improve a scenario is by
reaching the maximal reduction in indirect and direct transmission earlier. This is
illustrated by comparing the scenarios ABCD, BDE, BE, and BD, which reach the
same Rh = 0.16 after 0, 70, 100, and 170 days respectively. The expected duration
and size increase in the same order, as seen in Table 5.6.
For scenario AD, the sensitivity of the duration and size for the model
parameters r, R, βind, α, and Rh is shown in Figure 5.2a. The sensitivity plots are
representative for all other scenarios. None of the parameters seem to determine the
duration and size of the epidemic, although Rh is of importance as noted after
comparison of the scenarios ABCD, ACD, and ABD above. Apparently, within the
estimated range of Rh, stochasticity is the main source of variation in both duration
and size. Figure 5.2b shows a clear correlation between size and duration of the
simulated epidemics with scenario AD.
5.6. Discussion
We presented a mathematical model for the transmission of CSFV between pig
herds. We showed that the model structure was in accordance with available data of
Table 5.6. The expected durations and sizes and 95% confidence intervals of the control
scenarios with zf = zm = 1.
Scenario duration (days) size (herds)
1 f. a 95% CI 1 m. b 95% CI 5 + 5 c 95% CI 5 + 5 c 95% CI
ABCD 32 8 - 92 32 8 - 92 68 38 - 136 11 10 - 16
ABD 38 6 - 442 38 6 - 442 226 63 - 1070 42 13 - 452
ACD 35 7 - 151 35 7 - 151 103 47 - 239 16 10 - 35
AD 38 6 - 442 38 6 - 442 226 63 - 1070 42 13 - 452
BCD 32 8 - 92 32 8 - 92 68 38 - 136 11 10 - 16
BC 39 9 - 129 39 9 - 129 112 62 - 176 21 12 - 38
BDE 38 7 - 158 61 7 - 161 135 89 - 203 35 15 - 69
BD 43 6 - 215 72 7 - 213 194 108 - 264 67 20 - 157
BE 41 7 - 181 86 7 - 169 145 97 - 220 53 22 - 110
B 63 8 - 230 114 8 - 232 206 152 - 270 108.5 37 - 238
CD 35 7 - 151 35 7 - 151 103 47 - 239 16 10 - 35
C 46 7 - 197 46 7 - 197 157 76 - 293 33 15 - 73
a The initial situation of only one infected finishing herd
b The initial situation of only one infected multiplier herd
c The initial situation of five infected finishing herds and five infected multiplier herds
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Figure 5.2. Investigation of the epidemic size and duration with respect to the
distribution of the model parameters. Each dot represents one of 1000
stochastic simulations, each with a different set of model parameters,
randomly drawn from their distribution. Each simulation started with five
infected finishing herds and five infected multiplier herds. (a) The sensitivity
plots of the duration (top row) and epidemic size (bottom row) against the
four transformed parameters logr, log(R-1), logα, and logβind, and against the
derived parameter logRh. (b) The plot of the correlation between duration and
epidemic size.
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the Dutch CSFV epidemic and we used the data to estimate the model parameters.
With the model we were able to predict the effects of several scenarios for the
control of CSFV epidemics. Two general conditions for extinction of CSFV
epidemics could be derived and two criteria for improving the effectiveness of a
scenario were discerned. Finally, the sensitivity analyses showed that the only
parameter of real importance is Rh, which is mainly determined by the quotient of
βind and α. A better estimate of Rh, however, will hardly improve the model
predictions, as most of the uncertainty in outcome lies in the stochasticity of the
epidemic process.
The conditions for extinction of an epidemic are (1) prevention of transmission
through pig transports and (2) reduction of indirect virus transmission by at least
50%. A striking result was that a transport prohibition can have a negative effect on
the effectiveness of a scenario compared to the same scenario without transport
prohibition (scenarios ABC vs. BC, AB vs. B, and AC vs. C). That is because the
second condition for extinction is met by scenarios BC, B, and C through removal of
the susceptible pigs in the finishing herds, which is prevented by a transport
prohibition. Permitting transport can be beneficial in another way as well, since it
will ‘wash out’ the tracks of small outbreaks on the farms. These small outbreaks,
which are not incorporated into the model but which will certainly arise during an
epidemic, can lead to problems at the end of the epidemic, when an area has to be
declared free of CSFV by a large-scale serological screening. Detection of minor
outbreaks in a screening will lengthen the duration of trading and export limitations
and increase the costs of the epidemic.
Two criteria for improving the effectiveness of CSFV control were
distinguished. The first was a stricter reduction of indirect transmission, which leads
to a decrease in Rh. If Rh is only just below 1, as with scenario ABD, the number of
infected herds in the next generations will decrease slowly and it will take many
generations before extinction is established. A more profound reduction in Rh will
decrease the number of generations and, as a result, the epidemic will take less time
and affect fewer herds. The second criterion was a quicker reduction of
transmission, which leads to a low Rh earlier after start of the control strategy. If
effectiveness is somehow delayed, as with scenario BDE, where transmission via
transport is blocked only from 70 days, the first one or two generations of infected
herds will still appear under a regime with Rh > 1. A quicker reduction of Rh will
lead to considerably less infected herds, and hence an earlier extinction of the
epidemic. The effect of quick action was also observed in the simulation study of
Mangen et al. (2001), where it appeared that a delay in implementing control
measures of 20 days could almost double the number of detected herds.
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The sensitivity analysis showed that the only parameter of real importance is Rh.
This parameter largely determines the probability of extinction as can be seen in
Figure 5.1. As for the duration and size of the epidemic, Rh is of minor effect within
its estimated range, although an increase in both duration and size is expected with
higher Rh. Here, the stochastic effects determine the major part of the variation. The
fact that r and R seem to be of no importance for the model outcomes does not mean
that they have been entirely useless. Incorporating within-herd dynamics made it
possible to do more reliable parameter estimations — otherwise the data would not
fit to the model — and that also increased the reliability of the parameter values that
do matter, namely, βind and α.
Since the parameter estimations are all based on the data of the Dutch CSFV
epidemic in the southeastern part of the Netherlands, the model results in fact only
account for that specific region. It is a very pig-dense area with relatively many
multiplier herds. A lower pig density will probably reduce the value of βind, although
the extent of this reduction will depend on the density-dependence of the contacts
implicitly incorporated in βind. A lower multiplier herd fraction will lead to relatively
fewer infected multiplier herds, which are most infectious if transport is allowed. In
conclusion, if a control scenario comes out positive in this model, it will be effective
in most other areas as well.
The within-herd exponential growth parameter r was estimated to be 0.13 (95%
CI 0.11-0.16). Stegeman et al. (1999a) estimated r from 7 breeding herds of the
same set of 82 herds we used and came up with an estimate of 0.11 (0.06-0.16),
which is in reasonable agreement. When the parameter µ of the within herd
transmission model (Eq. (5.1)) is calculated from the estimates of r and R, it is
possible to estimate the mean generation time of the within herd transmission as
0.5µ-1 = 6.8 days. The generation time can be compared to generation times
estimated from transmission experiments with CSFV (Chapters 2, 3, 4), which are
equal to the estimated latent period — the period an animal is infected but not yet
infectious — plus half of the average infectious period. This results in generation
times of 10.9 and 9.2 (weaner and adult pig groups of Chapter 2, respectively), and
of 13.9 and 8.2 (3 months and 6 months old groups of Chapter 4, respectively;
values of µ not presented in the paper). These are slightly higher than the estimate in
this paper, but still reasonably close, considering the rough simplification of the
within-herd transmission in our model.
The basic reproduction ratio between herds Rh was estimated to be 1.7 without
transport contacts (95% CI 1.4-2.0). This is in fact an estimate for Rh in the first ten
weeks of the Dutch CSFV epidemic. Stegeman et al. (1999b) estimated Rh in the
same period at 1.3. The difference can be completely attributed for by the different
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estimate of the mean duration of the infectious period, which is proportional to Rh. If
calculated by Eq. (5.9), the infectious period in our model is 32 days, which is equal
to the mean duration of the 82 herds in the dataset of the second log-likelihood
function. Stegeman et al. (1999b) estimated the average infectious period at 25 days,
from a dataset that for a major part contains infectious period lengths estimated from
serological data.
An important aspect of our model compared to most existing models for CSF
epidemics is its relatively simple structure (cf. Jalvingh et al., 1999; Mangen et al.,
2001; Nielen et al., 1999). Only six parameters are included, of which five were
directly estimated with data of the Dutch CSF epidemic and one (βtr) was related to
the average transport frequency. The simplicity enabled us to generalise the model
outcomes and come up with requirements for good control strategies. Besides, it
provided the opportunity to point out parameters for which more precise estimates
are needed. Because the parameters could be estimated from data of a previous
epidemic, we can be confident that the quantitative results are reliable. Nevertheless,
two assumptions need further attention.
First, a branching process model as presented in this paper does not take the
susceptible herds into account. This means that there is an implicit assumption of
unlimited availability of susceptible herds. Hence, effects like local depletion or
other spatial heterogeneities are not included. Because of the lack of spatial
structure, some control measures cannot be incorporated into the model easily; for
example, preventive slaughter or vaccination within short distance of infected herds.
These control measures can only be incorporated by modelling their effect on the
indirect between-herd transmission through adjustment of the functions ϕ(t). The
effects should then be estimated from data of previous epidemics. Lack of spatial
structure also leads to the implicit assumption that all control measures are
implemented in a large enough area. Escape of virus from the area would be the start
of a new epidemic in terms of our model.
The second major assumption is the reduction of the population structure into
two herd types, multiplier herds and finishing herds. This is by far not as detailed as
the true diversity in herd types, ignoring the existence of mixed herds (with sows
and finishers), breeding farms (supplying gilts for the multiplier herds), and artificial
insemination stations. The reason to include herd diversity in a model would be the
different epidemiological impact of different herd types. Regarding within-herd
virus transmission, experiments have shown different transmission rates between
weaner and slaughter pigs (Chapter 2). The sensitivity analyses in this paper,
however, show that both parameters involved in within-herd transmission, r and R,
appear to be of hardly any importance in determining the model outcomes (Fig. 5.1
and 5.2). It is, therefore, not expected that breaking down the population into herd
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types with different within-herd transmission parameters would change the model
results. As far as between-herd transmission is concerned, different herd types
would be included to account for heterogeneity in the contact pattern. In the model,
we included two herd types since we wanted to account for the possibility to relax
the transport prohibition and allow transport of piglets to finishing herds and of
finishing pigs to the slaughterhouse. As a result of the division into two herd types, a
βf:βm ratio had to be determined. This was complicated by the diversity in herd types
in the data set, which consisted for about a quarter of mixed and breeding herds.
Because the herd type is only important for the rate at which the herd itself causes
new infections, and not for the type of herd it is infected by, the rest group could
simply be included in the finishing herds group.  This led to a βf:βm ratio of 1:1.
The political decision to use a specific control strategy will not only depend on
its epidemiological effectiveness. Other major roles will be played by the economic
effectiveness and the public opinion. Regarding the economic effectiveness, costs of
an epidemic are of course related to its duration and to the number of infected herds,
but in addition other costs can result from implementing specific control measures.
Especially if these control measures are related to export, the costs can become high
(Mangen et al., 2001). An important aspect of export-related costs is the acceptance
of vaccinated pigs by importing countries. The acceptance will depend on the
quality of the diagnostic tests in vaccinated and unvaccinated pigs, but should also
depend on the possible consequences of importing a false-negatively tested pig and
the expected number of infected, yet undetected pigs. A risk analysis might be used
to weigh these factors. Regarding the public opinion, we have seen that preventive
slaughter has raised a major discussion on the ethics of killing and destroying
healthy animals (Terpstra et al., 2000), which can influence the eventual decision on
which control scenario to use. However, it will be helpful if the epidemiological
aspects of the decision making are already quantified and available before a new
CSFV entry occurs. We think the model results can prove useful for optimally
preparing for CSFV epidemics.
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Appendix 5A
5A.1 Parameters
Input parameters
λ within-herd transmission parameter
µ animal recovery rate
R (:= λ/µ) within-herd basic reproduction ratio
r (:= λ – µ) within-herd exponential growth rate
βf between-herd transmission parameter for infection of finishing
herds through indirect contacts
βm between-herd transmission parameter for infection of multiplier
herds through indirect contacts
βind (:= βf + βm) total between-herd transmission parameter for indirect contacts
βtr between-herd transmission parameter for infection of finishing
herds by multiplier herds through transport contacts
α herd detection parameter
Derived parameters
β’f := βf⋅ϕf(⋅) adjusted finishing herd transmission parameter for indirect
contacts
β’m := βm⋅ϕm(⋅) adjusted multiplier herd transmission parameter for indirect
contacts
β’tr := βtr⋅ϕtr(⋅) adjusted transmission parameter for transport contacts
Rh between-herd basic reproduction ratio
zf probability of extinction if only one finishing herd is infected
zm probability of extinction if only one multiplier herd is infected
5A.2. Variables
General model
t time since start of the control scenario
H height of the within-herd exponential infectious curve
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Likelihood function L1(r, R)
tdet time between infection and detection
ntot total number of animals in the herd
ntest number of animals serologically tested
Nser total number of serologically positive animals in the herd
Npos number of serologically positive animals in the group of tested
animals
Likelihood function L2(r, R, α)
Tdet time between infection and detection
Likelihood function L3(r, R, α, βind)
j average number of infected herds within the week
C number of newly infected herds (cases) within the week
5A.3 Functions
General model
I(t) number of infectious animals within the herd as a function of time
since infection of the herd
ϕf(t) reduction factor of the transmission to finishing herds through
indirect contacts as a function of time since start of the control
scenario
ϕm(t) reduction factor of the transmission to multiplier herds through
indirect contacts as a function of time since start of the control
scenario
ϕtr(t) reduction factor of the transmission from multiplier herds to
finishing herds through transport contacts as a function of time
since start of the control scenario
Likelihood function L3(r, R, α, βind)
ν(r, R, α) conversion factor for converting the number of infectious herds
within a week to the number of infectious ‘animal days’ within a
week
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Appendix 5B
Here we derive the distribution of the continuous variable I’(t), which has been used
as an approximation to the distribution of the discrete variable I(t), defined as
( )( ) ( )( ) ( )( ) ( )( ) ( )( )ii tRptRp
tRp
tRptRpitIP 0
0
01
00
1
1
−=−== − . (5.3)
By using Eq. (5.2.1), P(I(t)=i) can be rewritten as
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For large t, the following approximations can be made:
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Hence, P(I(t) = i) can be approximated by
( )( ) ( ) ( ) 

 −−−−−≈= irt
R
Rrt
R
RitIP exp1expexp1 ,
which has the form of the pdf of an exponential distribution. Therefore, the
continuous variable I’(t) is distributed as
( ) ( )

 −−≅ rt
R
RionlDistributExponentiatI exp1'
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By defining H = I’(t)exp(–rt) and by dropping the accent for notational convenience,
I(t) becomes
I(t) = Hexp(rt), with (5.4.1)


 −≅
R
RionlDistributExponentiaH 1 (5.4.2)
Appendix 5C
Here we derive equations (5.19) for determining the probabilities of extinction zf and
zm starting with one finishing herd or multiplier herd, respectively. Diekmann and
Heesterbeek (Diekmann and Heesterbeek, 2000) derive a similar equation from a
model with one type of infectious individual. Since both equations (5.19) are derived
in a similar way, only the derivation for the first of the two equations is shown.
The probability zf, that a chain of infected herds starting with one finishing herd
will eventually go extinct, is
∑∑∞
=
∞
=
=
0 0
,
k l
l
m
k
flkf zzqz , (5C.1)
in which qk,l is the probability that a finishing herd infects k finishing herds and l
multiplier herds:
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The first two lines of Eq. (5C.2) are the probabilities of infecting k finishing herds
and l multiplier herds according to a Poisson distribution with a mean depending on
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the height h of the infectious curve and detection time t of the infectious finishing
herd. The third line consists of the distributions for h and t over which the Poisson
probabilities are integrated.
If qk,l is put into the formula for zf, the generating function for the Poisson
distribution can be used to obtain
( )( ) ( ) ( )( )
dtdhh
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R
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hrthz mmfff
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Evaluation of Eq. (5C.3) leads to the final result:
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Appendix 5D
Continuous time stochastic simulations were performed in Mathematica® (Wolfram,
1999). Epidemics were simulated in generations of infected herds. The initially
infected herds were the 0th generation and were by definition infected at t = 0, the
moment the control strategy was implemented. For each herd of the 0th generation,
the following values were drawn from the appropriate distributions in the designated
order:
1. The height of the infectious curve
2. The detection time
3. The numbers of finishing herds and multiplier herds in the 1st generation,
infected by this herd
4. The infection times of these herds of the 1st generation
When for each herd of the 0th generation all the values had been drawn, the same 4
values were drawn for each herd of the 1st generation, etc.
The distributions for the 4 steps in the simulation for each herd in generation i
were:
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1. The height H of the infectious curve of the herd in generation i was
exponentially distributed with parameter (R-1)/R
2. The detection time tdet of the herd in generation i was equal to its infection time
(determined in step 4 of its source herd in generation i-1, or equal to 0 if i = 0)
plus a random number from the distribution of the length of the infectious
period δ, with probability density function:
( ) ( )( )

 −−= 1expexp δαδαδ r
r
hrhpdf , (5D.1)
in which h was the height of the infectious curve, drawn in step 1.
3. The numbers of finishing and multiplier herds infected in generation i+1 by the
considered herd in generation i were Poisson distributed with parameters
depending on the herd type of the herd in generation i. If the herd is a finishing
herd, the parameters of the Poisson distributions for the numbers of finishing
herds σff and multiplier herds σmf in generation i+1 were:
( ) ( )( )∫ += det
inf
exp
t
t
infffff dtr τττϕβσ (5D.2.1)
( ) ( )( )∫ += det
inf
exp
t
t
infmmmf dtr τττϕβσ (5D.2.2)
If the herd is a multiplier herd, the parameters of the Poisson distributions for
the numbers of finishing herds σfm and multiplier herds σmm in generation i+1
were:
( ) ( )( ) ( ) ( )( )∫∫ +++= det
inf
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inf
expexp
t
t
inftrtr
t
t
inffffm dtrdtr τττϕβτττϕβσ (5D.2.3)
( ) ( )( )∫ += det
inf
exp
t
t
infmmmm dtr τττϕβσ (5D.2.4)
4. The infection times of the infected herds of generation i+1 were distributed
according to the normalised infectious curve of the source herd in generation i.
For example, the probability density function for infection times of finishing
herds in generation i+1, tinf,i+1, infected by a finishing herd in generation i with
infection time tinf,i and detection time tdet,i, is
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The pdfs for infection times of other herd types were derived analogously.
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Abstract
We test the performance of a real-time prediction model for Classical Swine Fever
epidemics, introduced by Meester et al. (2002). The model is a two-type branching
process, with two parameters representing farm infection and farm detection. A
maximum likelihood (ML) method uses the number of detected cases per week to
estimate the parameters of the ongoing epidemic. Subsequently, the estimates are
used to obtain a distribution of the (unknown) current number of infected farms. We
test the model with simulated epidemics and conclude that the proposed ML method
has serious problems, which need further study. If the detection parameter would be
estimated otherwise, the model can produce a reasonable prediction of the number
of infected herds, which improves if the dataset contains more weeks. We suggest to
study simpler models to understand the qualitative behaviour of the ML estimator.
For the time being, for practical application, the use of additional data is suggested
to force the ML method into a restricted region in parameter space.
6.1. Introduction
Epidemics of contagious animal diseases, like foot-and-mouth disease and classical
swine fever, can have a major impact on the economy and public acceptance of
animal production, as was confirmed during the 1997-1998 Dutch classical swine
fever epidemic (Meuwissen et al., 1999; Terpstra et al., 2000). Epidemic control,
therefore, should aim at minimal losses, both financial and in terms of the number of
slaughtered animals. There is, however, no such thing as one optimal control
strategy, since every epidemic will be unique in factors like virus strain, location,
and random effects. Methods to analyse ongoing epidemics are therefore necessary
to optimise the disease control.
Meester et al. (2002) proposed a branching process model to analyse the
transmission of classical swine fever virus (CSFV) between pig farms in real time.
They described a maximum likelihood (ML) method to estimate the parameters of
the model in ongoing epidemics. Furthermore, they showed how to use the estimates
to obtain a distribution of the current number of unobserved infected farms, and how
to use this distribution for a prediction of the nearby future. The methods were
applied to the data of the large Dutch CSFV epidemic in 1997-1998, and they
concluded that the epidemic could have been analysed reasonably well. Its use
during real CSFV epidemics in the future was suggested.
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To use the model in a real ongoing epidemic, it is necessary to know the
reliability of the results for different datasets. Important questions are whether CSFV
epidemics can be described by the branching process model sufficiently well, and if
so, whether the proposed estimation and prediction methods produce results that
contribute to a better epidemic control. In this paper we address the second question
and test the performance of the model with a set of simulated epidemics.
6.2. The model
The model is a discrete-time, two-type branching process with a one week time unit.
The two types of herds in the model are infectious herds of type i and depopulated
herds of type d. Furthermore, it is assumed that each epidemic starts with one herd
of type i and no herds of type d. The numbers of infectious and depopulated herds in
week k are random quantities and denoted by Xk and Zk, respectively. We define the
number of newly infected herds in week k by Yk. The triplet (Xk+1, Yk+1, Zk+1) is
related to Xk by:
Zk+1 ≅ BinomialDistribution(Xk, µ)
Yk+1 ≅ PoissonDistribution(λ (Xk – Zk+1/2))
Xk+1 = Xk + Yk+1 – Zk+1
In words, each herd of type i in week k has a probability µ to be detected and
depopulated in week k+1, so to become of type d. Moreover, each herd of type i in
week k infects a random number of susceptible herds in week k+1. This number is
Poisson distributed with either a mean of λ, if the herd is still of type i in week k+1,
or a mean of λ/2, if the herd is of type d in week k+1. Each herd of type d in week k
does not reappear in week k+1. In Meester et al. (Meester et al., 2002), the Poisson
distributions of the number of new infections per infectious herd per week (with
parameters λ and λ/2) were right-truncated to save computation time. In
reprogramming the model in Mathematica® (Wolfram, 1999) we did not use the
truncation.
Two important epidemic quantities can be derived from λ and µ. The first is the
basic reproduction ratio between herds Rh, defined as the average number of herds
that is infected by one typical herd until it is detected. Rh is equal to:
Rh = λ(2–µ)/(2µ),
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as already shown by Meester et al. (2002). The second is the average epidemic
growth rate ρ, defined by the relation E(Xk+1|Xk = xk) = ρxk, which is equal to:
ρ = (1–µ)(1+λ)+µλ/2.
Both Rh and ρ have threshold value 1, below which an epidemic will die out with
probability 1. Because of the transparent interpretation of ρ and because it made the
estimation procedure faster (as will be explained below), we reparametrised the
model from (λ, µ) to (ρ, µ).
After detection and depopulation of the first infected herd, it is very likely that a
control strategy will be implemented that will affect the parameters ρ and µ. Also in
a later stage of the epidemic, the parameters might change when the control
measures are changed. It is possible to incorporate these changes into the model by
defining different ρ’s and µ’s for different stages of the epidemic.
During an epidemic, only realisations of Zk are observed, which are called dk for
each week k, where the week in which the first depopulation takes place is defined
as week 1. The event {Zk = dk, Zk+1 = dk+1,…, Zm = dm}, in which m is the current
week, is called Dk+. The event D1+ = {Z1 = d1,…, Zm =  dm}, with d1 > 0, is simply
denoted by D.
6.3. The simulations
We simulated epidemics with the described branching process model, by assuming
two stages in the epidemic with different (ρ, µ) sets. The first stage ran until the first
herd was detected and depopulated, which was followed by the second stage.
In the first stage, (ρ1, µ1) = (2, 0.2) in all simulations, which is considered
realistic, since the accompanying Rh of 6.0 and average time between infection and
detection of 5 weeks are close to what Stegeman et al. (1999b) reported for the
Dutch 1997-1998 epidemic, 6.8 and 6.2 respectively. In the second stage, the four
combinations with ρ2 = 1.1 or 1.3, and µ2 = 0.15 or 0.5 were used. We did not
simulate with ρ2 values smaller than 1, as these values are not expected to be a
problem in real life. The µ2 values are considered extreme, though not unrealistic,
and were chosen so different as to make a proper distinction by the ML method
more likely.
We let the simulations run until the 10th time step (week) after the first
detection. The reason not to produce longer datasets was the very time-consuming
estimation procedure. We ran 100 simulations per (ρ2, µ2) parameter set and
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distinguished three types
of simulated epidemics.
The first were epidemics
which were over within
the first 4 weeks of the
second stage, i.e. no
infected herds were left.
These epidemics were
considered irrelevant for
this model, since they
need not to be analysed in
reality. The second were
epidemics with less than 5 detected herds in the first 4 weeks of the second stage.
These epidemics were left out, because the dataset was considered too small, and
hence too unspecific for the parameter set used. The third were the remaining
epidemics with 5 or more detected herds in the first 4 weeks of the second stage. We
used only the first 20 of these epidemics for the parameter estimations, initially to
save time, and later because no more estimations were needed for our conclusions.
The division of the 100 simulations per (ρ2, µ2) set over the three types of simulated
epidemics is given in Table 6.1.
6.4. Estimation of the model parameters
We tested the ML method for estimation of the model parameters, as proposed by
Meester et al. (2002). The ML method selects the parameters that maximise the
probability P(D), on a parameter grid.
6.4.1 The estimation procedure
The probability to observe D is computed by
P(D) = ( ) ( )∑ ==
i
iXPiXDP 00 .
In Meester et al. (2002), it is shown how to compute P(X0 = i). As far as P(D|X0 = i)
is concerned, after calculating P(Zm = dm|Xm–1 = i) for all i, one can recursively
compute P(Dk+|Xk–1 = i) for all i, until P(D|X0 = i) is obtained. In the last computation
step from P(D2+|X1 = i) to P(D|X0 = i), a correction has to be made to take account of
Table 6.1. Distribution of the simulations over three types
ρ2 = 1.1 ρ2 = 1.3
extincta 25 31
too smallb 31 8
µ2 = 0.15
rest 44 61
extincta 32 16
too smallb 8 4
µ2 = 0.5
rest 60 80
a Epidemics that were extinct before week 5
b Epidemics with less than 5 detections in weeks 2-5
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the definition of D, which states that d1 > 0. This correction was not made in
Meester et al. (2002), but hardly affects the estimation results in most cases. As it is
impossible to do the recursions for all i, an upper boundary imax has to be chosen
beforehand, so that the number of infected herds can never exceed imax.
Two problems arose with programming and running the estimation procedure.
The first problem had to do with imax. The calculation of P(D) does not take into
account the excess probability P(Xk > imax|Zk = dk ∩ Xk–1 = j), which can become
important if imax is too low in relation to D and the parameter values. If the excess
probability is ignored, the value of the likelihood will be too low. On the other hand,
if it is included into P(Xk = imax), the likelihood value can become too high for some
parameter values, as P(Xk = imax) can become almost 1, which causes the underlying
development of (large) Xk’s to become more or less deterministic. Therefore,
ignoring P(Xk > imax) appeared to be the best option.
The second problem had to do with the search procedure on the parameter grid.
Instead of the (λ, µ) grid used by Meester et al. (2002), we decided to use a
(logρ, logitµ) grid, where logitµ = log(µ/(1–µ)). The new grid made location of the
maximum easier, because the (λ, µ) grid appeared to contain a diagonal ‘likelihood
ridge’, which disappeared in the (logρ, logitµ) grid. Furthermore, the log and logit
transformations removed the boundaries of the grid and decreased the step sizes near
small ρ and µ. The mesh width we used was 1/64 in the logρ direction and 1/32 in
the logitµ direction.
6.4.2 The estimation performance on simulations
The four sets of 20 simulated epidemics were used to estimate ρ1, µ1, ρ2, and µ2. We
will treat the estimates as functions of imax and refer to them as 1ρˆ (imax), 1µˆ (imax),
Table 6.2. Summary a of the 2ρˆ  by both the original and the adjusted ML method
Current week m (ρ2, µ2) 2ρˆ  by original method 2ρˆ  by adjusted method
5 (1.1, 0.15) 1.1 [0.8 – 1.7] 1.0 [0.5 – 1.2]
5 (1.1, 0.5) 1.0 [0.9 – 1.7] 1.0 [0.9 – 1.4]
5 (1.3, 0.15) 1.2 [0.8 – 2.5] 1.2 [0.6 – 1.4]
5 (1.3, 0.5) 1.4 [0.8 – 1.9] 1.2 [0.6 – 1.5]
10 (1.1, 0.15) 1.1 [0.9 – 1.3] 1.1 [0.9 – 1.1]
a Median of 20 estimates [second lowest, second highest]
Chapter 6
126
2ρˆ (imax), and 2µˆ (imax). We define
( )maxi imax 11 ˆlimˆ ρρ ∞→= ; 1µˆ , 2ρˆ , and
2µˆ  are defined likewise.
We determined 1ρˆ (imax),
1µˆ (imax), 2ρˆ (imax), and 2µˆ (imax)
with D = {d1,…,d5} of all 80
simulations, and with D = {d1,…,d10} of the 20 simulations with ρ2 = 1.1 and µ2 =
0.15. By using at least two values of imax, 50 and 100, the dependence of the
estimates on imax was checked.
It very soon appeared that 1ρˆ (imax) and 1µˆ (imax) did not have any relation to ρ1
and µ1 and often changed if imax was varied, as was the case with 2µˆ (imax). Only ρ2
could be estimated quite well (Table 6.2). By increasing the number of weeks in the
datasets from 5 to 10, 2ρˆ  was generally closer to the real ρ2, as shown in Table 2. It
was possible to approximate 2ρˆ  by means of a Generalised Linear Model (GLM),
e.g. in Genstat (1998). The GLM fits D2+ to the following model:
E(dk) = Cρ2k.
By using a log link function and assuming dk to be Poisson-distributed, an estimate
of ρ2 is obtained.
Close inspection of the estimates from the simulations revealed that all estimates
could be derived by simple rules in the following order, which are applied to the
dataset D = {3,5,2,6,5} as an illustration:
1. 2ρˆ  can be approximated with a GLM. With the example dataset, the GLM
estimate is 2ρˆ  = 1.09, whereas the ML gives 2ρˆ  = 1.02 if imax = 50, and
2ρˆ  = 1.03 if imax = 100.
2. 2µˆ  (the limit of 2µˆ (imax)) = 0 if 2ˆr  ≥ 1, whereas 2µˆ = 1– 2ρˆ  if 2ρˆ  < 1, which
corresponds to 2λˆ  = 0 (Table 6.3). Because the combination of 2µˆ  = 0 and the
dataset D reflect very large Xk’s, 2µˆ (imax) decreases with increasing imax. With
the example dataset, 2ρˆ  ≥ 0, so 2µˆ  = 0. With the imax values of 50 and 100, the
estimates were 2µˆ (50) = 0.14 and 2µˆ (100) = 0.07.
3. The link between the first and second epidemic stage is formed by X1, which is
the result of the first stage and the starting point of the second stage. The
Table 6.3. Relation between 2ρˆ , 2λˆ , and 2µˆ ,
as obtained with the original ML method
2ρˆ  < 1 2ρˆ  ≥ 1
2λˆ  = 0 2ρˆ  – 1
2µˆ  = 1 – 2ρˆ 0
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estimates 2ρˆ (imax) and 2µˆ (imax), together with the dataset D, can be used to
calculate E(X1|D∩ 2ρˆ (imax)∩ 2µˆ (imax)) as follows [for notational convenience,
we define ξk = E(Xk|D∩ 2ρˆ (imax)∩ 2µˆ (imax))]: first, the recurrence relation
E(Xk|Xk-1 = xk-1)= (xk-1-dk)(1+ 2λˆ )+dk 2λˆ /2 is used to express ξ2, ξ3,…, ξm-1 in
terms of ξ1; second, the equation 2µˆ =(d2+d3+…+dm)/(ξ1+ξ2+…+ξm-1) is used to
express ξ1 in terms of D, 2ρˆ (imax), and 2µˆ (imax). With the example dataset,
ξ1 = 31.8 if imax = 50 and ξ1 = 61.4 if imax = 100.
4. 1ρˆ  and 1µˆ  together are estimated such that the average outcome of the first
epidemic stage will be ξ1, as computed in the previous step. The exact values of
1ρˆ  and 1µˆ  are always such that they reflect the shortest history possible.
Therefore, 1µˆ  = 1 and 1ρˆ  = ξ1 if d1 = 1, which means that the epidemic must
have started in week 0. If d1>1, then 1µˆ (imax) takes a value reflecting that X–1 =
1, so that the epidemic must have started in week –1. With the example dataset,
the resulting estimates were 1ρˆ (50) = 5.0 and 1µˆ (50) = 0.38, which lead to
E(X1) = 31.8; and 1ρˆ (100) = 7.2 and 1µˆ (100) = 0.30, leading to E(X1) = 61.4.
The predictability of the estimates indicates that the method can only extract ρ2
from the data. Two problems appear to occur. First, it is impossible to obtain a good
estimate of µ2, which suggests that the data, if used with the ML method, do not
contain information on the magnitude of the Xk values, but only on their relative
change by 2ρˆ . Second, it is impossible to estimate both 1ρˆ  and 1µˆ , which is
probably due to the fact that only one observation d1 is available for the first
epidemic stage.
In order to check whether the problems of the first epidemic stage also cause the
problems of estimating µ2, we analysed the simulations with an adjusted ML
method. In the adjusted method, estimation of ρ1 and µ1 was replaced by estimation
of x1, the realised number of infected herds at the start of the second stage. Instead of
P(D), P(D2+|X1 = x1) had to be maximised.
As with the original ML method, 2ρˆ  was always in reasonable agreement with
ρ2 (Table 6.2), whereas the other parameters were not. Now, the ML estimates could
not be derived by one single procedure, but three different types of maxima were
observed:
– Maxima in which 2µˆ  = 0 and 1xˆ  → ∞. This is similar to what happened with
the original ML method and is only observed with 2ρˆ  ≥ 1.
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– Maxima in which 2µˆ  = 1 (or almost 1) and 1xˆ  = d2. Sometimes, 2µˆ  was not
exactly 1, namely, if for some k, dk = 0 and dk+1 > 0. This type of maximum is
observed with both 2ρˆ  < 1 and 2ρˆ  ≥ 1.
– Maxima in which 0 < 2µˆ  < 1 and 1xˆ  ≈ ∑ kd . Although at first 2µˆ  seems to
have a more realistic value, it is completely determined by the interplay
between 1xˆ  and 2ρˆ . Also this type of maximum is observed with 2ρˆ  < 1 and
2ρˆ  ≥ 1.
The difference between the adjusted and the original ML method is that the
estimates with the adjusted ML method are not completely predictable. However,
for all three types of maxima, the observation that the data, analysed with the ML
method, do not contain information on the magnitude of the Xk values still holds: the
first type implies that all Xk’s are infinitely large, the second type implies that all
Xk’s are as small as possible, and the third type gives an estimate of x1 near ∑ kd .
In conclusion, only ρ can be accurately estimated by maximum likelihood if a
sequence of detections is known, but that can also be done by a much faster GLM.
The failure to estimate both ρ and µ from simulated epidemics leads to the
conclusion that the ML method that only uses D is not suitable for the branching
process model.
6.5. The distribution of Xm
Before seeking methods to improve the estimations of ρ and µ, we considered it
useful to test the prediction capacities of the model. Predictions by the model consist
of distributions of the Xk conditioned on D, of which the distribution of Xm is the
most crucial, because it reflects the current situation and is the base for prediction of
the future. Therefore, we tested the accuracy of the distributions of Xm with the 80
simulated epidemics, with 5-weeks and 10-weeks datasets.
The distribution of Xm is determined as described in Meester et al. (2002). In
short, P(D) is first calculated as described in section 4. Then, P(D), all P(D|X0 = i),
and all P(X0 = i) are used to obtain the distribution of X0 conditioned on D, where
the fact that d1 > 0 has to be taken into account as was the case with the computation
of P(D). Subsequently, the distributions of X1, X2, etc. are computed recursively,
until finally, the distribution of Xm conditioned on D is obtained.
To determine Xm distributions with the model, values for the parameters ρ1, µ1,
ρ2, and µ2 are needed, which were originally supposed to be estimated by the ML
method. Because the ML method does not work properly, we adjusted it by
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assuming that µ1 and µ2 were known, so only the accompanying ρ1 and ρ2 were
estimated with µ1 and µ2 at their simulation value. We assumed knowledge of µ1 and
µ2, because they might be estimated through alternative methods (as will be
explained in the Discussion). We let Xmax be 200 for estimation of ρ1 and ρ2 and 350
for determination of the Xm distribution, and did not use the result if those values
appeared too low. Because Xmax was too low for 22 of the 40 10-weeks simulations
with ρ2 = 1.3, only the 10-weeks datasets with ρ2 = 1.1 were used.
We used Pearson’s pλ statistic (Rao, 1973), p.168) to test whether the observed
simulated values of Xm, denoted by xm, can be regarded as random draws from the
distributions of Xm conditioned on D. Pearson’s pλ is equal to:
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in which j refers to the jth simulation, n is the number of simulations, and the
P(Xm,j = k|Dj) make up the distribution of Xm,j, conditioned on Dj. If the distributions
are correct, the P(Xm,j ≤ xm,j) are uniformly distributed on [0,1], and pλ is
χ2 distributed with 2n degrees of freedom. We computed pλ separately for all
Xm distributions of the 5-weeks datasets, and for the 40 Xm distributions of the 5-
weeks and 10-weeks datasets from the simulations with r2 = 1.1. Subsequently, the
P-values corresponding to the pλ’s were determined, and interpreted as a quality
measure for the Xm distributions.
The P-value for all 5-weeks datasets was 0.003, which indicates that many of the
Xm distributions largely deviated from the real xm. By observing the individual
Xm distributions, it appeared that as much as 26 of 77 P(Xm,j ≤ xm,j) were smaller than
0.025 or larger than 0.975 (for 3 distributions, imax was too low), which means that
the 95% CI of the accompanying Xm distributions did not include the simulated xm. If
the datasets were made 5 weeks longer, the Xm distributions tended to improve if
only the datasets of the 40 simulations with ρ2 = 1.1 are considered: the P-value
increased from 0.04 to 0.15 and the number of Xm distributions of which the 95% CI
did not include the simulated xm decreased from 12 to 5.
Closer inspection of all Xm distributions and xm realisations reveals that the ‘bad’
Xm distributions are mostly due to bad ρ2 estimates, i.e. estimates that differ from the
real ρ2 by more than 0.15. This explains why longer datasets give better results: the
ρ2 estimates are generally better. Whereas 33 of the 40 ρ2 estimates based on 10
weeks of data are within the range (0.95-1.25), only 15 of the 40 ρ2 estimates are, if
5 weeks of data of the same simulations are used.
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6.6. Discussion
Summarising, the maximum likelihood procedure is well able to provide a useful
estimate of ρ, if a sequence of detections is known. From the simulations, the
median estimates were always close to the simulation parameters and a longer
dataset improved 2ρˆ . It should be noted, however, that ρˆ  can be very well
approximated by a GLM, by fitting the sequence of detections to an exponential
curve. Therefore, if ρˆ  would be the only interesting result, the time-consuming
estimation procedure of the model is not needed.
To be able to predict the current number of infected farms, however, estimates of
µ and of parameters of previous stages are also necessary. Unfortunately, with none
of the simulations it appeared possible to obtain a reasonable 2µˆ . Some simple
rules, irrelevant to the branching process model, determined the outcome of 2µˆ , and
of 1ρˆ , 1µˆ , and 1xˆ . The conclusion is that the maximum likelihood method is not
suitable to obtain information about µ2. The maximum always appears to lie in an
area of the multidimensional parameter space which has nothing to do with the
meaning of µ2: either 2λˆ  is close to 0, 2µˆ  is close to 0 or 1, or 1xˆ  is near ∑ kd .
These results lead to questions concerning the theoretical background of the
observations, and concerning the analysis of CSFV epidemics if the virus would
enter the pig population in the near future.
An important theoretical question that needs to be answered is whether it is the
ML method that cannot extract information on µ2 (or the magnitude of the Xk’s) from
a series of detections, or whether it is the data itself that do not contain any
information on µ2. A related question concerns the mechanism behind the
predictable estimation results of our model; if we understand the mechanism we may
have an answer to the first question.
In order to answer the theoretical questions, it might be useful to formulate and
study a simpler model, which contains the key features of our epidemic model, i.e. a
discrete-time branching process with two parameters, of which only the individuals
with zero offspring are observed. An example is a model with the following
offspring distribution:
P(Xk+1 = 0|Xk = 1) = µ + (1-µ)e-λ
P(Xk+1 = k|Xk = 1) = (1-µ)e-λλk/k!
which means that there is a probability 1-µ that an individual does have offspring,
which is Poisson-distributed with parameter λ. The simple models should be used to
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study the relation between the input parameters and the output distributions, and to
get insight into the behaviour of ML methods for estimation of the model
parameters. If it would appear that it is the ML method and not the data that make
estimation of µ impossible, an estimation method that does provide estimates for
both ρ and µ should be developed.
Apart from the above theoretical questions, there is also the practical problem of
analysis of CSFV epidemics in the near future. A reasonable and simple practical
adjustment of the method seems to lie in putting constraints on the parameters, by
use of other data. For example, a distribution of X1 could be used as a constraint
before use of the ML method. Such a distribution might be available from tracing
data during an epidemic. Alternatively, the detection rate µ could be estimated with
data on the average time between detection and infection, which is equal to 1/µ
according to the model. Of the 1997-1998 epidemic, for 82 herds the times of
infection could be determined, which could be used to estimate the average
infection-detection time at 32 days (Stegeman et al., 1999a), which would mean that
µˆ  = 0.22 in our model. During each epidemic, new data on µ can be obtained,
which could make µˆ  more specific for that epidemic. When µˆ  is obtained, the ML
method can be used to estimate ρ. Because the model can give a reasonable
distribution of Xm, and because ρˆ  is estimated reasonably well, providing the model
with an estimate of µ looks promising.
Concluding, the ML method as described by Meester et al. (2002) cannot be used
directly to estimate both ρ and µ from a series of detections. The mechanism is yet
unclear and should be studied by use of simpler branching process models. For
practical purposes, the estimation method might be adjusted by use of additional
data, as the branching process model provides an accurate distribution of the current
number of infected farms if the detection parameter would be known beforehand.
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Abstract
This paper discusses the effectiveness of emergency vaccination with two E2
subunit vaccines during epidemics of classical swine fever virus (CSFV). Results of
animal experiments indicate a sufficient reduction of horizontal transmission
(reproduction ratio Ri < 1), but not of vertical transmission. This can lead to
problems with clinical detection of herds with persistently infected piglets, which
might be overcome by a control strategy in which sows are not vaccinated. This
strategy effectively limits the epidemic size and duration, as observed in a
mathematical model of between-herd CSFV transmission, reflecting the
circumstances of the Dutch 1997-1998 epidemic without spatial structure.
Furthermore, potential endscreening problems with the discriminatory Erns ELISA’s
can be solved by declaring a herd infected only if the number of seropositive
samples is above some ‘positivity threshold’, provided that no other pestiviruses are
prevalent. In conclusion, E2 marker vaccines can be effectively employed in CSFV
epidemics.
7.1. Introduction
In 1980, a common classical swine fever (CSF) policy came into force in the
European Union (EU), which urged all member states to first eradicate CSF virus
(CSFV) and then stop vaccination (Anonymous, 1980; Vandeputte and Chappuis,
1999). Since then, CSFV epidemics have been controlled by EU-prescribed control
measures, which involve hygiene measures, contact tracing and inspection, and a
transport prohibition in the affected area (Anonymous, 1980; Elbers et al., 1999;
Koenen et al., 1996; Vandeputte and Chappuis, 1999; Williams and Matthews,
1988). However, these control measures appeared insufficient in pig farm dense
areas like the area of the Dutch 1997-1998 epidemic. Only when preventive culling
of traced contacts and of herds within a radius of 1 kilometre was applied as an extra
control measure (Elbers et al., 1999; Stegeman et al., 1999b), the reproduction ratio
between herds Rh – defined as the average number of herds infected by one typical
infectious herd – decreased below the threshold value of 1, below which epidemics
certainly die out (Stegeman et al., 1999b).
Preventive culling resulted in the killing and destruction of 1.1 million pigs in
possibly infected herds, although a safe and highly effective C-strain vaccine was
available, which was known to accomplish CSFV eradication when applied in a
mass-vaccination campaign (Terpstra and Wensvoort, 1987; Terpstra et al., 1990;
Chapter 7
136
Van Oirschot, 1994; Vandeputte and Chappuis, 1999). However, emergency
vaccination was not applied, since the C-strain vaccine evokes an immune response
just like the wild-type CSFV, which interferes with the serological endscreening
(Blaha, 1995; Moennig, 2000). An endscreening has to be carried out 30 days after
the last detected case to establish if the pig population in the previously affected area
is CSFV free (Anonymous, 1980; Anonymous, 2001).
In the early 1990’s, it was realised that the difficulty with diagnosis in vaccinated
animals might be solved by so-called ‘marker vaccines’ (Blaha, 1995; Van Oirschot,
1994). Marker vaccines are vaccines that are accompanied by a discriminatory
serological test to diagnose infection with the wild-type virus in a vaccinated
population. At present, two commercial CSF marker vaccines are available, each
with its own discriminatory test: Bayer’s Bayovac® CSF marker is accompanied by
the Ceditest Erns ELISA and Intervet’s Porcilis® Pesti by the Chekit CSF marker Erns
ELISA. Both vaccines contain the E2 protein of the virus and both ELISA’s test for
antibodies against the Erns protein of the wild-type virus (Hulst et al., 1993;
Moormann et al., 2000).
This paper discusses the possibility of using the E2 vaccines in an emergency
vaccination campaign. First, an overview of relevant studies regarding the
effectiveness of the vaccines against virus transmission and the performance of the
Erns ELISA’s is given. Then, an effective control strategy with emergency
vaccination is proposed and suggestions are done for an effective endscreening.
7.2. Effectiveness of the E2 vaccines against virus transmission
Studies into the effectiveness of CSF vaccines have to aim at two modes of virus
transmission. Besides the usual horizontal virus transmission through direct or
indirect contacts between animals, CSFV can also be transmitted from sows to
unborn foetuses by vertical transmission (Van Oirschot, 1992). Vertical transmission
often leads to mummification, stillbirth, or birth of diseased piglets, but so-called
‘carrier sows’ sometimes give birth to persistently infected piglets (Van Oirschot,
1992; Van Oirschot and Terpstra, 1977). Persistently infected piglets excrete large
amounts of virus, do not develop an immune response, and are initially clinically
healthy until mild symptoms can arise after a few months. Therefore, they are
infectious during their entire life and will not be easily detected (Van Oirschot,
1992).
Many horizontal transmission studies have been conducted, from which can be
concluded that the E2 vaccines have their greatest effect on the infectiousness of
infected pigs, and not so much on the susceptibility of uninfected pigs (Bouma et al.,
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1999; De Smit et al., 2001a; Dewulf et al., 2001; Dewulf et al., 2000; Chapter 3).
The reproduction ratio between individual animals Ri, which is – analogous to Rh –
the average number of animals infected by one typical infectious animal in a virus
free population, can be brought significantly below 1, and therefore the vaccines can
prevent major outbreaks in herds (Bouma et al., 2000; Chapters 3 and 4). In
conventional animals, complete protection against transmission is reached in three
weeks and lasts for at least six months (Chapters 3 and 4; Uttenthal et al., 2001).
Therefore, both vaccines are capable of limiting an outbreak on the herd level to a
few infected pigs, even if the herd would be infected only a week after vaccination
(Chapter 3). Maternal antibodies in piglets reduce the serological response upon
vaccination, because the maternal antibodies interfere with the vaccines, but Ri is
still estimated smaller than 1 (Chapter 4).
Vertical transmission studies show that both vaccines are effective at the sow
level, which means that either a sow does not transmit virus, or a sow does transmit
virus and infects most of its piglets. Neither vaccine does completely prevent
vertical transmission (Ahrens et al., 2000; De Smit et al., 2000a; Depner et al., 2001;
Dewulf et al., 2001). Double vaccination gives a higher probability of uninfected
litters than single vaccination and Bayovac® appears to induce a greater reduction of
vertical virus transmission. After a single vaccination, Porcilis® Pesti did not induce
any reduction, while a double vaccination variably affected virus transmission: in
three experiments together, 16 out of 25 litters were virus free (Ahrens et al., 2000;
Depner et al., 2001; Dewulf et al., 2001). Single vaccination with Bayovac®
prevented CSFV transmission in 10 out of 17 sows in two experiments, whereas
double vaccination resulted in 14 virus negative litters out of 15 (De Smit et al.,
2000a; Depner et al., 2001).
In conclusion, both vaccines can prevent CSFV outbreaks on herds without
breeding sows, as Ri due to horizontal transmission is reduced to below 1. However,
vertical transmission cannot be blocked completely, which may lead to the birth of
persistently infected piglets, which can act as continuous virus sources.
7.3. Characteristics of the Erns ELISA’s
The discriminatory Erns ELISA’s are designed for serological testing of vaccinated
animals. The sensitivities of the Ceditest ELISA (provided with Bayovac®) and of
the Chekit ELISA (with Porcilis® Pesti) were determined from reference sera to be
73.5% and 94.1%, respectively (Floegel Niesmann, 2001). The specificities of the
tests depend on the choice of reference sera. If reference sera with antibodies against
other pestiviruses (bovine viral diarrhoea virus and border disease virus) are used,
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the specificities of the Ceditest and Chekit ELISA’s were estimated to be 91.8% and
70.6%, respectively (Floegel Niesmann, 2001). However, with random CSF-
negative field sera from the Dutch 1999 pig population, the specificity of the
Ceditest is 98.7% (Moormann et al., 2000). This is in accordance with the
specificities of both tests, measured from recent European CSF-negative field sera
and sera from pigs vaccinated with the marker vaccine: 100% and 98% with
Ceditest and Chekit, respectively (Floegel Niesmann, 2001).
Serological tests are carried out during CSFV epidemics and in endscreenings
after CSFV epidemics “in order to detect the possible presence of classical swine
fever virus” (Anonymous, 2001). Notwithstanding the importance of the test
characteristics, the sensitivity and specificity of the complete testing procedure at the
herd level also depend on the expected seroprevalence, the sample size, and the use
of confirmation tests. In animals vaccinated with the E2 vaccine, however,
serological confirmation tests are not (yet) available.
During CSF epidemics, it is important to detect as many CSFV-infected herds as
possible, so herd sensitivity has to be very high. Generally, herd sensitivity can be
improved by increasing the sample size, which will decrease herd specificity if no
confirmation tests are applied. However, during epidemics a very high herd
specificity is not crucial, because occasional false positive herds do hardly affect the
further epidemic course.
After CSFV epidemics, however, when endscreenings are conducted, a low herd
specificity can become a real burden, as false-positive results can continuously delay
declaring an area CSFV free. Moreover, a low herd specificity can become costly if
herds have to be sampled again and confirmation tests need to be conducted.
Therefore, the major problem of the Erns ELISA’s seems to be the specificity, or
rather the absence of serological confirmation tests, and not the low sensitivity,
which can be adjusted for by increasing the sample size.
7.4. The E2 vaccine in an emergency vaccination campaign
As described above, the E2 vaccines are very effective in reducing horizontal
transmission, and the Erns-ELISA’s can be applied during epidemics. However,
emergency vaccination may lead to some problems involving vaccinated sows, and
it may lead to problems with herd specificity during an endscreening.
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7.4.1. Problems with vaccinated sows
Regarding the vaccination of sows, there are some uncertainties. First, the level of
virus transmission between newborn maternally immune piglets is unknown.
Second, the effectiveness of vaccination of maternally immune piglets may be
reduced. Third, vertical transmission can still occur and lead to the birth of
persistently infected piglets. Whereas herds with persistently infected piglets are
usually detected through the contact infections they cause, detection is prevented if
the herd is completely vaccinated. All these problems of an emergency vaccination
campaign might be avoided by omitting vaccination of breeding sows.
Omitting the vaccination of breeding sows is only legitimate if the resulting
control strategy is effective, i.e. if Rh can still be brought below 1. The effectiveness
of this control strategy, as of many more strategies, was studied with a mathematical
model by Klinkenberg et al. (Chapter 5).
The model was a very basic description of CSFV transmission within and
between two types of pig herds, herds with and herds without breeding sows. It was
fitted to data of the Dutch 1997-1998 epidemic, which means that the model
described CSFV epidemics in a pig dense area with a moderately virulent CSFV
strain. The model did not take account of local differences with respect to herd
density and the proportions of both herd types. All virus transmission routes except
animal transport were subject to the EU-prescribed control measures and were
joined into one transmission parameter. Furthermore, assumptions were made
regarding the effectiveness of vaccination. Because the vaccines mainly reduce the
infectiousness of infected pigs, it was assumed that major outbreaks within herds do
not occur if the first infected pig is vaccinated. Therefore, vaccination affects the
probability that virus entry into a herd leads to a major outbreak, e.g. if 60% of the
pigs in a herd is vaccinated, then the probability of a major outbreak is reduced by
60%. Vaccination was assumed not to affect detection of herds nor virus
transmission within herds with major outbreaks (Chapter 5).
Two conditions that are necessary to ensure extinction of a CSFV epidemic
could be derived from the model: (i) no virus transmission through transport and (ii)
reduction of the number of major outbreaks by at least 50%. The proposed control
scenario, with vaccination of all piglets and finishing pigs but not the breeding sows,
amply meets these conditions. If only piglets and finishing pigs in herds with
breeding sows are vaccinated, Rh is still above 1, whereas vaccination of only the
herds without breeding sows does reduce Rh sufficiently, but can lead to very long-
lasting epidemics with many infected herds (Table 7.1) (Chapter 5).
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7.4.2. Problems with herd specificity
The specificity of the Erns ELISA’s, or rather the absence of confirmation tests, was
recognised as a potential problem during endscreenings. It is, however, possible to
achieve a high herd specificity with only the Erns ELISA, by declaring a herd to be
infected only if the number of positively tested samples is above some ‘positivity
threshold’. Table 2 gives some positivity thresholds to achieve a herd specificity of
99.9% with the Ceditest ELISA (test specificity of 99.4%, mean of two publications
(Floegel Niesmann, 2001; Moormann et al., 2000)) and with the Chekit ELISA (test
specificity of 98% (Floegel Niesmann, 2001)).
Of course, adjusting the positivity threshold to increase the herd specificity leads
to a decrease in herd sensitivity. However, because the herd sensitivity strongly
depends on the expected seroprevalence, it is positively affected by the 30 day delay
between the last detection and the endscreening. Namely, if CSFV infected herds are
still present during an endscreening, the seroprevalence on those herds will be
reasonably high, which will increase the herd sensitivity. As an example for both
ELISA’s, Table 2 shows the herd sensitivity in a herd of 1000 animals with different
sample sizes, if the herd specificity is set at 99.9% by adjusting the positivity
threshold and the expected seroprevalence is 5%. Table 7.2 indicates that both Erns
ELISA’s can be used to design an endscreening procedure with high herd sensitivity
and high herd specificity.
Table 7.1. Expected effectiveness of vaccination scenarios a
Vaccination of
all herds without
breeding sows
Vaccination of all
piglets and finishing
pigs in herds with
breeding sows
Duration
(days)
95% CI b Size
(infected
herds)
95% CI b
– – ND c ND c
+ – 226 63 - 1070 42 13 - 452
– + ND c ND c
+ + 103 47 - 239 16 10 - 35
a The model (Chapter 5) simulated CSFV epidemics under the circumstances of the Dutch
1997-1998 CSFV epidemic without spatial structure. It contained two types of herds, viz.
herds with and herds without breeding sows. The results have been obtained by
simulating epidemics with a starting condition of 5 undetected infected herds of both
types (10 infected herds in total). The shaded scenario is the scenario, as proposed in this
paper
b Confidence interval.
c Not determined, because Rh > 1.
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7.5. Discussion
Previous publications on the E2 marker vaccines often concluded that the vaccines
reduced virus transmission rather late after vaccination. For instance, Dewulf et al.
(2000) state that “a 2 weeks interval between vaccination and protection will be an
important hindrance for the use of the vaccine in emergency vaccination
programmes” since about half of the outbreaks on herds would occur within the first
two weeks after the nearest neighbouring outbreak. This reasoning overlooks the
fact that vaccination contributes to a reduction of Rh not by preventing that herds
become infected upon CSFV uptake, but by preventing that vaccinated herds do
develop major outbreaks and spread the virus to other herds. In short, vaccination
affects herd infectiousness more than herd susceptibility, and that is already
achieved if virus enters a herd one week after vaccination (Chapter 3).
A second often-expressed objection against the E2 vaccines is their effect on
vertical transmission, which cannot be prevented even after double vaccination
(Depner et al., 2001; Dewulf et al., 2001). Vertical transmission can lead to the birth
of persistently infected piglets, which will result in an infectious herd that cannot be
clinically detected. This problem is avoided in a CSFV control strategy in which the
EU-prescribed control measures are accompanied by vaccination of all piglets and
finishing pigs, but not the sows. Under the circumstances of the Dutch 1997/1998
epidemic, it appears that the strategy results in an Rh smaller than 1, with limited
outbreak size and duration (16 herds in 3 months, if 10 infected herds are yet
undetected at time of vaccination).
The final and major objection against the E2 vaccines of many authors was not
the vaccines themselves, but the limited performance of the accompanying Erns
Table 7.2. Positivity threshold with 99.9% herd specificity, and resulting herd sensitivity
in a herd of 1000 pigs a
Ceditest ELISA b Chekit ELISA c
Sample size Positivity
threshold
Herd
sensitivity
Positivity
threshold
Herd
sensitivity
100 4 42.1% 7 33.8%
200 6 76.6% 11 69.0%
500 10 99.9% 21 99.6%
1000 15 >99.9% 35 >99.9%
a Expected seroprevalence of 5%, calculation method as in Cameron and Baldock (1998)
b Test sensitivity at animal level is 73.5%, test specificity is 99.4%
c Test sensitivity at animal level is 94.1%, test specificity is 98.0%
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ELISA’s. To cite Floegel-Niesmann (Floegel Niesmann, 2001), “the limitation of
the two discriminatory ELISA’s is the major factor that would prevent the use of
these two marker vaccines under emergency field conditions.” In contrast, in this
paper it was argued that the ELISA’s can be effectively applied during CSF
epidemics by increasing the sample size. In an endscreening procedure, high herd
specificity is important to avoid unnecessary long epidemics. By increasing the
sample size and adjusting the positivity threshold, both herd sensitivity and herd
specificity can become very high, provided that no other pestivirus infections are
present in the population. Then, a serological confirmation test is needed.
Aside from adjusting the sample size and the positivity threshold, the
endscreening procedure might also be optimised by adjusting the test characteristics
at the laboratory level, i.e. by increasing the test specificity, which decreases the test
sensitivity. It is also possible to perform an endscreening in two steps: a first quick
screening with small sample sizes and low herd specificity, and a second screening
with larger samples in the positive herds of the first screening.
The most important remaining question about the effectiveness of the E2
vaccines is whether maternal immunity reduces virus transmission between newborn
piglets. Although the proposed control strategy without vaccination of sows does not
need an answer to this question, extra research is needed to fill this gap if
vaccination of sows would be considered.
The decision to use emergency vaccination will hinge on economic and ethical
considerations, which have to be weighed in a political process influenced by
scientific knowledge and public opinion. Studies into the economic effects of control
scenarios concluded that emergency vaccination can be useful as a buffer in case of
restricted destruction capacity, and that it works out very positive if vaccinated
animals can be traded after the epidemic (Mangen et al., 2001; Saatkamp et al.,
2000).
In conclusion, the positive results of experiments and models have made that,
from epidemiological perspective, emergency vaccination with E2 marker vaccines
is a good alternative to preventive culling.
Acknowledgements
We gratefully acknowledge financial support from STW (Technology Foundation),
Utrecht, The Netherlands.
References

References
145
Aitkin, M., Anderson, D., Francis, B., Hinde, J., 1989. Survival data, Statistical
modelling in GLIM, Oxford.
Anderson, R.M., May, R.M., 1979. Population biology of infectious diseases: Part I.
Nature 280, 361-367.
Anderson, R.M., May, R.M. (Eds.), 1991. Infectious diseases of humans. Oxford
University Press, New York.
Anonymous, 1980. EU Council Directive 80/217/EEC on Community measures for
the control of Classical Swine Fever.
Anonymous, 2001. EU Council Directive 2001/89/EC on Community measures for
the control of Classical Swine Fever.
Bailey, N.T.J., 1975. General Epidemics. In: Bailey, N.T.J. (Ed.), The mathematical
theory of infectious diseases and its applications. Hafner Press, New York, pp. 81-
133.
Beaumont, G.P. (Ed.), 1980. Intermediate mathematical statistics. Chapman and
Hall, London.
Becker, N.G. (Ed.), 1989. Analysis of infectious disease data. Chapman and Hall,
London.
Beynon, A.G., 1969. The eradication of swine fever from Great Britain. Vet Rec 84,
623-624.
Birkes, D., 1998. Likelihood ratio tests. In: Armitage, P., Colton, T. (Eds.),
Encyclopedia of biostatistics. John Wiley & Sons Ltd, Chichester, West Sussex,
pp. 2245-2248.
Biront, P., Leunen, J., Vandeputte, J., 1987. Inhibition of virus replication in the
tonsils of pigs previously vaccinated with a Chinese strain vaccine and challenged
oronasally with a virulent strain of classical swine fever virus. Vet Microbiol 14,
105-113.
Bouma, A., De Jong, M.C., Kimman, T.G., 1997. The influence of maternal
immunity on the transmission of pseudorabies virus and on the effectiveness of
vaccination. Vaccine 15, 287-294.
Bouma, A., De Jong, M.C.M., Kimman, T.G., 1996. Transmission of two
pseudorabies virus strains that differ in virulence and virus excretion in groups of
vaccinated pigs. Am J Vet Res 57, 43-47.
Bouma, A., De Smit, A.J., De Jong, M.C.M., De Kluijver, E.P., Moormann, R.J.M.,
2000. Determination of the onset of the herd-immunity induced by the E2 sub-unit
vaccine against classical swine fever virus. Vaccine 18, 1374-1381.
Bouma, A., de Smit, A.J., de Kluijver, E.P., Terpstra, C., Moormann, R.J.M., 1999.
Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical
swine fever virus. Vet Microbiol 66, 101-114.
Campbell, A.D., 1969. Swine fever. Proc R Soc Med 62, 824-826.
Chenut, G., Saintilan, A.F., Burger, C., Rosenthal, F., Cruciere, C., Picard, M.,
Bruyere, V., Albina, E., 1999. Oral immunisation of swine with a classical swine
fever vaccine (Chinese strain) and transmission studies in rabbits and sheep. Vet
Microbiol 64, 265-276.
Colijn, E.O., Bloemraad, M., Wensvoort, G., 1997. An improved ELISA for the
detection of serum antibodies directed against classical swine fever virus. Vet
Microbiol 59, 15-25.
References
146
Cox, D.R., Miller, H.D. (Eds.), 1965. The theory of stochastic processes. Chapman
and Hall Ltd., London.
Crauwels, A.P.P., De Koning, R., Nielen, M., Elbers, A.R.W., Dijkhuizen, A.A.,
Tielen, M.J.M., 2001. A concept for a decision support system based on practical
experiences from a national disease emergency - the Dutch experience. Acta Vet
Scand Suppl. 94, 61-69.
Crauwels, A.P.P., De Koning, R., Nielen, M., Tielen, M.J., 2000. Decision support
in animal disease control. In: Tielen, M.J.M., Voets, M.T. (Eds.), Proceedings of
the Xth International Congress on Animal Hygiene. Maastricht, pp. 362-365
Dahle, J., Liess, B., 1992. A review on classical swine fever infections in pigs:
epizootiology, clinical disease and pathology. Comp Immunol Microbiol Infect
Dis 15, 203-211.
De Jong, M.C.M., Kimman, T.G., 1994. Experimental quantification of vaccine-
induced reduction in virus transmission. Vaccine 12, 761-766.
De Smit, A.J., Bouma, A., de Kluijver, E.P., Terpstra, C., Moormann, R.J.M.,
2001a. Duration of the protection of an E2 subunit marker vaccine against classical
swine fever after a single vaccination. Vet Microbiol 78, 307-317.
De Smit, A.J., Bouma, A., van Gennip, H.G.P., de Kluijver, E.P., Moormann,
R.J.M., 2001b. Chimeric (marker) C-strain viruses induce clinical protection
against virulent classical swine fever virus (CSFV) and reduce transmission of
CSFV between vaccinated pigs. Vaccine 19, 1467-1476.
De Smit, A.J., Van de Wetering, G., Colijn, E.C., Hulst, M., Kramps, J.A., Van den
Blink, A., Moormann, R.J.M., 2000. Evaluation of an ELISA for the detection of
antibodies against the Erns envelope protein of classical swine fever virus. In: de
Smit, A.J. (Ed.), Classical Swine Fever. Efficacy of marker vaccines and
laboratory diagnosis. Thesis University Utrecht, Utrecht, pp. 117-131.
Depner, K.R., Bouma, A., Koenen, F., Klinkenberg, D., Lange, E., de Smit, H.,
Vanderhallen, H., 2001. Classical swine fever (CSF) marker vaccine - Trial II.
Challenge study in pregnant sows. Vet Microbiol 83, 107-120.
Dewulf, J., Laevens, H., Koenen, F., Mintiens, K., de Kruif, A., 2001. An E2 sub-
unit marker vaccine does not prevent horizontal or vertical transmission of
classical swine fever virus. Vaccine 20, 86-91.
Dewulf, J., Laevens, H., Koenen, F., Vanderhallen, H., Mintiens, K., Deluyker, H.,
De Kruif, A., 2000. An experimental infection with classical swine fever in E2
sub-unit marker-vaccine vaccinated and in non-vaccinated pigs. Vaccine 19, 475-
482.
Diekmann, O., Heesterbeek, J.A.P. (Eds.), 2000. Mathematical epidemiology of
infectious diseases. Model building, analysis and interpretation. John Wiley &
Sons Ltd, Chichester, West Sussex.
Dunne, H.W., 1966. The control of pig diseases by immunization. Cornell Vet 56,
293-299.
Edwards, S., Fukusho, A., Lefevre, P.-C., Lipowski, A., Pejsak, Z., Roehe, P.,
Westergaard, J., 2000. Classical swine fever: The global situation. Vet Microbiol
73, 103-119.
References
147
Elbers, A.R.W., Stegeman, A., Moser, H., Ekker, H.M., Smak, J.A., Pluimers, F.H.,
1999. The classical swine fever epidemic 1997-1998 in the Netherlands:
descriptive epidemiology. Prev Vet Med 42, 157-184.
Floegel-Niesmann, G., 2001. Classical swine fever (CSF) marker vaccine - Trial III.
Evaluation of discriminatory ELISAs. Vet Microbiol 83, 121-136.
Fritzemeier, J., Teuffert, J., Greiser Wilke, I., Staubach, C., Schluter, H., Moennig,
V., 2000. Epidemiology of classical swine fever in Germany in the 1990s. Vet
Microbiol 77, 29-41.
Genstat, 1998. 5 ed. Rothamsted: Lawes Agricultural Trust.
Greiser Wilke, I., Depner, K., Fritzemeier, J., Haas, L., Moennig, V., 1998.
Application of a computer program for genetic typing of classical swine fever
virus isolates from Germany. J Virol Meth 75, 141-150.
Hulst, M.M., Westra, D.F., Wensvoort, G., Moormann, R.J., 1993. Glycoprotein E1
of hog cholera virus expressed in insect cells protects swine from hog cholera. J
Virol 67, 5435-5442.
Jalvingh, A.W., Nielen, M., Maurice, H., Stegeman, A.J., Elbers, A.R.W.,
Dijkhuizen, A.A., 1999. Spatial and stochastic simulation to evaluate the impact of
events and control measures ion the 1997-1998 classical swine fever epidemic in
The Netherlands. I. Description of simulation model. Prev Vet Med 42, 271-295.
Kaden, V., Lange, B., 2001. Oral immunisation against classical swine fever (CSF):
onset and duration of immunity. Vet Microbiol 82, 301-310.
Kaden, V., Lange, E., Fischer, U., Strebelow, G., 2000. Oral immunisation of wild
boar against classical swine fever: evaluation of the first field study in Germany.
Vet Microbiol 73, 239-252.
Kermack, W.O., McKendrick, A.G., 1991. Contributions to the mathematical theory
of epidemics--I. 1927 [classical article]. Bull Math Biol 53, 33-55.
Koenen, F., VanCaenegem, G., Vermeersch, J.P., Vandenheede, J., Deluyker, H.,
1996. Epidemiological characteristics of an outbreak of classical swine fever in an
area of high pig density. Vet Rec 139, 367-371.
König, M., Lengsfeld, T., Pauly, T., Stark, R., Thiel, H.J., 1995. Classical swine
fever virus: Independent induction of protective immunity by two structural
glycoproteins. J Virol 69, 6479-6486.
Kroese, A.H., De Jong, M.C.M., 2001. Design and analysis of transmission
experiments. In: Menzies, F.D., Reid, S.W.J. (Eds.), Proceedings of the Society for
Veterinary Epidemiology and Preventive Medicine. Noordwijkerhout, the
Netherlands, pp. xxi - xxxvii
Laddomada, A., 2000. Incidence and control of CSF in wild boar in Europe. Vet
Microbiol 73, 121-130.
Laevens, H., Koenen, F., Deluyker, H., Berkvens, D., deKruif, A., 1998. An
experimental infection with classical swine fever virus in weaner pigs - I.
Transmission of the virus, course of the disease, and antibody response. Vet Q 20,
41-45.
Laevens, H., Koenen, F., Deluyker, H., de Kruif, A., 1999. Experimental infection
of slaughter pigs with classical swine fever virus: transmission of the virus, course
of the disease and antibody response. Vet Rec 145, 243-248.
References
148
Lehmann, E.L. (Ed.), 1959. Testing Statistical Hypotheses. John Wiley & Sons, Inc.,
New York.
Lipowski, A., Drexler, C., Pejsak, Z., 2000. Safety and efficacy of a classical swine
fever subunit vaccine in pregnant sows and their offspring. Vet Microbiol 77, 99-
108.
Mangen, M.J., Jalvingh, A.W., Nielen, M., Mourits, M.C., Klinkenberg, D.,
Dijkhuizen, A.A., 2001. Spatial and stochastic simulation to compare two
emergency-vaccination strategies with a marker vaccine in the 1997/1998 Dutch
Classical Swine Fever epidemic. Prev Vet Med 48, 177-200.
Mangen, M.-J.J., 2002. Economic welfare analysis of simulated control strategies
for Classical Swine Fever epidemics, Department of social sciences. Wageningen:
Wageningen University.
Mangen, M.-J.J., Nielen, M., Burrell, A.M., 2002. Simulated effect of pig-
population density on epidemic size and choice of control strategy for classical
swine fever epidemics in The Netherlands. Prev Vet Med 56, 141-163.
Meester, R., De Koning, J., De Jong, M.C.M., Diekmann, O., 2002. Modeling and
Real-Time Prediction of Classical Swine Fever Epidemics. Biometrics 58, 178-
184.
Meuwissen, M.P.M., Horst, S.H., Huirne, R.B.M., Dijkhuizen, A.A., 1999. A model
to estimate the financial consequences of classical swine fever outbreaks:
principles and outcomes. Prev Vet Med 42, 249-270.
Mintiens, K., Deluyker, H., Laevens, H., Koenen, F., Dewulf, J., De Kruif, A., 2001.
Descriptive epidemiology of a classical swine fever outbreak in the Limburg
Province of Belgium in 1997. J Vet Med B Infect Dis Vet Public Health 48, 143-
149.
Moennig, V., 2000. Introduction to classical swine fever: virus, disease and control
policy. Vet Microbiol 73, 93-102.
Moormann, R.J.M., Bouma, A., Kramps, J.A., Terpstra, C., De Smit, H.J., 2000.
Development of a classical swine fever subunit marker vaccine and companion
diagnostic test. Vet Microbiol 73, 209-219.
Moormann, R.J.M., de Smit, A.J., Van Rijn, P., Wensvoort, G., Gielkens, A., Hulst,
M., van Gennip, R., Miedema, C., de Kluijver, E.P., Terpstra, C., 1997. The
potential use of marker vaccines for classical swine fever. In: Edwards, S., Paton,
A., Wensvoort, G. (Eds.), Proceedings of the 3rd ESVV symposium on pestivirus
infections. CVL, Weybridge, UK, pp. 180-187
Nielen, M., Jalvingh, A.W., Meuwissen, M.P.M., Horst, S.H., Dijkhuizen, A.A.,
1999. Spatial and stochastic simulation to evaluate the impact of events and
control measures on the 1997-1998 classical swine fever epidemic in The
Netherlands. II. Comparison of control strategies. Prev Vet Med 42, 297-317.
OIE, 2002. International Animal Health Code. 11th ed.
Pensaert, M., 1978. Bestrijdingsmogelijkheden van virale ziekten bij het varken nu
en in de toekomst. II. Specifieke toepassingen. Tijdschr Diergeneesk 103, 523-531.
Pittler, H., 1986. Bekämpfung der Europäischen Schweinepest unter
Berücksichtigung neuer EG-Vorschriften. Tierärztl Prax 14, 55-65.
Precausta, P., Kato, F., Brun, A., 1978. Peste porcine classique. immunisation active
conferee par la souche chinoise CL aux porcelets issus de truies immunes. [Hog
References
149
cholera: active immunity conferred by the Chinese strain vaccine to young pigs
born to immune sows]. Dev Biol Stand, 41367-41379.
Precausta, P., Kato, F., Brun, A., 1983. Swine fever immunisation of piglets. Comp
Immunol Microbiol Infect Dis 6, 281-289.
Rao, C.R. (Ed.), 1973. Linear statistical inference and its applications. John Wiley &
sons, New York.
Ressang, A.A., Den Boer, J.L., 1967. A comparison between the cell culture, frozen
tissue section and mucosal smear technique for fluorescent antibody in the
diagnosis of hog cholera. Tijdschr Diergeneesk 92, 567-586.
Robijns, K.G., 1971. Swine fever and swine fever eradication in the Netherlands.
Bull Off Int Epiz 95, 532-552.
Saatkamp, H.W., Berentsen, P.B.M., Horst, S.H., 2000. Economic aspects of the
control of classical swine fever outbreaks in the European Union. Vet Microbiol
73, 221-237.
Saulmon, E.E., 1973. Hog cholera eradication - dream or reality. J Am Vet Med
Assoc 163, 1103-1105.
Sharpe, K., Gibbens, J., Morris, H., Drew, T., 2001. Epidemiology of the 2000 CSF
outbreak in East Anglia: preliminary findings. Vet Rec 148, 91.
Siegrist, C.-A., 2001. Neonatal and early life vaccinology. Vaccine 19, 3331-3346.
Siva software B.V., 2001. Bedrijfsvergelijking 2000. Wageningen, The Netherlands.
Sokal, R.R., Rohlf, F.J. (Eds.), 1981. Biometry. W.H. Freeman and company, New
York.
Soos, P., Mojzis, M., Pollner, A., Sumeghy, L., 2001. Evaluation of vaccine-induced
maternal immunity against classical swine fever. Acta Vet Hung 49, 17-24.
Staubach, C., Teuffert, J., Thulke, H.H., 1997. Risk analysis and local spread
mechanisms of classical swine fever. Epidemiol Sante Animale, 31-32.
Stegeman, A., Elbers, A., de Smit, H., Moser, H., Smak, J., Pluimers, F., 2000. The
1997-1998 epidemic of classical swine fever in the Netherlands. Vet Microbiol 73,
183-196.
Stegeman, A., Elbers, A.R.W., Bouma, A., de Smit, H., de Jong, M.C.M., 1999a.
Transmission of classical swine fever virus within herds during the 1997-1998
epidemic in The Netherlands. Prev Vet Med 42, 201-218.
Stegeman, A., Elbers, A.R.W., Smak, J., de Jong, M.C.M., 1999b. Quantification of
the transmission of classical swine fever virus between herds during the 1997-1998
epidemic in The Netherlands. Prev Vet Med 42, 219-234.
Taylor, D.J., 1995. Classical swine fever (hog cholera). In: Taylor, D.J. (Ed.), Pig
Diseases. Burlington Press, Cambridge.
Terpstra, C., 1978. Aantonen van C-virus in varkens na vaccinatie tegen
varkenspest. Tijdschr Diergeneesk 103, 678-684.
Terpstra, C., 1987. Epizootiology of swine fever. Vet Q 9 Suppl 1, 50s-60s.
Terpstra, C., 1988. Epizootiology of hog cholera. In: Liess, B. (Ed.), Classical swine
fever and related viral infections. Martinus Nijhoff publishing, Boston, pp. 201-
216.
Terpstra, C., Bloemraad, M., Gielkens, A.L., 1984. The neutralizing peroxidase-
linked assay for detection of antibody against swine fever virus. Vet Microbiol 9,
113-120.
References
150
Terpstra, C., de Smit, A.J., Stegeman, A., Elbers, A., de Smit, H., Moser, H., Smak,
J., Pluimers, F., 2000. The 1997/1998 epizootic of swine fever in the Netherlands:
control strategies under a non-vaccination regimen. Vet Microbiol 77, 3-15.
Terpstra, C., Robijns, K.G., 1977. Experience with regional vaccination against
swine fever in enzootic areas for limited periods using C-strain virus. Tijdschr
Diergeneesk 102, 106-112.
Terpstra, C., Tielen, M.J., 1976. Antibody response against swine fever following
vaccination with C-strain virus. Zentralbl Veterinarmed [B] 23, 809-821.
Terpstra, C., Wensvoort, G., 1987. Influence of the vaccination regime on the herd
immune response for swine fever. Vet Microbiol 13, 143-151.
Uttenthal, A., Le Potier, M.F., Romero, L., De Mia, G.M., Floegel Niesmann, G.,
2001. Classical swine fever (CSF) marker vaccine - Trial I. Challenge studies in
weaner pigs. Vet Microbiol 83, 85-106.
Vagsholm, I., 1996. Benefit-cost analysis and simulation models: Tools in the
decision making process whether starting a vaccination programme or not. Acta
Vet Scand Suppl. 90, 17-24.
Van Nes, A., De Jong, M.C.M., Schoevers, E.J., Van Oirschot, J.T., Verheijden,
J.H.M., 2001. Pseudorabies virus is transmitted among vaccinated conventional
pigs, but not among vaccinated SPF pigs. Vet Microbiol 80, 303-312.
Van Oirschot, J.T., 1992. Hog cholera. In: Leman, A.D., Straw, B.E., Mengeling,
W.L., D'Allaire, S., Taylor, D.J. (Eds.), Diseases of swine. Iowa State University
Press, Ames, Iowa, pp. 274-285.
Van Oirschot, J.T., 1994. Vaccination in food animal populations. Vaccine 12, 415-
418.
Van Oirschot, J.T., 1999. Diva vaccines that reduce virus transmission. J Biotechnol
73, 195-205.
Van Oirschot, J.T., Terpstra, C., 1977. A congenital persistent swine fever infection,
I. Clinical and virological observations. Vet Microbiol 2, 121-132.
Van Rijn, P.A., Van Gennip, H.G.P., Moormann, R.J.M., 1999. An experimental
marker vaccine and accompanying serological diagnostic test both based on
envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine 17, 433-
440.
Vandeputte, J., Chappuis, G., 1999. Classical swine fever: the European experience
and a guide for infected areas. Rev Sci Tech 18, 638-647.
Wensvoort, G., Terpstra, C., Boonstra, J., Bloemraad, M., Van Zaane, D., 1986.
Production of monoclonal antibodies against swine fever virus and their use in
laboratory diagnosis. Vet Microbiol 12, 101-108.
Williams, D.R., Matthews, D., 1988. Outbreaks of classical swine fever in Great
Britain in 1986. Vet Rec 122, 479-483.
Wolfram, S. (Ed.), 1999. The Mathematica Book. University Press, Cambridge.
Summary

Summary
153
The thesis describes epidemiological research carried out to improve the control of
classical swine fever virus (CSFV) epidemics. The research was part of an STW
(Technology Foundation) funded project which also covered the management and
the economic consequences of CSFV control.
Two important aspects of improvement of CSFV control have been addressed.
The first is investigation of control measures and strategies in order to enable quick
and adequate action upon CSFV detection; a good preparation to virus entry. The
second is the development of epidemiological tools to make it possible to measure
the effectiveness of CSFV control during an epidemic; with such tools, it becomes
possible to steer the control strategy if it appears to be insufficient.
Regarding classical swine fever (CSF), the European Union (EU) has a non-
vaccination policy. Also during epidemics, vaccination has never been applied,
because vaccinated pigs could not be guaranteed to be virus free as the vaccines
evoked the same antibody response as the virus. To overcome the detection
problems, E2 subunit marker vaccines have been developed with accompanying
discriminatory tests, which react positive only after infection with the virus and not
after vaccination. Hence, it has become possible, also after vaccination, to guarantee
that an area is virus free.
The thesis describes CSFV transmission experiments and a mathematical model
of CSFV transmission between herds, used to assess the effectiveness of the marker
vaccines with respect to CSFV transmission. Quantification of the effectiveness was
done with the ‘basic reproduction ratio’ R, defined as the number of individuals that
is infected by one typical infectious individual in a completely susceptible
population. Only if R exceeds 1, a major epidemic is possible. For the analysis of the
transmission experiments, R was used at the level of the individual animal (Ri: the
number of animals infected by one animal), whereas the mathematical modelling
study made use of R at the herd level (Rh: the number of herds infected by one herd).
The transmission experiments pointed out that Ri decreases to below 1 as of three
weeks after vaccination until at least six months after vaccination. Already one week
after vaccination of a pig herd, virus entry will lead to only minor outbreaks. It
appeared that the presence of maternal antibodies at the time of vaccination may
reduce the antibody levels at later age, but these lower levels still keep Ri below 1.
Vertical CSFV transmission can lead to the birth of persistently infected piglets,
which shed large amounts of virus and show only few clinical symptoms after some
months. Therefore, clinical detection of a herd with persistently infected piglets
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occurs through the contact infections of those piglets. If a herd is completely
vaccinated, however, clinical detection has become impossible, and because
vaccination does not prevent vertical transmission, completely vaccinated herds can
become a risk. This risk might be avoided by omitting the vaccination of breeding
sows, which leads to the continuous presence of some unvaccinated young piglets.
These piglets can show clinical disease upon infection and hence make detection of
the herd possible.
The strategy with omitting the vaccination of breeding sows is one of the
strategies tested in a mathematical model of CSFV transmission. The model results
point out that an effective control strategy (Rh < 1) requires a complete prohibition
of transport of unvaccinated animals. Moreover, in addition to the control measures
that are obliged by EU legislation (like the tracing of infectious contacts and hygiene
measures), the virus transmission between herds should be halved, e.g. by
vaccinating 50% of all pig herds. If all animals but the breeding sows would be
vaccinated, the demands for a successful control strategy are well met. If ten
undetected, infected herds are present at the time the strategy is implemented, the
last infected herd is expected to be detected after three months. The total number of
infected herds will then be 16, including the 10 infected herds at the start.
For correct interpretation of the results, it is essential to realise that the model
was based on the Dutch CSFV epidemic of 1997/1998, with a moderately virulent
virus strain in a pig dense area with relatively many multiplier herds. Moreover, the
model described only the most essential elements of virus transmission within and
between herds ands it did not include local spatial effects.
In addition to the investigation of control strategies, a tool was tested, which had
been developed to analyse the effectiveness of the control strategy in an ongoing
epidemic. The tool consisted of a very simple model for CSFV transmission
between herds and was designed to use data of an ongoing epidemic for estimation
of Rh and the number of infected, but yet undetected herds. The only data needed for
the calculations are the numbers of detected herds in each week of the epidemic.
Unfortunately, the only result the model could generate was whether Rh was smaller
or larger than 1.
In order to understand why the model cannot give more precise estimates and
why it cannot estimate the present number of undetected infected herds, it will be
necessary to thoroughly study simpler versions of the model. To be able to analyse
ongoing epidemics until a better model is available, some extra data might be used,
e.g. an estimate of the number of infected herds at the day of the first detection, or
an estimate of the average time between infection of a herd and detection.
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Doel van het onderzoek
Als klassieke-varkenspestvirus (KVPV), dat klassieke varkenspest (KVP)
veroorzaakt, binnenkomt in de Nederlandse (gedomesticeerde) varkenspopulatie,
dan kan dat tot grote KVP-epidemieën leiden. Een voorbeeld hiervan was de KVP-
epidemie in 1997 en 1998, die 12 miljoen varkens het leven kostte en resulteerde in
een economische schade van ongeveer 2,3 miljard euro. Naar aanleiding van deze
epidemie is er discussie ontstaan over de effectiviteit en de ethische
aanvaardbaarheid van de gebruikte bestrijdingsmaatregelen, met name het preventief
slachten van op het oog gezonde varkens.
Schade als gevolg van KVP kan worden beperkt door te werken aan preventie,
dus voorkomen dat het virus Nederland binnenkomt, en door effectievere bestrijding
van epidemieën als het virus eenmaal binnen is. In een door STW (Stichting
Technische Wetenschappen) gefinancierd project is vanaf 1998 onderzoek gedaan
naar voornamelijk het tweede onderdeel, bestrijding van epidemieën. Het werk in dit
proefschrift maakt deel uit van dat project, en beslaat het epidemiologische aspect
van KVPV-bestrijding. Andere aandachtspunten in het project waren de organisatie
van KVPV-bestrijding en de economische gevolgen van KVP-epidemieën.
Epidemiologisch onderzoek ter verbetering van KVPV-bestrijding kan zich
richten op twee belangrijke doelen. In de eerste plaats is het gewenst om
maatregelen en strategieën te onderzoeken om snel tot adequaat ingrijpen te kunnen
overgaan zodra het virus wordt gedetecteerd; een goede voorbereiding op
virusintroductie dus. Ten tweede is het nuttig om tijdens de bestrijding te beschikken
over epidemiologische tools, hulpmiddelen die het mogelijk maken om gedurende
de epidemie de effectiviteit van de bestrijding te meten. De bestrijding kan dan snel
worden bijgestuurd als het mis gaat. Aan beide doelen, onderzoek van
bestrijdingsmaatregelen en ontwikkelen van tools, wordt in dit proefschrift aandacht
besteed.
Onderzoek aan bestrijdingsstrategieën
Achtergrond
Met betrekking tot KVP wordt er in de Europese Unie (EU) een non-
vaccinatiebeleid gevoerd, waarmee de internationale handelsregels worden gevolgd
zoals die zijn opgesteld door de OIE (Office Internationale des Epizooties). Deze
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regels stellen dat een varkenspopulatie met de hoogste gezondheidsstatus (wat
varkenspest betreft) bestaat uit niet-besmette, niet-gevaccineerde dieren. Landen of
gebieden die deze status hebben, kunnen import van varkens of varkensproducten
weigeren uit gebieden zonder deze status, en dus biedt de status een economisch
voordeel. Het gevolg van dit beleid is dat eventuele introducties van KVPV tot grote
problemen kunnen leiden omdat de volledige varkenspopulatie vatbaar is. Het is
zaak om binnen dit beleid tot optimale bestrijdingsstrategieën te komen.
Hoewel vaccinatie als bestrijdingsmaatregel tijdens epidemieën volgens de EU-
wetgeving nooit verboden is geweest, is het nooit toegepast. Immers, om de hoogste
gezondheidsstatus weer te bereiken hadden in zo’n geval alle gevaccineerde dieren
weer moeten worden geruimd, wat de zin van vaccinatie op zijn minst twijfelachtig
zou hebben gemaakt. Ook een alternatieve regeling waarin gevaccineerde dieren
alleen binnen de EU worden geconsumeerd, werd als een te groot risico beschouwd,
omdat vaccinatie de KVP-detectie zou bemoeilijken. De ELISA (antilichaamtest)
die gebruikt werd om gebieden infectievrij te verklaren reageert namelijk ook
positief op serummonsters van gevaccineerde dieren, waardoor een gedegen
screening op aanwezigheid van KVPV onmogelijk werd.
Om dit detectieprobleem te omzeilen, is in de jaren ’90 gewerkt aan de
ontwikkeling van zogenaamde markervaccins. Dit zijn vaccins waarin één of meer
(stukjes van) eiwitten van het virus ontbreken, waardoor een infectie met het
werkelijke virus kan worden opgespoord door te testen op antilichamen tegen deze
ontbrekende stukjes. Dat gebeurt met een discriminerende ELISA-test. Twee
markervaccins zijn momenteel voorhanden, beide bestaand uit alleen het E2-eiwit
van het virus. De bijbehorende discriminerende test (de Erns-ELISA) reageert op
antilichamen tegen het Erns-eiwit.
Het gebruik van een E2-markervaccin
Het inzetten van vaccinatie als bestrijdingsmaatregel is natuurlijk alleen maar nuttig
als het de verspreiding van het virus voldoende remt. Een zinvolle maat voor de
virusverspreiding is het begrip ‘basaal reproductiegetal’ of ‘basic reproduction
ratio’, dat wordt weergegeven door de letter R. De R is gedefinieerd als het aantal
individuen dat gemiddeld door één typisch besmet individu wordt geïnfecteerd in
een volledig vatbare populatie. Alleen als R groter is dan 1, dus als elk individu
gemiddeld het virus naar meer dan één ander individu doorgeeft, is een epidemie
mogelijk. De R kan worden gedefinieerd op verschillende niveaus, bijvoorbeeld op
individueel dierniveau (Ri: het aantal dieren dat wordt geïnfecteerd door één dier) of
op bedrijfsniveau (Rh: het aantal bedrijven geïnfecteerd door één bedrijf). Een
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effectieve bestrijdingsstrategie zal in staat moeten zijn de Rh onder de 1 te brengen,
want alleen dan zal de epidemie uiteindelijk doodlopen.
Als een vaccin in staat is de Ri onder de 1 te brengen, dan wordt voorkomen dat
KVPV kan spreiden in een gevaccineerd bedrijf, wat ook de Rh onder de 1 zal
brengen. Het is mogelijk te toetsen of Ri daalt als gevolg van vaccinatie met
transmissie-experimenten met KVPV, dierexperimenten waarin geïnfecteerde en
vatbare dieren worden samengebracht en waarin de transmissie van het virus tussen
dieren wordt gevolgd met verschillende diagnostische testen. Deze experimenten
kunnen ook worden gebruikt om Ri te schatten. Dit proefschrift beschrijft eerst een
methode om Ri te schatten en vervolgens enkele transmissie-experimenten waarmee
de effectiviteit van de E2-vaccins is getest.
Het blijkt dat beide vaccins de virustransmissie reduceren, waarbij vanaf drie
weken tot tenminste zes maanden na vaccinatie de reductie maximaal is. De Ri is
dan statistisch significant tot onder de 1 gedaald, wat dus betekent dat op
gevaccineerde varkensbedrijven geen uitbraken meer kunnen plaatsvinden en Rh
kleiner dan 1 zal zijn. Hoewel de vaccins pas na drie weken de Ri onder de 1
brengen, wordt een grote uitbraak op een bedrijf al voorkomen als het virus slechts
één week na vaccinatie wordt geïntroduceerd. Dat is het gevolg van de
tijdsvertraging die optreedt doordat het virus zich eerst moet vermenigvuldigen
binnen een dier voordat het dier nieuwe infecties kan veroorzaken. Hierdoor kan het
eerst geïnfecteerde dier nog wel meer dan één contactinfecties veroorzaken, maar
kunnen deze contactgeïnfecteerde dieren het virus nauwelijks meer verder
verspreiden.
De effectiviteit van vaccinatie van jonge dieren wordt bij veel infectieziekten
gehinderd door de aanwezigheid van maternale antilichamen, antilichamen die de
jongen van de (gevaccineerde) moederdieren krijgen via de melk. Deze antilichamen
kunnen het vaccin ‘wegvangen’, waardoor de reactie van het immuunsysteem van de
jonge dieren vermindert. In een transmissie-experiment, beschreven in dit
proefschrift, kon worden aangetoond dat, ook in het geval van het E2-vaccin tegen
KVP, maternale antilichamen tegen het E2-vaccin de immuunreactie beïnvloeden bij
vaccinatie op twee weken leeftijd: de hoeveelheid antilichamen in het bloed op
latere leeftijd, drie en zes maanden, is lager in dieren van gevaccineerde zeugen dan
in dieren van niet-gevaccineerde zeugen. Vaccinatie blijft echter voldoende effectief,
want ook in maternaal immuun gevaccineerde dieren daalt Ri tot onder de 1.
Omdat vaccinatie van alle varkens op een bedrijf het ontstaan van een grote
uitbraak voorkomt, zal volledige vaccinatie van alle varkensbedrijven zeker leiden
tot een Rh onder de 1, en zal dat dus een effectieve strategie zijn. Er is echter ook een
belangrijk nadeel aan volledige vaccinatie en dat heeft te maken met verticale
transmissie: virusoverdracht van de moederzeug naar de ongeboren biggen. Uit
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experimenten blijkt dat vaccinatie verticale transmissie niet volledig kan
voorkomen. Een eigenschap van varkenspestvirus is dat verticale transmissie kan
leiden tot de geboorte van persistent geïnfecteerde biggen, die immuuntolerant zijn
voor KVPV. Dat betekent dat het immuunsysteem van deze biggen niet reageert op
de infectie, waardoor de dieren gedurende lange tijd veel virus kunnen uitscheiden.
Omdat ze pas na enkele maanden lichte klinische symptomen vertonen, is detectie
op basis van kliniek niet waarschijnlijk. Echter, omdat ze zich normaal gesproken
bevinden tussen veel dieren die wél ziek worden van het virus, zal het getroffen
bedrijf gedetecteerd worden via de contactinfecties die de persistent geïnfecteerde
biggen veroorzaken. Op volledig gevaccineerde bedrijven zijn alle dieren klinisch
beschermd, waardoor geïnfecteerde bedrijven onopgemerkt zouden kunnen blijven.
Het probleem van het niet detecteren van bedrijven met persistent geïnfecteerde
biggen kan worden vermeden door de moederzeugen niet te vaccineren, maar Rh zou
dan nog altijd onder de 1 moeten blijven. Dit is één van de bestrijdingsstrategieën
die getest zijn met een mathematisch model dat de verspreiding van KVPV tussen
varkensbedrijven beschrijft. Het model is een sterke vereenvoudiging van de
werkelijkheid, waarbij alleen de meest essentiële elementen van virustransmissie
zijn opgenomen. Een belangrijke aanname is dat er twee bedrijfstypes zijn, ten
eerste vermeerderingsbedrijven die meer biggen produceren dan afmesten en
derhalve dieren verkopen aan andere bedrijven (mestbedrijven), en ten tweede alle
andere bedrijven, zoals mestbedrijven en gemengde bedrijven. Het eerste type is een
veel groter risico voor verdere virusspreiding dan het tweede type.
Het model geeft aan dat voor een effectieve strategie (Rh < 1) geen vervoer van
niet-gevaccineerde dieren tussen bedrijven mag worden toegestaan, wat in de
huidige bestrijdingsstrategie ook verboden is. Bovendien moet, bovenop alle
maatregelen die door de EU worden opgelegd (zoals hygiënemaatregelen en het
traceren van infectieuze contacten), de transmissie tussen bedrijven tenminste
worden gehalveerd, bijvoorbeeld door minimaal de helft van de bedrijven te
vaccineren. Indien, met uitzondering van de moederzeugen, alle varkens worden
gevaccineerd, dan wordt ruimschoots aan deze minimumeisen voldaan. Wanneer er
tien ongedetecteerde, geïnfecteerde bedrijven aanwezig zijn op het moment dat de
strategie wordt ingezet, dan wordt naar verwachting drie maanden later het laatste
geïnfecteerde bedrijf ontdekt. Het totaal aantal besmette bedrijven komt dan op 16,
inclusief de 10 die er al waren.
Om de resultaten te kunnen gebruiken voor beslissingen in toekomstige
epidemieën, is het nodig te beseffen op welke aannames ze gebaseerd zijn en waar
de essentiële verschillen tussen werkelijkheid en model zitten. Een belangrijke
aanname is de al eerder aangegeven verdeling van de varkenspopulatie in twee
bedrijfstypes waar er eigenlijk meer zijn. Ook is van belang dat alle parameters in
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het model, die de verspreiding van KVPV binnen en tussen bedrijven kwantificeren,
zijn geschat uit de Nederlandse epidemie in 1997 en 1998. Dat betekent dat de
resultaten met name gelden voor gemiddeld varkensdichte gebieden met relatief veel
vermeerderingsbedrijven, en dat ze betrekking hebben op een mild-virulente
virusstam zoals die tijdens de epidemie voorkwam. Tenslotte kunnen in de
werkelijkheid lokale concentraties van varkensbedrijven maken dat de Rh lokaal wat
verhoogd of verlaagd is.
Onderzoek aan een epidemiologische tool
Behalve onderzoek aan bestrijdingsmaatregelen beschrijft dit proefschrift ook het
onderzoek aan een tool, die was ontworpen om tijdens een epidemie te analyseren
hoe het met de bestrijding loopt. Deze tool bestaat uit een zeer eenvoudig model
voor de verspreiding van KVPV tussen bedrijven. Het zou kunnen worden gebruikt
om, met behulp van gegevens uit de lopende epidemie, Rh te schatten en om het
aantal nog niet gedetecteerde geïnfecteerde bedrijven te schatten. De gebruikte
gegevens bestaan enkel uit de aantallen bedrijven, die in elke week van de epidemie
tot dan toe gedetecteerd zijn. Met behulp van gesimuleerde epidemieën op basis van
het verspreidingsmodel is onderzocht hoe goed het model Rh en het aantal
geïnfecteerde bedrijven kan schatten.
Helaas bleek dat het model alleen in staat is om in te schatten of Rh groter danwel
kleiner dan 1 is, maar een preciezere schatting bleek onmogelijk, laat staan dat het
aantal nog geïnfecteerde bedrijven kon worden ingeschat. Om te begrijpen waarom
het model deze schattingen niet kan geven, zal het noodzakelijk zijn wiskundige
studies te doen naar eenvoudiger versies van het model. Om tot die tijd toch nog
lopende epidemieën te kunnen analyseren, zal gebruik moeten worden gemaakt van
extra gegevens, bijvoorbeeld een inschatting van het aantal geïnfecteerde bedrijven
op het moment van de eerste detectie, of een schatting van de gemiddelde tijd tussen
infectie en detectie van een bedrijf.
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Dankwoord
Tegen het dankwoord heb ik het langst opgezien van alle stukken tekst in het
proefschrift. Ik hoop dan ook dat iedereen die op enigerlei wijze tot het
totstandkomen van dit proefschrift heeft bijgedragen zich realiseert dat ik die
bijdrage zeer waardeer.
Mart, zeer intensief is de begeleiding niet altijd geweest, maar meestal vond ik
dat wel prettig. Je gaf namelijk altijd de mogelijkheid tijd op te eisen als ik wilde.
Door jou ben ik ervan overtuigd dat echte wetenschappelijke interesse nooit hoeft te
verdrinken in grote hoeveelheden managementtaken: als het om de inhoud ging, was
je enthousiasme aanstekelijk, en dat maakte je begeleiding echt belangrijk.
Rob, in het maternale-antilichamenexperiment ligt onze duidelijkste
samenwerking, maar tijdens het hele project heb ik via discussies van jouw inzichten
mogen profiteren. Tevens heb jij me betrokken bij al het overige
varkenspestonderzoek op het instituut, wat de breedte van mijn kennis erg goed
heeft gedaan. Het bloedtappen op de Tolakker zal ik niet gauw vergeten.
Jos, buiten het regelmatige overleg heb ik je weinig bij mijn werk betrokken,
maar je oprechte interesse en je vermogen snel de essentie van problemen te
benoemen maakten je begeleiding waardevol.
Jan, ook jou wil ik graag bedanken voor je bijdragen in de totstandkoming van
dit proefschrift.
Met plezier kijk ik terug naar mijn vrijdagochtenden en –middagen in de
Leeuwenborch, voor het STW-overleg. Alle STW-ers wil ik graag bedanken voor de
samenwerking en jullie inbreng in mijn onderzoek, en natuurlijk voor jullie geduld
als ik weer eens te laat was. Mirjam, jij dwong mij af en toe het overzicht over mijn
werk te bewaren, een zeer welkome stimulans. Bij deze dank ik tevens de STW-
gebruikercommissie voor de getoonde belangstelling en het gestelde vertrouwen.
Ook bij QVE hebben veel mensen mij geholpen. Joop en Bas, met veel
problemen en vragen ging mocht ik jullie hulp inschakelen, bedankt. Eerst Arjan en
later Annemarie, met vele praktische vragen over de KVP-epidemie, over
experimenten en over varkenspest in het algemeen kon ik bij jullie terecht, waarvoor
dank. Annemarie, bedankt ook voor je hulp bij mijn schrijfwerk en natuurlijk alle
‘trein’-gesprekken, zowel in als over. Annelie, onze samenwerking heeft mij veel
geleerd en ik kijk er nog graag op terug, dank je wel.
Met mijn transmissieproef hebben me enorm veel mensen geholpen.
Dierverzorgers op de Tolakker, bij DB aan de Edelhertweg en bij DB aan de
Houtribweg, enorm bedankt voor jullie zorg en inzet. De mensen van het
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varkenspestlab wil ik bedanken voor al het werk aan mijn proef, en met name voor
het mij aanleren van diverse technieken. Ook jullie gezelschap tijdens al mijn dagen
‘binnen’ heb ik plezierig gevonden.
Nog verscheidene mensen hebben me in de loop van de tijd geholpen. De
afdeling AIV, Fred van Welie, de bibliotheek en Marian Jonker vanuit Wageningen,
allen hartelijk dank.
De hele QVE-groep wil ik graag bedanken voor een ontzettend leuke werktijd.
De dagelijkse trip naar Lelystad werd een stuk draaglijker met het vooruitzicht dat in
elk geval de pauzes het vroege opstaan al waard waren. Als dan het werk ook nog
een beetje opschoot, was het helemaal mooi. Ook de QVE’ers in Wageningen en
andere ID’ers, o.a. van IPE en I&K, hebben trouwens bijgedragen aan een leuke
periode, waarvoor dank.
De dagelijkse rit naar Amsterdam terug was de moeite waard vanwege het
thuiskomen, eerst bij Marije en later bij Rutger. Ik vertel niet veel over mijn werk,
maar de alledaagse gesprekjes met jullie bij thuiskomst heb ik altijd erg prettig
gevonden. Ook Yuri en vele anderen in Amsterdam bedankt: jullie hebben mij elke
dag weer drie uur doen reizen, simpelweg door niet in Lelystad te wonen.
Nu ik na ruim 28 jaar ook eindelijk de schooltas aan de vlaggenstok mag hangen,
dank ik nog Maurice, Lucienne, Joy en andere vrienden en familie die mijn leven
compleet maken. En tenslotte, lieve vader en moeder, jullie dank ik voor alles wat ik
heb mogen leren; jullie steun was en is onmisbaar.
Curriculum Vitae
Ik ben geboren op 28 februari 1975, in Apeldoorn. Ik heb in Apeldoorn gewoond tot
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Gymnasium Apeldoorn, in Apeldoorn. Vervolgens ben ik (in 1993) Medische
Biologie gaan studeren in Amsterdam, aan de UvA-faculteit der Biologie. In 1998
slaagde ik voor mijn doctoraalexamen. In datzelfde jaar ben ik begonnen als
onderzoeker in opleiding (OIO), in dienst bij de Stichting Technische
Wetenschappen en werkend bij het Instituut voor Dierhouderij en Diergezondheid
(ID-DLO, thans ID-Lelystad), bij het cluster Kwantitatieve Veterinaire
Epidemiologie. Tijdens dit dienstverband heb ik het onderzoek gedaan dat
beschreven is in dit proefschrift.
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